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ABSTRACT 
  
 Guanine nucleotide exchange factors (GEFs) regulate and organize diverse 
cellular processes through their role in converting GTPases from the inactive GDP bound 
state to the active GTP bound state.  An increasing number of GEFs undergo 
autoregulatory mechanisms through complex intramolecular interactions.  Relief of 
autoinhibition involves specific phosphorylation or binding to lipid and/or effector 
proteins at sites distal from the catalytic domain, and is often coupled to membrane 
recruitment.  In Cytohesin Arf GEFs, the catalytic Sec7 domain is autoinhibited by a 
linker region and C-terminal helix flanking a Pleckstrin Homology (PH) domain.  Upon 
binding of the PH domain to low abundance phosphoinositides, the GTPase Arf6-GTP 
can both relieve autoinhibition and recruit Cytohesins to the plasma membrane.  This 
thesis focuses on determining the molecular mechanism underlying both these functions. 
The structural mechanisms by which Arf6-GTP binding relieves autoinhibition 
were studied using biochemical and crystallographic studies.  The crystal structure of the 
Grp1 PH domain in complex with Arf6 revealed that Arf6-GTP binding relieves 
autoinhibition through competitive sequestration of the inhibitory elements into grooves 
formed at the periphery of the interface.  Importantly, the interaction orients all known 
membrane targeting components to a common surface.  Detailed biochemical studies 
showed a common mode of binding among Cytohesin family members in which 
phosphoinositide head group binding primes the interaction with Arf6, and membrane 
recruitment of both stimulatory and substrate Arf enhances the effect. 
v
To assess changes in the Sec7 domain conformation upon activation, Size 
Exclusion Chromatography in line with Small Angle X-Ray Scattering (SEC-SAXS) was 
performed.  The unique nature of this data led to the development of a novel data analysis 
and processing strategy.  A graphically based, python-extensible software package was 
created for data normalization, buffer correction, Guinier Analysis, and constant 
background subtraction.  As an unbiased substitute for traditional buffer subtraction, a 
method to reconstruct the protein scattering through singular value decomposition (SVD) 
and linear combination of the basis vectors was developed.  These methods produced 
exceptional data quality and allowed versatility for application to other data collection 
techniques or systems, especially those lacking confident buffer matching or low signal. 
SEC-SAXS confirmed the overall structure of autoinhibited Grp1 in solution and 
showed only slight overall changes upon activation by deletion of the autoinhibitory C-
terminal helix.  Fusion of Arf6 with Grp1 produced a consistently elongated shape in the 
active state that was incompatible with the autoinhibited or theoretical active positions of 
the Sec7 domain.  Monte Carlo and rigid body modeling using known structural domains 
revealed a requirement for Sec7-PH linker flexibility in addition to Sec7 domain 
mobility.  These data support an integrated structural model whereby phosphoinositides 
and Arf-GTP support nucleotide exchange at membranes through allosteric activation, 
membrane recruitment, and large-scale rearrangement of the Sec7 domain.  Overall, these 
findings offer insight into Cytohesin function that can be applied to assess relief of 
autoinhibition in the context of other GEFs and GTPases. 
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nucleotide exchange factors.” Proceedings of the National Academy of Sciences, 
USA. 2013 Aug 27;110(35):14213-8 
 
Andrew Malaby did all biochemistry, crystallization, and structural refinement 
described and Dr. Bert van den Berg collected synchrotron diffraction data.  Dr. 
David Lambright helped with design of the membrane targeting model. 
 
CHAPTERS III and IV are in preparation for a unified publication.  For clarity, they are 
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the biological system.  The development of the software package DELA and its use for 
SAXS data processing is described in part in: 
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donated from the lab of Dr. Craig Roy.  Dr. Jonathan DiNitto generated plasmids 
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CHAPTER I: INTRODUCTION 
 
Abstract 
 Membrane trafficking is an essential process in eukaryotes.  Throughout the cell, 
GTPases act as molecular switches and organizers of these events through their ability to 
couple membrane localization and recruitment of effector molecules with a nucleotide 
cycling mechanism.  Nucleotide binding and thus effector function are elegantly 
regulated through structural mechanisms that allow selectivity of diverse effectors for 
specific nucleotide states.  One key example of GTPases is the Arf family, which controls 
membrane traffic at both internal organelles and the cell periphery.  These and other 
GTPases require diverse effector molecules to facilitate nucleotide exchange and 
hydrolysis. 
 Sec7 family guanine nucleotide exchange factors (GEFs) and Arf GAP family 
GTPase activating proteins (GAPs) control nucleotide cycling process through well 
studied mechanisms of GDP-GTP exchange and GTP hydrolysis.  In addition to catalytic 
domains, many GEFs and GAPs have membrane binding and regulatory domains to 
organize events at particular cellular locations.  Membrane binding domains such as the 
PH domain have evolved for specialized recognition of phosphoinositides that 
incorporates binding of diverse species through variable geometries.  Autoregulatory 
interactions serve to modulate catalytic activity based on specific protein or membrane 
interactions.  Autoregulation provides key integration of GTPase, effector, and membrane 
inputs and may represent a unified theme in the organization of complex trafficking 
networks into more discrete pathways for cellular function. 
1
Membrane trafficking and disease 
 The packaging and traffic of cellular components between various organelles is 
vital to cellular homeostasis and function. Channel components functioning at the cell 
periphery, for example, need to undergo trafficking from the endoplasmic reticulum (ER) 
to the plasma membrane (PM).  Similarly, protein receptor levels at the PM are 
continually adjusted by endocytosis of receptors and subsequent recycling or degradation 
(Figure I.1).   
 Due to the complexity of cellular transport, a wide range of disease states occur 
when trafficking is compromised by defects in the cargo molecules, defects in the 
trafficking molecules, or external infection [1-4]. For example, mutation of the insulin 
receptor gene results in decreased trafficking of receptors to the cell surface and therefore 
widespread insulin resistance associated with diabetes [5].  Mutations in the dynein 
motors which create movement on scaffold microtubules can cause developmental 
defects in the lungs and neurons [6].  Additionally, bacterial pathogens such as 
Legionella pneumophila hijack host trafficking pathways by injecting competing 
trafficking proteins into the cell, avoiding degradation by the cell’s defense mechanisms 
and fostering widespread proliferation of the infection [7, 8]. 
 The wide spectrum of disorders from defects in transport is evidence that 
trafficking is a complex process for homeostatic regulation and specialized function as 
might be the case upon hormone stimulation.  Myriads of on-off interactions at all 
membrane bound organelles, each a unique milieu of diverse membrane compositions 
and internal cargo, have to be coordinated for efficient, dynamic transport of materials.  
2
 
 
 
 
 
 
 
 
Figure I.1: Cellular Trafficking.  Schematic representing steps of endocytosis and 
exocytosis.  ER, Endoplasmic Reticulum; TGN, Trans Golgi Network; ERGIC, ER-Golgi 
Intermediate Compartment    
3
Spatiotemporal organization comes from an incredibly large array of proteins with 
versatile, but also regulated function at every key step in the process 
 
GTPases as Molecular Switches and Organizers of Cellular Trafficking 
 
The GTPase Cycle 
Membrane trafficking requires versatile but regulated effector binding to effect 
widespread changes.  One group of molecules serving this function is small GTPases, 
which serve as molecular switches by binding to either guanosine diphosphate (GDP) or 
guanosine triphosphate (GTP).  The GDP-bound state is considered inactive, whereas the 
GTP-bound state is the “active” state capable of binding classical effectors to promote 
cellular trafficking events (Figure I.2A).  Besides controlling effector binding, nucleotide 
state also plays a role in membrane recruitment of some GTPases [9, 10]. 
 The nucleotide state of GTPases is actively regulated.  To overcome slow intrinsic 
kinetics for nucleotide exchange, the cell uses guanine nucleotide exchange factors 
(GEFs) and GTPase Activating Proteins (GAPs).  GEFs activate GTPases by facilitating 
GDP release, allowing GTP to bind.  GAPs increase the intrinsic levels of hydrolysis of 
GTP to GDP on the protein [11].  Further regulation comes from GDP or GTP-specific 
effectors that can sequester or recruit GTPases as well as complex regulation of GEF and 
GAP function which will be focused on in subsequent sections [12, 13]. 
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Membrane Recruitment of GTPases 
In addition to their roles as molecular switches, GTPases facilitate cellular 
trafficking through transient recruitment to membrane environments via post-translational 
addition of fatty acid and/or prenyl groups.  Although the nature and location of the 
specific modifications varies greatly, each modification cooperates with other factors 
such as membrane insertion elements to provide stable membrane attachment [14].  For 
example, the protooncogenic kinase Src is stabilized at membrane environments through 
a polybasic region as well as a myristate group at the N-terminus [15-19], and the 
GTPases N-and H-Ras use both C-terminal farensylation as well as palmitoylation for 
membrane docking [20, 21]. 
Fatty acid or prenyl attachments to the membrane can be controlled in multiple 
ways.  Palmitoylation is controlled by expression, localization, and activity of palmitoyl 
acyltransferases (PATs) and depalmitoylases.  In the case of Ras GTPases, expression of 
PATs in the Golgi and depalmitoylases at the PM membrane coordinate regulation of the 
GTPase distribution in the cell.  Prenyl modifications can be stably associated with 
membranes until extraction by effector molecules.  A notable example of this is 
membrane extraction of Rab and Rho GTPases by GDI (guanine nucleotide dissociation 
inhibitor) through sequestration of geranylgeranyl groups on the GTPase [14].  Although 
Rab GEFs are essential and sufficient for membrane targeting upon activation in many 
cases, in other cases, other Rab effectors contribute, such as GDF (GDI displacement 
factor), which competitively binds GDI [22]. 
5
 
 
 
 
 
 
 
Figure I.2: The GTPase Cycle.  A) Schematic of the GTPase ‘molecular switch’ in which 
GDP or GTP bound states control effector binding.  B) Schematic of Arf GTPases as 
organizers of membrane traffic.  Arf GTPases can recruit primary and secondary 
effectors onto membrane environments, localizing trafficking signals to sites of GTPase 
activation. 
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The use of membrane anchoring switches is a key way GTPases can use 
nucleotide cycling to act as organizers of cellular transport.  This is exemplified by the 
myristoyl switch in Arf GTPases (Figure I.2B).  Unlike other fatty acid modifications, 
myristoyl groups are permanently attached to an amphipathic helix via N-myristoyl 
transferases, as no mammalian demyristoylase has been identified to date [23].  To 
regulate membrane association, the helix is sequestered in the GDP bound state and 
exposed when bound to GTP, promoting insertion of the hydrophobic group into the 
membrane [24].  Association with membranes allows organization of many factors at 
sites of action. 
 
GTPase Networks. 
In addition to transducing signals through membrane attachments at specific 
locations, GTPases often are involved in coordination, amplification, and crosstalk 
among or between trafficking steps in GTPase networks, first clearly demonstrated in 
Rab GTPases (Figure I.3) [12].  Coordination of multiple steps can be achieved by a 
GTPase recruiting the GEF or GAP for a downstream GTPase.  An example is in 
exocytosis from the Golgi, in which subsequent secretion in yeast is coordinated by the 
GTPase Ypt31/32 and continued on secretory vesicles by another GTPase Sec4, a Rab8 
homolog.  Ypt32 coordinates these processes by recruiting Sec2, the GEF for Sec4 [25].   
Importantly, Sec2 is not a GEF for Ypt32, confirming coordination rather than 
competition of these GTPases.  Similarly, in endocytosis from early to late endosomes, 
the early endosome GTPase Rab22 recruits the Rab5 GEF Rabex-5, which in turn can 
7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure I.3: GTPase networks.  Examples of GEF or GAP cascades in which the GEF or 
GAP for one GTPase recruits a GEF or GAP for the sequential GTPase.  Left) Feedback 
loop in which an active GTPase stimulates it’s own GEF..  
8
recruit the GEF complex for the late endosome GTPase Rab7 [26-28].  These “Rab 
cascades” for GEFs and GAPs have since been extended to other GTPase families at 
many cellular compartments [12]. 
In select cases, feedback loops have emerged to amplify or terminate signals 
within GTPase networks.  These loops highlight GTPases as central directors of 
widespread cellular processes rather than simple checkpoints for specialized downstream 
functions [29].  The oncogenic Ras GTPase and its GEF Son of Sevenless (Sos) typify 
this phenomenon.  Ras activation promotes recruitment and activity of Sos to specific 
plasma membrane environments [30].  As will be expanded on further, Arf6 and Arl4 
GTPases recruit Cytohesin family GEFs to the plasma membrane for increased Arf6 
activation implicated in cell proliferation, actin rearrangement, and endocytosis among 
other processes [31, 32].  In this way, signals from even small amounts of Arf6 activation 
such as from the Arf6 specific GEF EFA6 would be amplified through downstream 
effects of the activated GTPase [29, 33]. 
Finally, current evidence suggests that many GTPases function in crosstalk 
between pathways often defined by nucleotide-state specific binding.  Besides acting in a 
feedback loop in the GTP-bound state as mentioned above, Arf6 in its GDP bound state 
recruits the Rac GEF Kalirin5 to the plasma membrane, with subsequent activation of 
both GTPases leading to cytoskeletal rearrangement and membrane ruffling [34, 35].  
And more recently, Rab35 has been shown to promote Arf6 deactivation by recruiting the 
ArfGAP ACAP1 [36, 37]. 
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Arf GTPases 
 Arf GTPases are members of the Ras superfamily of small GTPases and include 
five Arfs and over 20 Arf-like (Arl) and Sar proteins in mammals [10, 38].  Within this 
larger family, the Arfs fall into three classes, Class I (Arf1/3), Class II (Arf4/5), and Class 
III (Arf6) based on sequence homology.  Arl proteins and most Sar family members are 
less well characterized and have not been grouped according to sequence or functional 
homology. 
 Arfs function in a variety of cellular pathways and are localized throughout the 
cell (Figure I.4), but share unified functional themes of recruiting coat proteins and 
activating lipid remodeling enzymes [39-41].  Arf1 functions at Golgi and endosome 
membranes to initiate vesicle budding by recruitment of coat proteins COPI and Adaptor-
Protein (AP-1, AP-3, and AP-4) and GGA protein coat complexes [42, 43].  It also can 
activate phosphatidylinositol 4- and 5-phosphate kinases (PI4K, PI5K) at the Golgi to aid 
in actin rearrangement and polymerization [44].  While Arf3, Arf4, and Arf5 all 
contribute to inter-Golgi transport [41], Arf4 also has a unique role in the development of 
primary cilia by undergoing an essential interaction with rhodopsin and another protein 
complex for efficient transport of rhodopsin to the rod outer segment [45, 46]. 
Arf6 is unique in that it acts as a key regulator in large scale dynamic changes at 
the plasma membrane such as actin rearrangement, cell migration, cytokinesis, and 
tumorogenesis [36, 47-50].  One of the most well studied roles of Arf6 is in rapid and 
widespread endocytosis at the plasma membrane.  By enhancing activity of two key lipid 
remodeling enzymes phospholipase D (PLD) and PI5K, Arf6-GTP enhances both clathrin 
10
 
 
 
 
 
 
Figure I.4: Cellular Localization of Arf family GTPases.  Specific roles of Arf4 and Arl3 
in retina cell trafficking to the rod outer segment (ROS) are indicated. ER, Endoplasmic 
Reticulum; ERGIC, ER-Golgi Intermediate Compartment. 
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mediated (CME) and clathrin independent endocytosis (CIE) [51-54].  Additionally, Arf6 
further regulates CIE through interactions with adaptor proteins, which require 
deactivation of Arf6 for full internalization of the vesicle cargo.  Arf proteins 
communicate such diverse changes through a conserved mechanism of nucleotide 
switching. 
 
Arf structural elements and nucleotide binding: 
 Arf and Arl GTPases consist of a core domain architecture conserved across the 
Ras superfamily of over 150 proteins  (Figure I.5) [55-57].  Within its compact structure 
is contained a minimal G domain for binding nucleotide and structural ‘switch’ regions 
termed switch 1 (SW1), interswitch (ISW), and switch 2 (SW2) flanked by N- and C-
terminal regions primarily used to localize the molecule to membrane environments [58].   
The G domain includes five consensus motifs spanning the primary sequence that wrap 
around the guanine nucleotide (Figure I.6A).  At the base, the N/TKXD motif coordinates 
the guanadynyl ring and an alanine in the C/SAK/L/T motif affords specificity for 
guanine over adenine through main chain hydrogen bonding with the carbonyl oxygen 
allowed by the small size of the alanine side chain.  The ‘P-loop’ GXXXXGKS/T motif 
anchors the phosphate groups through hydrogen bonding of the glycine and coordinates a 
Mg2+ cofactor at the S/T residues.  The aspartic acid side chain in the DXXG motif 
coordinates the Mg2+ through a water mediated hydrogen bond, and a T consensus motif 
hydrogen bonds with both the Mg2+ and the gamma phosphate of GTP in the active state. 
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Figure I.5: Domain Architecture and Sequence Conservation of Arf Family GTPases.  
Switch regions and terminal regions contributing to membrane insertion are colored and 
labeled as indicated.  SW1, Switch I, ISW, interswitch, SW2, Switch II.  Sequence 
identity of family members with Arf1 or Arf6 was calculated with Clustal Omega [56-
57].  
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Figure I.6: Arf GTPase Structural Elements A) The nucleotide binding pocket of Arf 
GTPases.  The superimposed Arf6-GTP (PDB ID 2W83) and Arf-GDP (PDB ID 1E0S) 
structures showing sequence motifs from Arf6-GTP and Mg2+, nucleotide, and DXXG 
motifs from Arf-GDP. B) Superposition as in A highlighting switch and N-terminal 
regions. 
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 Included in and adjacent to the nucleotide binding site, the switch regions are so 
named because they switch between two distinct conformations in GDP and GTP bound 
forms (Figure I.6B) to propagate the GDP to GTP signal from the nucleotide binding 
pocket to the rest of the molecule and are thus the sites for effector recognition.   They 
consist of the switch 1 (SW1), interswitch (ISW), and switch 2 (SW2) regions.  The Arf 
family has a largely conserved sequence and structure within the switch regions, with a 
notable exception being the Arl4/6/7 subgroup containing a five residue insertion in the 
interswitch region [59]. 
 Structural studies of GDP and GTP bound Arf proteins have elucidated how 
changes in nucleotide state cause widespread effects through conformational 
rearrangement [24].   In the Arf6-GDP bound structure, the aspartic acid in the DXXG 
motif mimics the gamma phosphate of GTP and docks the SWI and DXXG regions in 
positions incompatible with nucleotide binding.   The interswitch and SWII regions are 
locked into their orientation by a tryptophan clamping interaction with the core.  The N-
terminal helix docks in a hydrophobic pocket formed at the top interswitch, sequestering 
it from membrane insertion.  Upon binding to GTP, the aspartic acid is reoriented, 
allowing nucleotide binding of SWI and the DXXG motifs.  The SWII region is docked 
into a new position by a hydrogen bond network coordinated by the tryptophan clamp 
and an arginine.  Interestingly, the ISW undergoes a 3 angstrom (Å) ‘interswitch toggle’ 
which promotes an extended conformation competent for membrane insertion. [59]. 
The change in ISW structure upon nucleotide cycling is unique to Arf family 
GTPases, as other GTPases show no change in this region as compared in GDP and GTP 
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bound structures.  The interswitch toggle is presumably conserved in all Arf family 
members except Arl4, Arl6, and Arl7, which have longer ISW regions.  Additionally, 
recent evidence supports the idea that structural rearrangements such as the toggle 
involved in nucleotide cycling are aided by both effector-mediated as well as spontaneous 
membrane docking, seamlessly connecting GDP-GTP structural rearrangements and 
membrane recruitment [60, 61]. 
 
Arf Effector Binding 
 As shown in Figure 1.2, the GTPase cycle determines binding of Arf GTPases 
with various effectors.  These protein interactions by definition do not change the 
nucleotide state of the Arf, but instead serve to either sequester the GTPase or aid in 
general signaling pathways through domains outside of the Arf binding motif.  Although 
specific effectors for the GDP bound form of Arf GTPases have been demonstrated [34, 
35], the most well studied class is the classical GTP bound effectors.  A great deal of 
structural evidence points to a common hydrophobic area (CHA) on Arfs similar to that 
observed in Rabs that allows binding with very diverse molecules on the largely 
conserved surface while maintaining sensitivity to nucleotide states (Figure 1.7a and b) 
[62, 63].  The CHA (Figure 1.7c) includes key residues at the junction of SW1, ISW, and 
SW2 which form a deep hydrophobic pocket studded with three conserved residues 
termed the ‘hydrophobic triad’.  Most effector molecules studied to date form lock and 
key interactions by burying non-polar residue side chains in the pocket.  In contrast, 
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Figure I.7: Arf:Effector Specificity Determinants A) Sequence alignment of Arf isoforms. 
B) Conservation analysis within Arf switch regions.  Structure is Arf6-GTP (from PDB 
ID 4KAX) with cartoon colored as in A.  Surface coloring represents scores in a 
BLOSSUM62 substitution matrix between Arf6 and Arf1 sequences.  C) Structures of 
Arf-GTP bound to the effectors JIP4, Cholera Toxin (CT), GGA, or Golgin345 proteins.  
Only relevant portions of effectors are shown for clarity.  Arf6 and Arf1 effectors are 
represented as ribbon/sphere and cartoon, respectively. 
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epitope of the effector main chain backbone with the triad are not conserved in 
Arf:effector complexes. 
These conserved features in the CHA complement other non-conserved elements 
shown to be instrumental in selective binding of effectors to particular Arf members.  As 
shown in a conservation map between the two most divergent Arf family members Arf1 
and Arf6 (Figure I.7A), of the ten substitutions between these proteins in and proximal to 
the switch regions, seven residues at the edges of the switch region and in the upper 
portion of the interswitch β-sheets are plausibly involved in Arf selectivity when 
considering the key CHA.  Specificity determinants have been well documented in the 
crystal structure of Arf6-GTP in complex with an effector JIP4, important in essential 
endosome trafficking during the completion of cytokinesis [64, 65].  The dimeric leucine 
zipper motif of JIP4, lays across the Arf6 switch regions, engaging poorly conserved 
residues Thr 53, Lys58, Asn60, and Thr79 while excluding interaction with the 
hydrophobic pocket.  Substitution of the analogous residues in Arf1 to the Arf6 
equivalents resulted in JIP4 binding equal to that observed with Arf6. 
Although these and other results suggest Arf specificity can arise solely from 
sequence differences [66], it is not clear whether exclusion from the Arf hydrophobic 
pocket and engagement of non-conserved residues represents a common mode for all 
Arf6 effectors or a specialized case of Arf6 discrimination.  For example, the interaction 
with Cholera Toxin (CT) from which the Arf proteins were first identified [67] occurs 
with multiple Arf proteins, and although the Arf6-CT structure identified a binding 
epitope excluding the hydrophobic pocket similar to the Arf6-JIP4 structure, it is shifted 
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dramatically away from the nonconserved switch region residues [68].  In general, 
specificity of Arf effectors has not been studied comprehensively, and some have been 
shown to interact with specific isoforms through coincidence detection of other lipid or 
protein interactions [69-74].  As will be expanded upon, specificity within Arf dependent 
cell signaling events seems to involve a mixture of strict biochemical selectivity for 
specific protein-protein recognition as well as colocalization of the proteins at 
membranes. 
 
Membrane Recruitment of Arf GTPases 
Arf family GTPases associate with membranes through regions flanking the core 
G domain (Figure I.5).  The N-terminus consists of an amphipathic helix that can orient 
into membrane bilayers based on hydrophobicity.  Additionally, all Arfs and many Arls 
are myristoylated at the 2-Gly position, and other Arl proteins are acetylated [10].  In 
Arfs, this modification aids in docking of the helix into the bilayer through insertion of 
hydrophobic sides chains and myristoyl moiety [23].  This association is dynamic within 
the membrane space, and allows for independent movement of the N-terminus and G 
domain [60, 61].  In addition, some Arl proteins also contain C-terminal basic regions for 
membrane attachment.  All isoforms of Arl4, for example, localizes to the plasma 
membrane in the active state, and mutation of the myristoylation site or truncation of the 
C-terminal polybasic region decreased this effect [75]. 
Arf membrane recruitment is coupled to nucleotide state, and in all cases studied 
to date Arf-GTP is more stably associated with membrane environments than Arf-GDP.  
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This fact coupled with the discovery of a buried N-terminus in the Arf–GDP crystal 
structures originally led to the idea that Arf GTPases were strictly excluded from 
membranes until activated [23, 76].  However, key biochemical, cell biological, and 
structural experiments have shown that the amphipathic helix can mediate association 
with membranes in the GDP-bound state [77].  Recently, nuclear magnetic resonance 
(NMR) studies of Arf1 bound to lipid bicelles have clarified association determinants 
[60, 61].  In the GDP-bound structure, the N-terminal amphipathic helix adopted a highly 
flexible structure and showed measureable bilayer association even in the absence of 
myristoylation.  Increased association occurred in the GTP-bound state coinciding with a 
more rigid position of the slightly elongated helix, although approximately 90° mobility 
was still possible.  Importantly, membrane binding of Arf-GDP brought about structural 
changes in the switch regions.  Additionally, a groove speculated to be the myristoyl 
group binding pocket in the Arf-GDP structure was covered in the GTP-bound structure 
by residues in the interswitch loop undergoing the toggle register shift during nucleotide 
exchange.  Together this evidence suggests that nucleotide exchange and membrane 
recruitment follow concerted rather than sequential mechanisms and define the role for 
amphipathic helix insertion in membrane recruitment. 
 
Arf GEFs and GAPs 
 GTPases undergo intrinsic GDP-GTP exchange and hydrolysis that is accelerated 
by GEFs and GAPs, respectively.  Arf family GTPases are activated by the Sec7 family 
of GEFs, which all have a conserved mechanism for nucleotide release [78, 79].  While 
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there are 15 Sec7 family GEFs, there are over 30 mammalian Arf GAPs.  Arf GEFs and 
GAPs can be broadly grouped into large and small members based on size and 
architecture.  The small GEFs have a simplified architecture with minimal features 
outside of the catalytic domain, and large family members typically include diverse 
regulatory features essential for coordinating and regulating cell signaling at sites of 
action. 
 
Sec7 Domain GEFs: 
 Sec7 domain GEFs are so named due to the presence of a catalytic domain 
analogous to the Sec7p in yeast [80, 81].  The Sec7 family consists of GBF/BIG, EFA6, 
BRAG/IQ, Fbox, and Cytohesin subfamilies [78].  Although all of these proteins studied 
to date have measured GEF activity, the specificity of these enzymes for the Arf isoforms 
is not well understood.  EFA6, for example, has clear preference for Arf6 over Arf1, 
whereas Cytohesin GEFs may be quite promiscuous in vivo, despite showing higher 
activity for Arf1 in solution [33, 82].  These GEFs may activate specific Arf isoforms 
through colocalization at membrane compartments via regulatory protein or membrane 
binding domains. 
Sequence conservation and structural studies of Sec7 domains have shown a 
highly conserved α-helical protein fold [59, 83-88].  The Arf interface can be separated 
into a seven member superhelix binding the SW1 region and a three helix bundle binding 
the ISW and SW2 regions (Figure I.8).  Structural studies using the Cytohesin family 
member ARNO in intermediate stages of nucleotide exchange have revealed the mode of 
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Figure I.8: The ARNO Sec7 Domain in Complex with Arf-GDP.  The structure of the 
ARNO Sec7 domain in complex with Arf1-GDP (PDB ID 1R8S).  Regions of interest are 
highlighted as indicated.  The mutation of the catalytic Glu in the Sec7 domain and the 
catalytic Gln for hydrolysis in Arf1 are represented in sticks. 
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interaction with substrate Arf and the catalytic mechanism by which GDP is released [79, 
89].  Arf-GDP forms an extensive interface with the Sec7 domain in which the 
interswitch region adopts its GTP-bound conformation.  A key structural element termed 
the glutamic acid finger inserts into the β-phosphate site on the Arf molecule.  Mutation 
of this residue to a lysine abolishes GEF activity by stabilizing the Arf-GDP complex 
[89].  Additionally, a Sec7 αF/αG loop aids in nucleotide release by competitive binding 
to SW1 residues involved in phosphate and Mg2+ binding.  Displacement of the 
nucleotide is stabilized by large rearrangements in the switch regions favoring a 
nucleotide free state of the Arf [79].  After release of the GDP, the excess of GTP in the 
cytosol favors completion of GDP-GTP exchange. 
 
GAP catalysis  
Arf GAPs fall into ten classes all containing a canonical GAP domain [90, 91].  
Although structural evidence for these proteins is limited, structures of the catalytic 
domains alone or in complex with Arf-GTP or transition state mimetics have shown a 
conserved domain structure but potentially diverse catalytic mechanisms [92-95].  An 
initial structure of ArfGAP1 in complex with the Arf1-GDP showed the catalytic domain 
only contacting the SW2 region of the substrate, and no catalytic residues in the 
nucleotide binding pocket, suggesting a mechanism different than Ras GAPs whereby the 
GAP accelerates hydrolysis by stabilization of SW2 possibly in association with other 
proteins [95].  In contrast, the structure of ASAP3 with Arf6 in the GDP-ALF3 transition 
state mimetic showed a flipped orientation of the GTPase with full engagement of both 
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the SW1 and SW2 regions and an ‘arginine finger’ protruding into the nucleotide binding 
site.  Unlike other GAPs however, an additional aspartic acid acts to stabilize the Arf 
DXXG motif and facilitate phosphate cleavage, with the arginine stabilizing the transition 
state.  Finally, ASAP3 and other ASAP family members were shown to be regulated by 
Ca2+ interactions at SW2 [92].  This suggests a possible divergence of catalytic 
mechanisms among Arf GAP members. 
Studies to date regarding the substrate recognition by the ArfGAP domain have 
been complicated by exclusion of external domains known to play key roles in functional 
specificity in vivo.  Examples include ankirin repeats in the ACAP subfamily of Arf 
GAPs that bind vesicle cargo, COPI binding sites in ArfGAP1, and PH and BAR 
domains that bind membranes in the ASAP subfamily [90].  It is therefore not surprising 
that, as with Arf GEFs, only weak determinants of Arf-GTP substrate specificity in Arf 
GAPs have been demonstrated.  As is the case with GEFs, functional specificity of Arf 
GAPs in vivo may often be controlled as much by colocalization via protein-protein or 
protein-lipid interactions of domains outside the catalytic domain as by minor sequence 
differences in the catalytic core. 
 
Membrane Binding Domains in GEFs and GAPs 
Whereas localization to membranes for GTPases is primarily through external 
lipid attachment and membrane insertion, GEFs and GAPs often couple membrane 
insertion elements like basic helices with large membrane binding domains (MBDs).  A 
consensus is developing that binding of MBDs and other insertion elements directly 
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contribute to the organization of trafficking events not only by recognizing low 
abundance membrane components that are upregulated at specific locations or times but 
also by sequestering lipids and defining the polarity of vesicles.  Additionally, multi-
domain GEFs and GAPs often serve as platforms for other trafficking molecules, 
enhancing the natural accumulation due exclusively to membrane components.  
Moreover, MBDs act in the physical process of membrane deformation by displacing 
outer leaflet lipids to establish curved membrane vesicle precursors [96, 97].  
Phosphatidyl inositol (PtdIns) (4,5)-diphosphate binding of ENTH domains has been 
directly linked to membrane tubulation, defining a possible role for these proteins in 
endocytosis at the plasma membrane [98].  BAR domains, such as the one found in the 
ArfGAP ASAP1, and the ALPS motif in ArfGAP1 use nonspecific curvature-dependent 
interactions for membrane recruitment [99-101]. 
 MBDs involved in membrane trafficking have varied membrane recruitment 
mechanisms.  Some domains such as C2, use nonspecific membrane insertion of basic 
regions into the polar surface of the membrane or hydrophobic regions into the 
hydrocarbon core.  In these types of proteins, membrane insertion can be regulated by 
calcium flux. C1 domains specifically recognize diacylglycerol (DAG) and phorbol 
esters, and are thought to be stabilized by interactions with acidic lipid head groups.  A 
large majority of membrane binding domains like PH, FYVE, PX, and ENTH domains 
can include recognition sites for low abundance phosphoinositides [102-105].  Each 
domain’s structure is evolved for specific function in membrane trafficking.  Since the 
following work focuses on the cytohesin family of Arf GEFs which contain a PH domain, 
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the proceeding will detail this particular domain’s phosphoinositide recognition and 
provide relevant context for further discussion.  
 
Phosphoinositide Recognition in PH domains 
The Pleckstrin Homology (PH) domain is a large family of MBDs, with over 250 
proteins involved in cellular signaling throughout the cell.  They consist of a β-barrel 
structure of seven β-strands with an α-helical ‘cap’ at one end (Figure I.9).  Although this 
basic fold is highly conserved, there is little sequence identity between family members. 
Phosphoinositide binding is mediated through a large electropositive groove in the open 
end of the β-barrel.  A conserved KXn(K/R)XR motif including residues  in and adjacent 
to the β1/β2 loop interacts with one or more phosphate groups.  With such a general 
mode of recognition, and little sequence conservation, it is not surprising that the 
majority of PH domains studied show low selectivity and bind any one of the seven 
occurring possible mono-, bis-, or tris-phosphorylated phosphoinositide species with 
equal affinity [106, 107].  Most PH domains, and MBDs in general, supplement weak 
binding with structural determinants outside the phosphoinositide binding pocket.  In 
some cases however, robust membrane targeting can be achieved almost completely 
through the increased phosphoinositide recognition or direct membrane insertion of the 
PH domain, owing to hypervariable loops extending away from the conserved barrel, 
β1-β2, β3-β4, and β6-β7 loops [106].  Structural studies of particular highly 
discriminating PH domains have been critical to elucidate the mechanisms by which they 
recognize polyphosphoinositides such as PtdIns (3,4)P2, PtdIns(4,5)P2, or PtdIns(3,4,5)P3. 
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Figure I.9: Overall Structure of Representative PH Domains.  Overall structures of PLC1-
δ (A) and Grp1 (B) depicting structural elements as indicated. 
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A wide variety of phosphoinositide recognition modes have been observed in 
these PH domains (Figure I.10). The PLC1-δ PH domain achieves high affinity binding 
through interactions between the 4- and 5-phosphates and Lys 32, Lys 57, and Asn 106 
from each of the three variable loops, forming a structure that precludes 3-substituted 
phosphoinositides (Figure I.10A) [108].  TAPP1 seems to bind PtdIns(3,4)P2 through 
similar means, but lacks any contribution from its β6-β7 loop and has a key alanine side 
chain to block 5-substituted species [109] demonstrating specificity through selectivity 
rather than affinity.  The related protein DAPP1 conversely allows binding of 
PtdIns(3,4,5)P3 through a substitution of this alanine to a glycine (Figure I.10B) [110].   
In addition to these studies, the presence of unique phosphoinositide recognition 
beyond simple affinity differences has been established in structural studies of PH 
domains from the cytohesin family Arf GEFs Grp1 and ARNO.  The phosphoinositide 
binding profiles have been exhaustively studied, and crystal structures have been 
obtained for multiple conserved family members bound to different species of 
phosphoinositide head groups.  Binding studies have shown clear preference for 
PtdIns(3,4,5)P3, which is negated in an alternately spliced form of these proteins resulting 
in a single insertion of a glycine at the beginning of the β1-β2 loop [82, 111-113].  These 
forms are referred to as the diglycine (2G) and triglycine (3G) forms.  Crystal structures 
of 2G and 3G PH domains bound to Ins(1,4,5)P3 or Ins(1,3,4,5)P4 helped explain these 
findings. 
High affinity selective binding of PtdIns(3,4,5)P3 is achieved through a large 
extension of the β6-β7 loop referred to as the hairpin insertion (βi1-βi2).  The crystal 
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Figure I.10: Phosphoinositide Recognition in PH Domains. A) PLC1d structure bound to 
Ins(1,4,5)P3 (PDB ID 1MAI).  B) TAPP1 (PDB ID 1EAZ) and DAPP (PDB ID 1FAO) 
structures superimposed and showing the Ins(1,3,4,5)P4 bound in the DAPP/TAPP 
structure.  The TAPP1 alanine key for selectivity is shown in spheres. C) Grp1 structure 
bound to Ins(1,3,4,5)P4 (PDB ID 1FHX).  D) 3G ARNO structure bound to Ins(1,3,4,5)P3 
(PDB ID 1U27). 
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structures of the 2G Grp1 and 3G ARNO in complex with Ins(1,3,4,5)P4 show 
interactions between side chains in the basic motif, β1-β2 loop, and β3 strand with the 1-, 
3-, and 4-phosphates.  In addition, the presence of the hairpin insertion along with key 
threonine and arginine residues from β1-β2 and β3-β4, respectively, helps create an 
extensive network of interactions to cradle all three substituted phosphates in the binding 
pocket.  Of particular note are interactions of Lys 343 and His 355 in β6-β7 with the 5-
phosphate.  In the 3G form, the extra glycine in the β1-β2 loop causes an overall 
structural change resulting in a loss of main chain hydrogen bonds with the 5-phosphate 
of PtdIns(3,4,5)P3 (Figure I.10C and D) [111, 114, 115]. 
Despite the fact that structural differences between 2G and 3G PH domains affect 
5-phosphate interactions seen in many other PH domains bound to di-substituted 
phosphoinositides, the net effect is only to reduce affinity for PtdIns(3,4,5)P3, as 
Ins(1,4,5)P3 and Ins(1,3,4)P3 are recognized equally well in in vitro experiments [111].  
This led to exploration of other possible binding geometries in phosphoinositide binding.  
A crystal structure with a 3G PH domain in complex with Ins(1,4,5)P3 showed rotated 
orientations of the phosphoinositide head group when compared to Ins(1,3,4,5)P4 to 
accommodate increased interactions away from the β1-β2 loop (Figure I.11A).  This 
organization of the binding pocket would also allow Ins(1,3,4)P3 to dock in a ‘flipped, 
rotated’ position [111]. Using the symmetric Ins(1,3,4,5)P4 orientation seen in multiple 
PH domains as a starting model, one can recognize that PLC1-δ adopts a ‘flipped’ 
position, suggesting that PH domains have structurally diverged for specialized 
phosphoinositide binding properties but maintain generalized functions (Figure I.11B). 
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Figure I.11: Variable Phosphoinositide Binding Geometries in PH domains.  A) Crystal 
structure of the 3G ARNO PH domain in complex with Ins(1,4,5)P3 (PDB ID 1U29).  For 
comparison, the Ins(1,3,4,5)P4 head group from the 3G ARNO PH domain structure 
(PDB ID 1U27) is shown offset after superposition of the two structures.  B, left) 
Ins(1,3,4,5)P4 in Grp1 (PDB ID 1FHX), DAPP1 (PDB ID 1FAO), and ARNO (PDB ID 
1U27).  B, middle) (Ins1,4,5)P3 in ARNO.  B, right) PLC1-d (PDB ID 1MAI).  Structures 
are shown after superposition of PH domains and offset for comparison. Grp1, DAPP1, 
and ARNO Ins(1,3,4,5)P4 molecules are overlaid. 
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 Membrane Insertion by PH domains 
 Although many PH domains can localize to membrane environments through 
phosphoinositide head group binding, phosphoinositide binding is weak or indiscriminate 
in most cases [107], such that phosphoinositide binding alone is insufficient to recruit 
these PH domains to membranes.  Indeed, even in the case of high affinity binders, the 
low abundance of phosphoinositides even in the presence of stimulating factors like 
insulin necessitates additional factors for association.  In at least some cases PH domains 
are localized through protein-protein interactions as well.  For example, FAPP1 PH 
domain simultaneously binds PI(4)P and Arf-GTP [73, 74].  A less well recognized mode 
of PH domain membrane recruitment is direct membrane insertion independent of but 
complementary to phosphoinositide recognition.  Two examples well-studied in 
computational and biophysical experiments are the proteins Akt and Grp1, both of which 
have high affinity for PtdIns(3,4,5)P3. 
Phosphoinositide binding in the Akt PH domain is dependent on a ‘sentry’ 
glutamate located in the β1-β2 loop that forms a bridge across the phosphoinositide 
binding pocket [116, 117].    A Glu to Lys mutation of this residue has been linked to 
ovarian cancer [118] by increasing PtdIns(4,5)P2 affinity, leading to rampant activation of 
the Akt pathway involved in cell proliferation.  Structural rearrangement of the glutamate 
is thought to aid in its direct insertion into the membrane.  A sentry glutamate was also 
identified in Grp1, where membrane insertion seems to be aided by the extra hairpin 
insertion in the β6-β7 loop [119].  Fluorescence Resonance Energy Transfer (FRET) 
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experiments showed association to anionic membranes containing phosphatidylserine but 
absent of PtdIns(3,4,5)P3 later confirmed by microscopy and biophysical measurements, 
pointing to interactions of the β1-β2, β3-β4, and β6-β7 barrel loops in membrane 
docking [120-123].  This was supported in molecular dynamics simulations and detected 
directly through monolayer penetration, dependent on portions of the all three Grp1 
variable loops and enhanced by PtdIns(3,4,5)P3 [124].  These findings suggest a 
mechanism whereby high PtdIns affinity PH domains use nonspecific insertion of their 
loops in a search for rare lipid bilayer species.  Insertion additionally anchors domains 
beyond recognition of single lipid species [125].  Although many PH domains do not 
have large extensions like Grp1, membrane insertion may still play a role in stabilizing 
membrane association after identification of a target phosphoinositide.  
 
Cytohesin GEFs 
Family Expression, Function, and Domain Organization 
 The small Arf GEFs of the cytohesin family consists of Cytohesin-1 (CYTH1), 
ADP Ribosylation Factor Nucleotide Site Opener (ARNO), General Receptor of 
Phosphoinositides (Grp1), and Cytohesin-4.  Of these only CYTH1, ARNO, and Grp1 are 
ubiquitously expressed, with Cytohesin-4 expressed only in blood leukocytes [126].  
Additionally, expression of the diglycine and triglycine splice variants described earlier is 
family member specific.  CYTH1 and ARNO are expressed predominantly in the 
triglycine form, whereas Grp1 and Cytohesin-4 are expressed in the diglycine form. 
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 Cytohesins are recruited to the plasma membrane upon receptor stimulation due 
to upregulation of phosphoinositol-3-OH-kinase (PI3K).  This finding combined with 
their role as GEFs for Arf GTPases implicates them as major players in many cellular 
responses such as cytoskeletal rearrangement, receptor endocytosis, and receptor 
trafficking at recycling endosomes, all of which are dependent on levels of active Arf6 
and PtdIns(3,4,5)P3.  Independent of Arf6 however, connections have been made between 
Cytohesins and insulin resistance by studying the Drosophila cytohesin steppke.  This 
homolog is essential for proper downstream insulin signaling, and knockdown or 
chemical inhibition of cytohesin function results in growth defects and insulin resistance 
[127, 128]. 
The Cytohesin domain architecture consists of an N-terminal Heptad Repeat (HR) 
coiled-coil domain, a catalytic Sec7 domain, a Pleckstrin Homology (PH) domain with 
splice variant dependent specificity for the phosphoinositide PtdIns(3,4,5)P3  and 
PtdIns(4,5)P2 or PtdIns(3,4,5)P3 discussed earlier, and a C-terminal helix (CtH) including 
an 8-10 residue polybasic region (pbr).  Although the Sec7 and PH domains perform 
essential, well-defined roles in Arf exchange and membrane targeting, the heptad repeat 
may also contribute as a scaffolding domain.  As will be expanded upon later, the pbr 
helps form a complex regulatory mechanism for these processes from only minimal 
structural components. 
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Heptad Repeat Coiled-Coil Dimerization 
The N-terminal HR region of cytohesins has been shown to interact with coiled 
coil modules in other proteins such as Grsp1 (Grp1 Signaling Protein), GRASP1 (Grp1 
Associated Scaffolding Protein), and CASP (Cytohesin-1 Associated Scaffolding Protein) 
[129-132].  These heterodimeric interactions, as the protein names imply, may help 
localize cytohesins to specific membrane-protein environments or organize higher-order 
complexes. 
The heterodimeric coiled-coil interaction of Grsp1 is the most well-studied of the 
three and is mediated through a heptad repeat region next to a FERM domain shown in 
some cases to interact with cytoplasmic tails of transmembrane proteins as well as 
PtdIns(4,5)P2 [129].  Grp1-Grsp1 dimers have been immunoprecipitated from cells and 
localize to the plasma membrane upon insulin stimulation. In in vitro experiments, Grsp1 
does not form homodimers, but heterodimers are readily formed with CYTH1 and Grp1 
in biochemical experiments, whereas ARNO, the most divergent family member, showed 
limited heterodimer formation [130].  
Interactions between Cytohesins and the CASP and GRASP proteins  are less well 
characterized, but have been identified through yeast two hybrid screens and 
characterized in in vitro binding and cell biological assays [131, 132].  Like the 
Cytohesin-Grsp1 interaction, these interactions occur on the plasma membrane, but they 
may have different cellular determinants.  Cytohesin recruits CASP from Golgi 
compartments to membrane ruffles at the PM upon Epidermal Growth Factor stimulation.  
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Conversely, GRASP1 recruits Cytohesin to the plasma membrane independent of 
stimulation [132]. 
 Interestingly, ARNO and Grp1 also form less well-characterized homodimers to 
potentially concentrate Cytohesin localization upon phosphoinositide signals, however 
the relative stability of homo- and heterodimeric complexes varies between Cytohesin 
family members and scaffolding partners [130].  Observations in vitro showed that 
phosphoinositide-dependent membrane recruitment as well as GEF activity was 
independent of dimer formation [133].  More recently, the ARNO coiled–coil domain has 
been shown to interact with its PH domain in cis at an Akt phosphorylation site.  
Disruption of this interaction through a pseudophosphorylation mutant resulted in 
increased plasma membrane recruitment [134].  Together, these data suggest that coiled-
coil interactions along with specific PH domain recruitment in Cytohesins may work 
competitively or cooperatively for variable recruitment under variable conditions of 
hormone stimulation or membrane composition, potentially offering fine-tuned regulation 
as well as levels of constitutive localization for homeostatic functions.  Additional studies 
are needed to clarify the physiological role of homo- and heterodimeric complexes. 
 
Autoregulatory Interactions in Guanine Nucleotide Exchange Factors 
 Autoregulation is a common mechanism in which the catalytic activity of an 
enzyme is controlled through inhibitory intramolecular interactions, typically relieved by 
post-translational modification or effector binding at an allosteric site.  This phenomenon 
has been seen in transcription factors, kinases, and actin organization proteins among 
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others [135].  A number of GEFs have shown structural autoregulation [26, 87, 133, 136-
140].  Two well-documented but distinct examples in Ras and Rho GTPase signaling are 
Son of Sevenless (Sos) and Vav1.  In the ArfGEF field, autoregulation in the presence or 
absence of membranes is a common theme, as evidenced by the yeast protein Sec7 and 
mammalian protein BRAG2.  Cytohesin GEFs have an intricate mechanism of 
autoinhibition using minimal architecture.  Together, these GEFs regulate exchange 
activity and membrane localization signals through diverse mechanisms. 
 
Son of Sevenless and Vav1: Autoregulation in Ras and Rho-GTPases 
Sos is a Ras GEF with Histone, Dbl Homology (DH), PH, Rem, and Cdc25 
domains with complex autoregulation that incorporates membrane recruitment with 
catalytic activation.  Sos acts in a feedback loop in which Ras-GTP stimulates exchange 
of Ras-GDP to Ras-GTP.  Ras-GTP binds an allosteric site, driving large-scale 
conformational changes allowing access to the catalytic Cdc25 domain by Ras-GDP [30].  
Structurally, the DH and PH domains block the allosteric site on the catalytic Dbl domain 
[138] and intriguingly, the histone domain contributes to this autoinhibition by stabilizing 
the DH-PH module [141] (Figure I.12A).  Autoinhibition relief is directly coupled to 
membrane recruitment.  As shown from extensive structural and biochemical studies, 
histone domain binding to acidic membrane lipids and PH domain binding to 
PtdIns(4,5)P2 allows rearrangement of all three inhibiting domains and in turn 
accessibility of both the allosteric and catalytic binding sites on Sos to Ras [141, 142]. 
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Figure I.12: Autoregulation in Sos and Vav1.  A) Structure of Son of Sevenless (Sos) in 
autoinhibited (PDB ID 3KSY, cartoon helices) and Ras-GTP/Ras bound (PDB ID 1XD2, 
transparent with cylindrical helices) conformations.  The Ras-GTP molecule has been 
eliminated for clarity and the Ras-GTP location when bound to the REM domain is 
outlined.  Note steric clashes between the Histone/DH/PH tandem in the autoinhibited 
structure and the active conformation of the REM domain.  B) Autoinhibited Vav1 
structure (PDB ID 3KY9).  Tyrosines that are substrates for Src kinase are shown in 
sticks and labeled. 
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 Vav1 is an oncogenic RhoGEF with a complex domain architecture resulting in 
multiple layers of autoregulation.  The catalytic DH domain is blocked by an N-terminal 
acidic domain (Ac) that docks into the Rho-GDP binding site (Figure I.12B) [143, 144].  
Phosphorylation of the Ac domain at Tyr 174 by Src kinases releases the helix and 
facilitates catalysis.  This first Ac-DH interaction is stabilized by a calponin homology 
(CH) domain with the DH, PH, and Ac domains, which promotes a completely closed 
conformation [145].  Two additional Src phosphorylation steps at Tyr 147 and Tyr 160 
release this first interaction.  Together this data show stepwise inhibition of GEF activity 
dependent on phosphorylation but independent of membrane environments, in contrast to 
Sos. 
 
Autoregulation in the ArfGEFs Sec7 and BRAG2 
The yeast ArfGEF Sec7 is the founding Sec7 domain family member first 
identified in Golgi traffic regulation and the sole ortholog of the BIG1/2 family of 
mammalian Arf GEFs [80, 146].  Autoinhibition stems from interaction of the GEF 
domain with the C-terminal HDS1 domain and is relieved by Arf1-GTP interaction with 
the HDS1 domain, which is sufficient for recruitment to Golgi membrane environments 
independent of the presence of Golgi phosphoinositide PtdIns(4)P (Figure I.13A).  Other 
portions of the protein, such as the N-terminal DCB and HUS domains or the C-terminal 
HDS 2-4 may relieve or promote inhibition, respectively [137, 147].  In this way it is a 
unique example of coupled regulation of both Arf GEF activity and localization 
independent of phosphoinositides. 
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Figure I.13: Autoregulation in Sec7 and BRAG2.  A) Schematic depicting relevant 
interactions in Sec7 autoregulation and a mechanism for autoinhibition relief and 
membrane recruitment.  B) The structure of BRAG2 in complex with Arf1-GDP (PDB 
ID 4C0A).  Unstructured amino acids in the Sec7-PH linker are modeled as circles.  
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An interesting example of regulation through simple membrane binding elements 
occurs in BRAG2, a member of the IQSec family of Arf GEFs.  It consists of an N-
terminal IQ motif which binds calmodulin, proline rich regions, a Sec7 domain, PH 
domain, and C-terminal coiled coil [78].  BRAG2 shows no clear autoinhibition in 
solution, and the structure of the protein in the absence of substrate is unknown.  
However activity in solution is increased by inclusion of the PH domain and enhanced 
further by membrane binding of either substrate Arf or BRAG2 [87].  Structural studies 
have found that the Sec7-PH domain linker actively contributes to PH domain stability 
and that these two regions contact substrate Arf-GDP during catalysis (Figure I.13B).  
Instead of autoinhibition in this system, the PH domain regulates activity through 
promiscuous binding of phosphoinositides, which encourages the combined stabilization 
of the Sec7-PH linker, PH domain, and Arf substrate at membrane environments.  This 
can be seen as an indirect autoregulation in which stabilization of the substrate bound 
conformation is limited by conformational rearrangements upon membrane binding. 
 
Autoregulation in Cytohesins 
 In addition to requirements for membrane recruitment in cytohesins discussed 
above, Cytohesins are structurally autoregulated through physical blockage at the Arf-
GDP binding site in the Sec7 domain by substrate mimicry (Figure I.14) [133].  The 
Sec7-PH domain linker and C-terminal helix tuck hydrophobic residues into the SW1 and 
SW2 Arf-GDP binding sites, respectively.  Key residues Leu 258 and Phe 262 in the 
linker mimic the packing of Phe 51 in the Arf-GDP SW1 region, and residues Phe 384, 
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Figure 1.14: The Structure of Autoinhibited Grp1 A) Domain architecture and overall 
structure of Grp163-399 (PDB ID 2R09).  B) View of autoinhibitory elements docked into 
the Arf-GDP binding site (gray). 
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Leu 388, and aliphatic portions of Met 387 and Lys 392 lay over the SW2 docking site.  
Consistent with the structure, substitution of autoinhibitory residues with alanine resulted 
in dramatic relief of autoinhibition, with the largest effects coming from L388A and 
K392A mutations in the CtH.  HR dimerization had negligible effects on this process in 
vitro, as both homo and heterodimers showed inhibition that was relieved by truncation 
of the CtH.  
Several studies have linked the molecular mechanism of Cytohesin autoinhibition 
relief to membrane recruitment, highlighting common themes seen in Sos, Vav1, Sec7, 
and BRAG2.  Most simply, mutation or truncation of residues in the CtH caused reduced 
plasma membrane recruitment upon insulin stimulation [133].  Phosphorylation of 
consensus sites for Phosphokinase C (PKC) on the CtH of ARNO and CYTH1 partially 
relieves autoinhibition and robustly recruits the proteins to membranes in response to 
phorbol ester [133, 148-150].  Independent of this, Arf6-GTP has been shown to relieve 
autoinhibition in the presence of the phosphoinositide head group for PIP3, and recruit 
Cytohesins to the plasma membrane upon PIP3 production through interaction with the 
PH domain [31, 75].  Arf1-GTP relieves autoinhibition in a similar membrane context as 
Arf6, but the ability of Arf1-GTP to recruit Cytohesins to membrane environments is not 
fully characterized [31, 151].  Conversely, Arl4 has been shown to recruit Cytohesins to 
the plasma membrane in a similar manner, but its effect on GEF activity has as of yet not 
been determined [32, 75]. 
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Thesis Rationale 
 As described above, much is known about the molecular mechanisms in GTPase 
biology.  For Arf GTPases, structural studies have elucidated the molecular details for 
nucleotide binding, GDP to GTP exchange, GTP hydrolysis, effector binding, and 
membrane recruitment [24, 58, 60, 61, 79, 89, 94, 95].  Additionally, Cytohesins have 
been well characterized with respect to details of GEF catalysis, PH domain 
phosphoinositide recognition and membrane insertion, and autoregulation [59, 82, 89, 
111, 112, 133].  From previous studies it is clear that Arf GTPase and phosphoinositide 
binding play roles in autoinhibition relief and membrane recruitment of Cytohesins, but 
the structural basis for this remains unknown.  Chapter II of this thesis describes the use 
of X-ray crystallography, biochemical, and biophysical techniques to define how 
cytohesins are stimulated and recruited to membrane environments via an integrated 
structural mechanism. 
Generally, active states of autoinhibited molecules have been hard to visualize, 
presumably due to high degrees of flexibility.  Indeed, structural information of all 
autoinhibited GEFs to date has come from either autoinhibited, or substrate-stabilized 
conformations, with information on specific regulatory mechanisms deduced from 
primarily biochemical observations.  While these studies have been immensely 
informative, there are often remaining questions as to conformational flexibility and 
overall domain organization of these molecules in the active forms.  In these cases of 
potentially flexible systems, Small Angle X-ray Scattering (SAXS) has proven an 
attractive supplement to crystallography, but obtaining clear, reliable data can prove 
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challenging.  Chapter III highlights some of the challenges of traditional SAXS 
experiments and documents a novel method of data collection and processing which 
navigates around them.  Additional improvements in data analysis with shape envelopes 
and modeling algorithms incorporating recent advances in the field will be discussed. 
Using the procedures outlined in Chapter III, Chapter IV details a biochemical 
and SAXS analysis to elucidate the dynamic Sec7 domain orientation in the active Arf-
GTP complex.  Overall, these findings provide the first structural evidence for a 
completely integrated mechanism of autoinhibition relief by Arf6-GTP and 
phosphoinositides that is compatible with structural reorganization of the Sec7 domain. 
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Chapter II: Structural Basis for Membrane Recruitment and Allosteric Activation 
in Cytohesin Family Arf GTPase Exchange Factors 
 
Abstract 
Membrane recruitment of Cytohesin family Arf guanine nucleotide exchange 
factors (GEFs) depends on interactions with phosphoinositides and active Arf GTPases, 
which in turn relieve autoinhibition of the catalytic Sec7 domain through an unknown 
structural mechanism.  Here, we show that Arf6-GTP relieves autoinhibition by binding 
to an allosteric site that includes the autoinhibitory elements in addition to the PH 
domain.  The crystal structure of a Cytohesin-3 (Grp1) construct encompassing the 
allosteric site in complex with the head group of phosphatidyl inositol 3,4,5-trisphosphate 
and N-terminally truncated Arf6-GTP reveals a large conformational rearrangement, 
whereby autoinhibition can be relieved by competitive sequestration of the autoinhibitory 
elements in grooves at the Arf6/PH domain interface.  Disposition of the known 
membrane targeting determinants on a common surface is compatible with multivalent 
membrane docking and subsequent activation of Arf substrates, suggesting a plausible 
model through which membrane recruitment and allosteric activation could be 
structurally integrated. 
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Introduction 
Guanine nucleotide exchange factors (GEFs) activate GTPases by catalyzing 
exchange of GDP for GTP [152].  Since many GEFs are recruited to membranes through 
interactions with phospholipids, active GTPases, or other membrane-associated proteins 
[78, 152-155], GTPase activation can be restricted or amplified by spatial-temporal 
overlap of GEFs with binding partners.  GEF activity can also be controlled by 
autoregulatory mechanisms, which may depend on membrane recruitment [26, 87, 138, 
145, 156-158].  Structural relationships between these mechanisms are poorly 
understood. 
Arf GTPases function in trafficking and cytoskeletal dynamics [155, 159, 160].  
Membrane partitioning of a myristoylated (myr) N-terminal amphipathic helix primes 
Arfs for activation by Sec7 domain GEFs [60, 161-163].  Cytohesins comprise a 
metazoan Arf GEF family that includes the mammalian proteins Cytohesin-1 (Cyth1), 
ARNO (Cyth2), and Grp1 (Cyth3).  The Drosophila homolog steppke functions in 
insulin-like growth factor signaling while Cyth1 and Grp1 have been implicated in 
insulin signaling and Glut4 trafficking, respectively [127, 128, 164].  Cytohesins share a 
modular architecture consisting of heptad repeats, a Sec7 domain with exchange activity 
for Arf1 and Arf6, a PH domain that binds phosphatidyl inositol (PI) polyphosphates, and 
a C-terminal helix (CtH) that overlaps with a polybasic region (PBR) [81, 149, 165-170].  
The overlapping CtH and PBR will be referred to as the CtH/PBR.  The phosphoinositide 
specificity of the PH domain is influenced by alternative splicing, which generates di- 
(2G) and triglycine (3G) variants differing by insertion of a glycine residue in the β1/β2 
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loop (Figure I.10) [171].  Despite similar PI(4,5)P2 (PIP2) affinities, the 2G variant has 30 
fold higher affinity for PI(3,4,5)P3 (PIP3) [111].  In both cases, PIP3 is required for 
plasma membrane (PM) recruitment [149, 166, 172-174], which is promoted by 
expression of constitutively active Arf6 or Arl4d and impaired by PH domain mutations 
that disrupt PIP3 or Arf6 binding, or by CtH/PBR mutations [75, 156, 175, 176]. 
Cytohesins are autoinhibited by the Sec7-PH linker and CtH/PBR, which obstruct 
substrate binding (Figure I.14) [156].  Autoinhibition can be relieved by Arf6-GTP 
binding in the presence of the PIP3 head group [156].  Active myr-Arf1 and myr-Arf6 
also stimulate exchange activity on PIP2–containing liposomes [177].  Whether this effect 
is due to relief of autoinhibition per se or enhanced membrane recruitment is not yet 
clear.  Phosphoinositide recognition by PH domains, catalysis of nucleotide exchange by 
Sec7 domains, and autoinhibition in Cytohesins are well characterized [60, 79, 89, 111, 
114, 156, 163, 178-180].  How Arf-GTP binding relieves autoinhibition and promotes 
membrane recruitment is unknown.  In this chapter, we determine the structural basis for 
relief of autoinhibition and investigate potential mechanistic relationships between 
allosteric regulation, phosphoinositide binding, and membrane targeting. 
 
Results 
Arf6-GTP binding requires autoinhibitory and membrane targeting elements 
Though necessary, it is not known if the PH domain is sufficient for Arf6-GTP 
binding or whether the N-terminal helix of Arf6 contributes to the overall interaction.  To 
delineate the structural requirements, in vitro nucleotide exchange and surface plasmon 
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resonance (SPR) experiments were performed in the presence of Ins(1,3,4,5)P4 (IP4) and  
constitutively active (Q67L) variants of full length Arf6 or a truncated construct lacking 
the N-terminal helix (Arf6NΔ13).  Both Arf6 constructs had similar stimulatory effects 
on Grp1 exchange activity (Figure II.1), with half maximal constants (K0.5 = 18 µM) 
similar to the value of 14 µM determined in experiments using Arf6-GppNHp [156].  
This effect was dependent on IP4 or PIP3 on liposomes (Figure II.1C). 
To quantify molecular requirements for this interaction, surface plasmon 
resonance (SPR) experiments were performed in the presence of Ins(1,3,4,5)P4 (IP4) 
using Arf6 and deletion constructs of Grp1.  As shown in Figure II.2, Arf6-GppNHp and 
N-terminally truncated Arf6 Q67L bound Grp1251-399, which contains the entire linker and 
CtH/PBR, with indistinguishable KD values of 16-18 µM similar to half-maximal 
activation constants in solution.  Comparable dissociation constants were observed for 
constructs truncating up to 10 residues in the linker region.  Affinity was reduced 4 fold 
by deletion of the entire linker, 2 fold by deletion of two residues at the C-terminus, and 
was strongly impaired by deletion of the CtH/PBR (KD > 200 µM).  The minimal 
construct with intact affinity, Grp1260-399, includes the CtH/PBR and five residues from 
the linker. 
 
Structure of the Arf6-GTP complex with Grp1-IP4 
Crystals diffracting to 1.8 Å were obtained for Arf6NΔ13 Q67L bound to Grp1247-
399 and IP4.  The structure was solved by molecular replacement (Materials and Methods, 
Table II.1 and Figure II.3).  The structures of Arf6-GTP and the PH domain resemble 
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Figure II.1: Relief of Autoinhibition by Arf6-GTP.  A) MantGDP dissociation from 
Arf1NΔ17 catalyzed by 125 nM Grp163-399 in the presence or absence of 80 µM 
Arf6NΔ13 Q67L.  B) Dependence of Grp163-399 catalyzed mantGDP dissociation from 
Arf1NΔ17 on Arf6 Q67L or Arf6NΔ13 Q67L.  C) Dependence of Grp163-399 catalyzed 
mantGDP dissociation from Arf1NΔ17 on liposome composition in the presence of 
80mM Arf6NΔ13 Q67L. 
50
 
 
 
 
 
 
 
 
 
 
 
Figure II.2: Direct Binding of Arf6-GTP to Grp1.  A) SPR sensorgrams for binding of 
6×His Arf6NΔ13 Q67L to immobilized GST-Grp1251-399.  B) Dependence of equilibrium 
SPR signals (Req) for selected Grp1 constructs on Arf6NΔ13 Q67L.  C) Dissociation 
constants for 6×His Arf6NΔ13 Q67L binding to GST-Grp1 constructs determined by 
SPR.  (A-C) Buffers contained 1 µM IP4. 
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those of the isolated proteins, as do the interactions with bound ligands [114, 178, 181].  
As illustrated in Figure II.3, the complex buries a surface area of 2450 Å2 within a 
tripartite interface that includes intermolecular interactions with the PH domain as well as 
inter- and intramolecular interactions involving the linker and CtH/PBR. 
At the core of the PH domain interface (Figure II.4A), the β1 strand, switch II, 
and interswitch regions of Arf6 engage the extended sheet comprised of the β1-β4 strands 
and βi1-βi2 hairpin insertion in the PH domain.  Notably, the βi1-βi2 hairpin is a unique 
feature of Cytohesins and supplies basic residues critical for phosphoinositide recognition 
[114, 178].  Invariant Arf6 residues from switch I (Phe 47), interswitch (Trp 62), and 
switch II (Leu 73, His 76 and Tyr 77) pack against non-polar residues from the β3-β4 
strands (Cys 292, Tyr 294, Ile 307 and Pro 309) and βi1-βi2 hairpin (Cys 342 and Val 
350) in the PH domain. 
At the periphery, interswitch (Asn 48) and switch II (Lys 69) residues mediate 
polar interactions with, respectively, residues from the β6-βi1 (Lys 340) and β2-β3 (Asp 
290) loops in the PH domain.  Arg 15 in the β1 strand of Arf6 also donates a hydrogen 
bond to the main chain carbonyl of Val 350 in the βi2 strand of the PH domain.  Despite 
differences in detail, the PH domain interaction epitope in Arf6 is centered on the 
invariant hydrophobic triad at the switch/interswitch junction (Figure II.4B) and, in this 
respect, resembles previously described Arf-effector complexes [62].  The interaction 
epitope in the PH domain, on the other hand, is distinct from GTPase interaction epitopes 
in other PH domain complexes, including Arf1-GTP/ARHGAP21 (Figure II.4C) [182]. 
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Figure II.3: The Grp1-IP4:Arf6-GTP Crystal Structure.  A) Overall view of the complex 
with the switch (SW), interswitch (ISW), and other regions colored as indicated.  IP4 is 
depicted as spheres.  B) Omit map for the Sec7-PH linker and C-terminal Helix.  The 
final refined model is overlaid with σA weighted 2Fo-Fc electron density maps after 
simulated annealing with the region shown omitted.  Maps include data from 39-1.83 Å 
and are contoured at 1.0 σ. 
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Arf6NΔ13-GTP / Grp1-Ins(1,3,4,5)P4 complex 
Data collection  
Space group P432121 
Cell dimensions    
    a, b, c (Å) 56.6, 56.6, 274.4 
    α, β, γ  (°)  90, 90, 90 
Resolution (Å) 20–1.83 
Rsym 0.041 (0.346) 
I / σI 24.7 (4.3) 
Completeness (%) 98.9 
Redundancy 2.7 (2.0) 
  
Refinement  
Resolution (Å) 20–1.83 
No. reflections 38345 
Rwork / Rfree 0.197 / 0.235 
No. atoms  
    Protein 
    Ligand/ion 
2501 
62 
    Water/solvent 491 
B-factors  
    Grp1 30.3 
    Arf6 31.3 
    Water/solvent 45.2 
R.m.s. deviations  
    Bond lengths (Å) 0.008 
    Bond angles (°) 1.18 
* Data were collected on a single crystal.  Values in parentheses are for highest-
resolution shell. 
 
 
 
 
 
 
 
 
 
 
 
 
Table II.1: Data collection and refinement statistics for the Grp1-IP4:Arf6-GTP Crystal 
Structure 
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Figure II.4: The Grp1 PH Domain Binding Epitope on Arf6-GTP.  A) Core interface 
between Arf6 and the Grp1 PH domain.  B) Grp1 Ile 307 is buried in the canonical non-
polar pocket formed by the hydrophobic triad of Arf6.  (C) Comparison of the Arf6/Grp1 
and Arf1/ARHGAP21 (PDB ID: 2J59) complexes after superposition of their respective 
PH domains. 
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 The interface of canonical Arf and non-canonical PH domain surfaces facilitates 
an unusual mode of interaction with the linker and CtH/PBR.  The CtH, including the 
first two residues of the PBR, and the last nine residues in the linker dock in distinct 
grooves formed at the periphery of the central Arf6-PH domain interface (Figure II.5).  In 
one groove, Leu 258 and Phe 262 in the linker occupy hydrophobic pockets derived from 
switch II residues (Pro 72, Leu 73, Arg 75, and His 76) and the PH domain β3/β4 loop 
(Ile 287, Tyr 294, Phe 296, and Lys 307).  In the other groove, Phe 384, Leu 388, and Lys 
392 from the CtH/PBR pack against a concave surface lined by switch I (Tyr 31) and 
interswitch (Thr 40 and Ile 42) residues.  Whereas the interactions with the CtH/PBR are 
mediated primarily by Arf6 residues, the linker contacts are more evenly distributed 
between Arf6 and the PH domain (Figure II.6).  These observations explain the stronger 
reduction in affinity accompanying deletion of the CtH/PBR compared with deletion of 
the linker, despite similar buried surface areas (757Å2 vs. 648Å2, respectively). 
 
Structural basis for relief of autoinhibition by Arf6-GTP 
Comparison of the active Arf6-Grp1 and autoinhibited Grp1 structures after 
superposition of the PH domain reveals large conformational rearrangements in which 
the linker rotates ~120° about Asp 266 at linker/PH domain junction while the CtH/PBR 
rotates ~90° about Ser 378 and Ile 379 in the turn preceding the CtH (Figure II.7).  The 
linker rotation is accompanied by changes in its irregular secondary structure.  Moreover, 
several residues that occupy the Sec7 domain exchange site in the autoinhibited structure, 
including Leu 258 in the linker and Phe 384, Leu 388 and Lys 392 in the CtH/PBR, are 
56
buried in the grooves formed at the Arf6-PH domain interface (Figure II.6 and II.7).  
Thus, Arf6-GTP binding relieves autoinhibition through an allosteric mechanism 
involving competitive sequestration of the linker and CtH/PBR in conformations 
incompatible with autoinhibition. 
 
Determinants of activation and Arf-GTP recognition 
The I307E and K340A mutations in the Grp1 PH domain interfere with Arf6-
dependent cell spreading and PM recruitment [175, 183].  The equivalent K336A 
mutation in ARNO impairs myr-Arf6-GTP stimulation of GEF activity for myr-Arf1 on 
liposomes containing PIP2 [177].  Lys 340 mediates a polar interaction with Asn 48 in the 
interswitch region whereas Ile 307 is buried in a pocket formed by the hydrophobic triad 
(Figure II.4) and conforms to a common theme in Arf:effector recognition [62].  Deletion 
of the polybasic region in Grp1 or CYTH1 as well as alanine substitution of Leu 388/385 
or Lys 392/389 in CYTH disrupted autoinhibition in solution as well as insulin-
stimulated PM recruitment [156].  This region makes extensive contact with the 
hydrophobic groove formed at the Grp1-Arf6 interface.  Consistent with this observation, 
the L388A and K392A substitutions in the CtH/PBR strongly reduce Arf6-GTP binding 
(Figure II.8). 
To further explore the significance of the structural observations and identify 
determinants for specific activation by Arf6-GTP, residues in the interface were mutated 
and the effects quantified by measuring direct binding by SPR or catalytic efficiency 
(kcat/KM) for Arf1NΔ17-mantGDP/GppNHp exchange in the presence or absence of 80 
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Figure II.5: Interactions of the Grp1 Autoinhibitory Elements within the Grp1-Arf6 
Binding Interface.  (A and B) Docking of the linker (A) and CtH/PBR (B) within grooves 
at the periphery of the Arf6-PH domain interface.  Molecules and relevant regions are 
colored as indicated in Figure II.4. 
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Figure II.6: Detailed Interaction Map of the Grp1-IP4:Arf6-GTP Complex. Schematic 
representation of intra- and intermolecular contacts in autoinhibited Grp1 and the active 
Arf6 complex.  Contacts were determined using a 4.0 Å cutoff subject to acceptable 
stereochemistry. 
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Figure II.7: Competitive Allosteric Mechanism for Relief of Autoinhibition.  A) 
Comparison of autoinhibited Grp1 (PDB ID 2R09) with the active Arf6 complex after 
superposition of the PH domains.  Arrows indicate the angular displacement of the linker 
and CtH/PBR.  B) Sequence Alignment of Grp1 showing shared contacts in autoinhibited 
and Arf6-bound structures 
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µM Arf6NΔ13 Q67L.  This concentration is 4 fold greater than K0.5 for activation and 
affords robust stimulation while maintaining sensitivity to changes in kcat/KM.  Arf6NΔ13 
Q67L increased kcat/KM 11 fold, which was moderately to severely impaired by switch I 
(F47A) or switch II (H76A) substitutions (Figure II.8 and Table II.2).  PH domain 
substitutions (Y294A in β3, I307A or I307E in β4, K340A in the β6-βi1 loop, or V350A 
in βi2) also rendered Grp1 refractory to activation.  Finally, alanine substitution of the 
terminal 2-3 residues in the PBR disrupted autoinhibition and, consequently, activation 
by Arf6NΔ13 Q67L.  Although disordered in both the autoinhibited Grp1 and active 
Grp1:Arf6 complex structures, the C-terminal lysine residues may contribute to the 
stability of the CtH through electrostatic interaction with the helix dipole. 
To clarify the specificity for active Arf GTPases, relief of autoinhibition by the 
five human Arf family members was examined (Figure II.8).  Compared to Arf6NΔ13 
Q67L, stimulation by the N-terminally truncated forms of other Arf GTPases was weaker 
(2-4 fold).  Assuming the extent of activation is similar at saturation, 2-4 fold stimulation 
is consistent with K0.5 values that are 10-25 fold lower than that for Arf6.  Given similar 
tertiary structures, the preference for Arf6 might reflect non-conservative substitutions in 
the binding interface.  Similarity within the interaction epitope (Figure II.8C) suggested 
five putative specificity determinants.  Individual mutation of these residues in Arf1 and 
Arf6 resulted in reciprocal perturbations of 2 fold or less.  The combination of all five 
substitutions in Arf1 had little additional effect, as was the case for an Arf1→6 chimera 
that included the complete set of 10 substitutions in the binding epitope (Figure II.8D and 
Table II.2).  Thus, whereas the specificity for some effectors can be reversed by 
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Figure II.8: Mutational Analysis of the Grp1-IP4:Arf6-GTP Interaction.  (A) Effect of 
mutations in the CtH/PBR of GST-Grp1251-399 on Req as a function of 6×His Arf6NΔ13-
GppNHp in buffer containing 1 µM IP4.  Curves are fitted models.  (B) Effect of 
mutations on the kcat/KM of Grp163-399 for Arf1NΔ17 in buffer containing 1 µM IP4 with 
or without 80 µM Arf6NΔ13 Q67L.  (C) Catalytic efficiency of Grp163-399 in the presence 
and absence of 80 µM constitutively active, N-terminally truncated Arf GTPases.  
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Grp1 Construct Active Arf 
kcat/KM / (103 M-1s-1) kcat/KM (a.u.)* 
GEF GEF Arf, IP4 
GEF 
Arf, IP4 
WT Arf6NΔ13 1.1 ± 0.04 12.5 ± 0.36 11.4 ± 0.33 
3G Arf6NΔ13 1.8 ± 0.13 3.8 ± 0.31 2.1 ± 0.17 
Y294A Arf6 NΔ13 1.3 ± 0.03 3.2 ± 0.29 2.5 ± 0.22 
I307A Arf6NΔ13 2.2 ± 0.02 4.3 ± 0.18 2.0 ± 0.08 
I307E Arf6NΔ13 2.3 ± 0.04 3.1 ± 0.07 1.3 ± 0.03 
K340A Arf6NΔ13 2.1 ± 0.06 3.6 ± 0.01 1.7 ± 0.005 
V350A Arf6NΔ13 2.8 ± 0.05 4.8 ± 0.11 1.7 ± 0.06 
397NKK/AAA399 Arf6NΔ13 15.4 ± 0.39 16.9 ± 0.52 1.1 ± .03 
K398A/K399A Arf6NΔ13 14.6 ± 0.36 14.9 ± 1.0 0.97 ± 0.06 
WT Arf6NΔ13 Q37E  14.7 ± 0.40 13.4 ± 0.36 
WT Arf6NΔ13 S38I  8.5 ± 0.18 7.7 ± 0.16 
WT Arf6NΔ13 F47A  4.0 ± 0.14 3.6 ± 0.13 
WT Arf6NΔ13 N60T  10.1 ± 0.56 9.2 ± 0.51 
WT Arf6NΔ13 T79Q  7.9 ± 0.26 7.2 ± 0.24 
WT Arf6NΔ13 G80N  6.8 ± 0.21 6.2 ± 0.19 
WT Arf1NΔ17-GTP  1.9 ± 0.08 1.7 ± 0.09 
WT Arf1NΔ17 E41Q-GTP  2.3 ± 0.17 2.0 ± 0.16 
WT Arf1NΔ17 I42S-GTP  2.7 ± 0.14 2.3 ± 0.15 
WT Arf1NΔ17 T64N  3.6 ± 0.33 3.3 ± 0.3 
WT Arf1NΔ17 Q83T  4.0 ± 0.07 3.6 ± 0.06 
WT Arf1NΔ17 N84G  3.8 ± 0.10 3.5 ± 0.09 
WT Arf1NΔ17 EITQN/QSNTG  3.7 ± 0.51 3.4 ± 0.46 
WT Arf1NΔ17 to Arf6 SW  4.5 ± 0.35 4.1 ± 0.32 
WT Arf3NΔ14  2.6 ± 0.43 2.4 ± 0.39 
WT Arf4NΔ17-GTP  4.7 ± 0.26 4.1 ± 0.26 WT Arf5ND14  3.6 ± 0.78 3.3 ± 0.71 
65
Table II.2: Catalytic efficiencies for Grp163-399 with active Arf GTPases.  All experiments 
with Arf and IP4 were at concentrations of 80 μM and 1 μM, respectively.  (*) Relative 
to the basal kcat/KM for each WT or mutant Grp1 protein. 
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interfacial substitutions in the switch/interswitch regions [184], the interaction with Grp1 
is also sensitive to determinants outside the binding epitope.   
 
Relationship between phosphoinositide and Arf6-GTP binding 
The IP4 requirement is a striking property of Arf6-GTP binding and relief of 
autoinhibition [156, 175].  The underlying structural basis may be related to 
conformational changes in the βi1/βi2 hairpin and β3/β4 loop, which mediate key 
contacts with both the head group and Arf6-GTP.  Indeed, subtle structural differences in 
these elements have been described for IP4 binding to the Grp1 PH domain [114].  Head 
group binding may also overcome an electrostatic barrier resulting from proximity of the 
electropositive PBR and head group site in the Arf6-GTP complex. 
Substantially higher Arf6-GTP concentrations are required to stimulate 3G 
ARNO or 3G Cyth1 compared to the 2G variants [156].  Since the residues in the Arf6-
GTP binding epitope are conserved and the β1/β2 loop containing the splice site is 
located distal to the interface (Figure II.9A), the differences in stimulation are likely an 
indirect effect of reduced affinity of the 3G variants for IP4 [111].  Consistent with this 
prediction, the 2G variants bound Arf6NΔ13 Q67L with comparable affinity and were 
robustly stimulated by Arf6NΔ13 Q67L (Figure II.9B and C).  The 3G variants, on the 
other hand, exhibited muted stimulation that was enhanced by increasing the IP4 
concentration.  Similar results were obtained for the T280A mutation in the β1/β2 loop, 
which eliminates polar interactions with the 1-phosphate and reduces the affinity for IP4 
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Figure II.9: Effect of Cytohesin Splice Variants on Arf6-GTP Binding and Nucleotide 
Exchange.  A) Comparison of head group binding sites in the 2G Grp1 PH domain from 
the Arf6 complex and the 3G Grp1 PH domain bound to IP4 (PDB ID 1U2B) after 
superposition.  B) Req for 6×His Arf6NΔ13 Q67L binding to 2G GST-Grp1251-399, 3G 
GST-Grp1251-399, 2G ARNO247-397, and 2G GST-Cyth1251-399.  Curves are fitted models.  
C) Effect of 2G vs. 3G splice variation on the kcat/KM of Grp163-399/400, ARNO57-397/398, 
and Cyth157-399/400 for Arf1NΔ17-mantGDP in the presence or absence of IP4, IP3, and/or 
Arf6NΔ13 Q67L.  D) Effect of IP4 on catalysis of mantGDP release from Arf1NΔ17 as a 
function of Grp163-399 T280A.  Lines are linear fits. 
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Cytohesin 
kcat/KM / (103 M-1s-1) 
GEF GEF + NΔ13Arf6 Q67L 
  1 μM IP4 10 μM IP4 10 μM IP3 
Grp1 2G T280D 1.3 ± 0.07 2.1 ± 0.38 7.0 ± 0.45 --- 
Grp1 2G 1.1 ± 0.04 12.5 ± 0.36 12.0 ± 1.8 1.8 ± 0.03 
Grp1 3G 1.8 ± 0.13 3.8 ± 0.31 7.4 ± 0.63 3.3 ± 0.83 
ARNO 2G 1.8 ± 0.27 44.7 ± 7.5 46.3 ± 7.0 3.8 ± 0.04 
ARNO 3G 3.7 ± 1.7 5.4 ± .96 13.7 ± 3.7 5.0 ± 0.53 
Cyth1 2G 1.7 ± 0.56 18.2 ± 2.0 30.4 ± 2.4 1.2 ± 0.20 
Cyth1 3G 3.6 ± 1.0 5.7 ± .94 17.5 ± 2.6 5.8 ± 0.84 
 
Cytohesin 
kcat/KM (a.u.) * 
GEF + NΔ13Arf6 Q67L 
1 μM IP4 10 μM IP4 10 μM IP3 
Grp1 2G T280D 1.6 ± 0.29 5.4 ± 0.35 --- 
Grp1 2G 11.4 ± 0.33 10.9 ± 1.6 1.6 ± 0.03 
Grp1 3G 2.1 ± 0.17 4.1 ± 0.35 1.8 ± 0.46 
ARNO 2G 24.8 ± 4.2 25.7 ± 3.9 2.1 ± 0.02 
ARNO 3G 1.5 ± 0.26 3.7 ± 1.0 1.4 ± 0.15 
Cyth1 2G 10.7 ± 1.2 17.9 ± 1.4 0.71 ± 0.12 
Cyth1 3G 1.6 ± 0.26 4.8 ± 0.72 1.6 ± 0.23 
 
 
 
 
 
 
 
 
 
Table II.3:  Catalytic Efficiencies of Cytohesin Variants.  (*) Relative to the basal kcat/KM 
for each Cytohesin protein 
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by 13 fold (Figure II.9d) [111].  Replacing IP4 with Ins(1,4,5)P3 (IP3) also substantially 
diminished Arf6NΔ13 Q67L stimulation (Figure II.9, Table II.3). 
 
Relief of autoinhibition in a membrane environment 
Membrane partitioning of Cytohesins and myristoylated Arfs results in high local 
concentrations within the restricted volume proximal to the membrane surface.  Since 
binding of myr-Arf-GTP can enhance membrane recruitment and since the product of the 
exchange reaction is also a potential activator/recruiter, experiments analyzing relief of 
autoinhibition on membranes must distinguish allosteric activation from restricted 
volume effects and feedback amplification [177].  Thus, Arf1NΔ17-mantGDP was used 
as a non-partitioning substrate reporter for the autoinhibitory status of 2G Grp1 in the 
presence and absence of myr-Arf6 Q67L or Arf6NΔ13 Q67L and liposomes with or 
without PIP3 or PIP2 (Figure II.10A).  Under the conditions of these experiments, the 
fraction of Grp1 partitioned with membranes in the absence of myr-Arf6 Q67L is >60% 
for LUVs containing PIP3 and <10% for LUVs containing either 3% PIP2 or no 
phosphoinositide (Figure II.10B).  As shown in Figure II.11, the exchange activity of 
Grp1 increased substantially with increasing concentrations of myr-Arf6 Q67L in the 
presence of liposomes containing PIP3 (K0.5 ≈ 75 nM) whereas weaker stimulation was 
observed in the presence of liposomes containing PIP2 (K0.5 ≈ 350 nM) or no 
phosphoinositide (K0.5 ≈ 800 nM).  Truncation of the Arf6 N-terminus increased K0.5 by 
2-3 orders of magnitude whereas the K340A mutation in the PH domain, which disrupts 
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Figure II.10: Experimental Setup for Studying Arf6 Stimulation of Cytohesin Activity in 
Membrane Environments Using Soluble Substrate.  A) Schematic of protein/lipid 
interactions and compositions relevant to Figure II.11.  B) Partitioning of Grp163-399 with 
liposomes.  500 nM Grp163-399 was incubated with liposomes containing 100% POPC, 
97% POPC:3% PtdIns(4,5)P2, or 97% POPC:3% PtdIns(3,4,5)P3 for 15 min at 22°C.  
Reactions were spun at 100,000 × g for 30 minutes and the supernatant and pellets ran on 
an SDS-PAGE gel stained with KryptonTM stain (Pierce).  Gels were imaged with a 
Kodak Image Station 4000mm using excitation and emission wavelengths of 520-530 
and 580-600 nm, respectively.  Bands were quantified by gel densitometry using ImageJ. 
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Figure II.11: Atf6-Stimulation of Cytohesin Activity in Membrane Environments Using 
Soluble Substrate.  A) Catalysis of mantGDP release from 1 µM Arf1NΔ17 by 125 nM 
Grp163-399 as a function of myr-Arf6 Q67L-GppNHp.  Curves are fitted quadratic models.  
B) Catalysis of mantGDP release from 1 µM Arf1NΔ17 by 125 nM Grp163-399 or the 
K340A mutant as a function of myr-Arf6 Q67L-GppNHp or Arf6NΔ13 Q67L-GTP.  C) 
Catalysis of mantGDP release from 1 µM Arf1NΔ17 by 125 nM Arno58-399 as a function 
of myr-Arf6 Q67L-GppNHp or Arf6NΔ13 Q67L-GTP.  Experiments were performed in 
the presence of 0.2 mM LUVs containing 67% POPC:30% POPS:3% PtdIns(3,4,5)P 3. 
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Arf6-GTP binding, eliminated the stimulatory effect.  Similar stimulation was observed 
for 2G ARNO in the presence of liposomes containing PIP3 (Figure II.11). 
When experiments were performed with myr-Arf1-mantGDP as the substrate and 
myr-Arf6 Q67L as the activating GTPase (Figure II.12A), strong stimulation was 
observed in the presence of PIP3 (K0.5 ≈ 50 nM), moderate stimulation in the presence of 
PIP2 (K0.5 ≈ 170 nM), and weaker stimulation in the absence of phosphoinositide (K0.5 ≈ 
330 nM) (Figure II.12B).  Substantially weaker stimulation in the presence PIP3 was 
observed for myr-Arf1 Q71L (K0.5 ≈ 1200 nM) as well as the Grp1 I307E mutant (K0.5 ≈ 
1600 nM) (Figure II.12C).  Although the experiments combining myristoylated substrate 
and activator GTPases do not distinguish membrane recruitment from allosteric 
activation per se, the overall trends are consistent with both the experiments using 
truncated substrate and myristoylated activator (Figure II.11) as well as experiments 
using truncated substrate and activator GTPases in the absence of membranes (Figure 
II.8).  This indicates that biochemical preferences for the protein-protein and protein-lipid 
interactions cooperate to achieve robust stimulation of GEF activity, the efficiency of 
which is highly dependent on membrane association. 
 
Discussion 
We have shown that high affinity Arf6-GTP binding to Grp1 requires the 
proximal elements previously implicated in autoinhibition and/or membrane targeting.  
The structure of the complex revealed an unusual binding modality whereby formation of 
the Arf6-GTP/PH domain interface creates grooves that sequester the linker and 
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Figure II.12: Arf6-Stimulation of Cytohesin Activity in Membrane Environments Using 
Membrane Associated Substrate.  A) Schematic of protein/lipid interactions and liposome 
compositions relevant to B) and C).  B) Catalysis of mantGDP release from 1 µM myr-
Arf1 by 10 nM Grp163-399 as a function of myr-Arf6 Q67L-GTP.  Curves are fitted 
quadratic (PIP3) or hyperbolic models (PIP2 and no PIP).  C) Catalysis of mantGDP 
release from 1 µM myr-Arf1 by 10 nM Grp163-399 or the I307E mutant as a function of 
myr-Arf6 Q67L-GTP.  Curves are fitted quadratic models. 
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CtH/PBR.  Substitutions within the binding interface contribute substantially to the 
observed specificity, but do not fully explain the preference for Arf6.  Unlike Arf6 
specific effectors studied to date, Grp1 engages common Arf recognition determinants 
[62] attributed to Arf1-GTP binding and has a more expansive interface, which is shifted 
away from the interswitch region compared to the Arf6-specific effector JIP4 (Figure I.7) 
[184] and is thus less sensitive to interswitch substitutions.  Careful experimentation will 
be required to delineate the remaining specificity determinants, which might include 
substitutions proximal to the binding interface and/or differences in isoelectric point.  
Moreover, since Arf6 is expressed at lower levels than Arf1 and has a steady state 
localization at the PM and on endosomes rather than the Golgi [185], the higher affinity 
for Arf6-GTP may have evolved to compensate for lower Arf6 levels.  Consistent with 
the observation that co-expression of ARNO with either Arf1 or Arf6 promotes Arf1 
recruitment to the PM [175], activation by Arf6-GTP may initiate a feedback 
amplification loop whereby Arf-GTP products further stimulate GEF activity [177]. 
The diminished ability of Arf6-GTP to stimulate 3G ARNO or 3G Cyth1 
compared to 2G Grp1 stems entirely from the splice variation, which reduces PIP3 
affinity and, consequently, the available pool of phosphoinositide-primed precursor.  
Since the effective concentrations of membrane-associated Cytohesins and myristoylated 
Arf GTPases may exceed those in the cytoplasm by several orders of magnitude, weak 
stimulation in solution does not exclude more robust stimulation on membranes, as 
observed for myr-Arf1-GTP and 3G ARNO on liposomes containing PIP2 [177].  
Notably, however, relief of autoinhibition shows similar characteristics in solution and 
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membrane environments.  Indeed, the main difference lies in the concentration range of 
activator GTPase required to stimulate the exchange activity.  CYTH1 and ARNO are 
expressed predominantly in the 3G form and Grp1 and Cytohesin-4 in the 2G form [126].  
This coupled with the fact that Cytohesin-4 is expressed almost exclusively in blood 
leukocytes [126] suggest that splice differences may have evolved for attenuated or 
specialized signaling characteristics from these isoforms in varied cell types and 
environments. 
Taken together, the structural and biochemical data suggest a plausible model 
integrating membrane targeting with allosteric activation.  As depicted in Figure II.13, 
the 1-phosphate of the bound IP4 can be aligned with the 1-phosphates of a simulated 
bilayer [186] in an orientation optimal for simultaneous partitioning of elements known 
to insert into the hydrocarbon core – in particular the myristoylated N-terminal helix of 
Arf6-GTP and residues in the β1/β2 loop (Val 278), β3/β4 loop (Tyr 298) and βi1/βi2 
hairpin (Ala 346) of the PH domain [60, 124, 163].  Other elements implicated in 
electrostatic interactions with anionic phospholipids, including the PBR and a 'sentry 
glutamate' that reduces basal membrane association [119, 170, 173], are located proximal 
to the membrane surface as are two basic residues in the β5/β6 loop (Arg 322 and Lys 
323).  Lateral extension of the linker suggests that the Sec7 domain may also be closer to 
the membrane in the Arf6-GTP complex than in the autoinhibited conformation. 
Autoinhibition has been observed in structurally unrelated GEFs for different 
GTPase families and can be relieved by various inputs, including phosphorylation and 
interaction with proteins or phospholipids [136, 138, 143, 145, 158].  In Sos, for example, 
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Figure II.13: Model for Integrated Relief of Autoinhibition and Membrane Recruitment 
of Cytohesins by Arf6-GTP.  Left) Autoinhibited Grp1 structure (PDB ID 2R09).  Right) 
Composite model for the active Grp1 complex with Arf6-GTP.  The models are depicted 
in a common orientation relative to a model lipid bilayer based on the bound head group 
and known membrane targeting determinants.  The N-terminal helix of Arf6 is modeled 
in an arbitrary orientation consistent with membrane partitioning.  The myristoyl and 
diacyl glycerol moieties are modeled in configurations compatible with membrane 
insertion.  The POPC bilayer membrane was derived from the coordinates of a molecular 
dynamics simulation [186]. 
78
membrane association of PH and histone domains exposes an allosteric site for Ras-GTP 
stimulation of GEF activity [158].  In BRAG2, association with membrane environments 
through nonspecific interaction at the PH domain stabilizes substrate binding and 
enhances catalytic activity [87].  In Cytohesins, membrane recruitment and allosteric 
relief of autoinhibition appear to be integrated through a unified structural mechanism 
whereby phosphoinositide binding primes Arf-GTP binding, which relieves 
autoinhibition by driving large scale conformational rearrangements that reposition the 
autoinhibitory elements to reinforce membrane partitioning and support Arf substrate 
activation by the Sec7 domain.  Given the similarity with Sos, integration of 
autoregulatory and membrane targeting mechanisms in GEFs may be more prevalent than 
previously appreciated.  Further investigation of the relationships between membrane 
targeting and allosteric activation will likely yield important insights into the molecular 
mechanisms underlying spatial-temporal-allosteric control of GTPase activation. 
 
Materials and Methods 
Constructs, Expression and Purification 
Constructs were amplified using Vent polymerase, digested with BamHI-hf or 
NdeI and SalI-hf or XhoI, and ligated into pGEX-6P1 for expression as GST fusions or 
modified pET15b and pET21a encoding N- and C-terminal 6×His tags, respectively.  
Mutants were generated using the QuikChange II XL kit (Stratagene).  Transformed 
BL21 (DE3) RIPL cells (Stratagene) were grown to an OD600 of 0.2-0.4 in 2×YT with 
100 mg/L ampicillin and induced with 50 µM IPTG for 14-16 hours at 18-22°C.  Cell 
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pellets were suspended in 50 mM Tris, pH 7.5 or 8.5, 150 mM NaCl, 2 mM MgCl2, 0.1 
mM PMSF, 0.2 mg/ml lysozyme, 0.01 mg/ml protease free DNAse I (Worthington), and 
0.05% 2-mercaptoethanol.  After sonication, lysates were supplemented with 0.5% Triton 
X-100 and centrifuged at 30,000×g for 1 hr.  Proteins were purified over HisTrap Ni-
NTA or glutathione-sepharose columns followed by ion exchange on HiTrap Q or SP and 
gel filtration on Superdex-75 (GE Healthcare). 
For myr-Arfs, BL21 (DE3) RIPL cells (Stratagene) were co-transformed with 
pET21a encoding Arf6 and pBB131 encoding N-myristoyl transferase.  Cells cultured in 
2×YT at 37°C to an OD600 of 0.6-0.8 were supplemented with 50 µM sodium myristate 
and induced with 1 mM IPTG for 3 hrs at 37°C (Arf1/6-6×His) or 0.1 mM IPTG for 16 
hrs at 22°C (untagged Arf1).  After lysis in the absence of detergent and 
ultracentrifugation at 100,000×g, myr-Arf6 was extracted from the membrane fraction 
with buffer containing 1% Triton X-100.  After ultracentrifugation at 100,000×g, the 
solubilized 6xHis protein was purified over Ni-NTA-Sepharose in buffer supplemented 
with 0.1% Triton X-100, concentrated, and stored in buffer containing 10 µM GDP and 
0.1% Triton X-100. 
 
Nucleotide Loading 
Arf GTPases were incubated overnight at 4°C in 20 mM Tris, pH 8.0, 150 mM 
NaCl, 5 mM EDTA, and 1 mM DTT with a 10 fold molar excess of GTP, GppNHp or 
mantGDP.  MgCl2 was added to a final concentration of 10 mM and excess nucleotide 
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removed by gel filtration on Superdex-75 (GE Healthcare) or using a D-Salt column 
(Pierce ThermoFisher). 
 
Determination of Nucleotide State 
Nucleotide state for loaded and/or constitutively active Arf GTPases was 
determined by monitoring the change in intrinsic tryptophan fluorescence accompanying 
nucleotide exchange for GDP and GTP in the presence of 5 mM EDTA.  The approach to 
equilibrium was monitored using a TECAN Safire microplate spectrometer, with 
emission and excitation wavelengths of 340 nm and 290 nm, respectively.  The GTP-
bound fraction was calculated as ΔIGTP / (ΔIGDP + ΔIGTP), where ΔIGTP and ΔIGDP were 
determined by a non-linear least squares fits to ΔIGTP (1 - e-kobs t) + Ieq and ΔIGTP e-kobs t + 
Ieq, respectively.  In cases where ΔIGDP was too small to be measured, the GTP-bound 
fraction was conservatively estimated as >90%. 
 
Liposome Preparation 
Liposomes containing 67-70% palmitoyloleolylphosphatidylcholine (Avanti), 
30% palmitoyloleolylphosphatidylserine (Avanti), and 3% PIP2 or PIP3 (Cell Signals) 
were prepared as follows.  Lipids dissolved in 2:1 chloroform:methanol were mixed and 
dried under an argon stream.  For GEF assays, lipid mixtures were rehydrated in 20 mM 
Tris HCl, pH 8.0, 150 mM NaCl, and 2 mM MgCl2.  Large Unilamelar Vesicles (LUVs) 
were prepared by extrusion through 0.1 µm filters (Avanti) after 10 freeze-thaw cycles in 
liquid nitrogen.  For liposome partitioning, lipid mixtures were rehydrated in 20 mM 
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Hepes, pH 7.5, and 170 mM sucrose.  Following 10 freeze-thaw cycles and extrusion as 
above, the liposomes were diluted 4:1 with 20 mM Hepes, pH 7.5, and 100 mM KCl, 
pelleted by ultracentrifugation at 100,000×g for 30 minutes, and resuspended at a total 
lipid concentration of 5 mM. 
 
Nucleotide Exchange Kinetics 
Nucleotide exchange was monitored as the fluorescence decrease upon mantGDP 
dissociation from Arf1NΔ17 in 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM MgCl2 and 
250 µM or 1 mM GppNHp.  Grp1 with or without active Arf GTPases, liposomes, 
phosphoinositides, and/or head groups was formatted into 96 well half area microplates 
(Corning) and incubated for 16-24 hrs at 25°C.  Reactions were initiated by addition of 1 
µM Arf1NΔ17- or myrArf1-mantGDP and monitored using a Safire microplate 
spectrophotometer (Tecan) with excitation and emission wavelengths of 360 nm and 440 
nm, respectively.  Observed rates constants (kobs) were obtained by fitting with It = (I0 - 
I∞) exp(-kobs t) + I∞, where It, I0, and I∞ are the emission intensities at times t, t = 0, and as 
t→∞.  Catalytic efficiencies (kcat/KM) were obtained from the slope of a linear least 
squares fit with kobs = (kcat/KM)[GEF] + kintr, where kintr is the intrinsic dissociation rate 
constant.  Half maximal activation constants (K0.5) were determined by fitting with the 
hyperbolic function kobs = (k∞ - k0) [Arf6-GTP] / (K0.5 + [Arf6-GTP]) + k0, where k0 and 
k∞ are the values of kobs at t = 0 and as [Arf6-GTP]→∞.  For experiments in which the 
effective K0.5 was comparable or less than the [GEF], the observed rate constants were fit 
with a quadratic function kobs = (k∞ - k0) {b - (b2 - 4 [Arf6-GTP] / (n [GEF]))1/2} + k0, 
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where b = 1 + [Arf6-GTP] / (n [GEF]) + K0.5 / (n [GEF]) and the binding stoichiometry n 
was fixed at 1. 
 
Surface Plasmon Resonance 
CM5 sensor chips were docked with Biacore S3000 or T100 instruments (GE 
Healthcare), activated, and coupled with anti-GST according to the manufacturers 
instructions.  Proteins were dialyzed into 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM 
MgCl2, and 0.005% P-20 surfactant.  Equivalent molar quantities of GST-Grp1 constructs 
or GST were loaded on the sample and reference channels, respectively.  6×His-tagged 
Arf6-GppNHp or Arf6NΔ13 Q67L was injected for 60 s at 10 µl/min.  After alignment, 
baseline correction, and reference subtraction, equilibrium responses (Req), which 
correspond to the equilibrium signal level, were determined from the average response 
over a 30-50 s range at the end of the injection.  Dissociation constants (KD) were 
determined by fitting with Req = Rmax [Arf6] / (KD + [Arf6]), where Rmax is the value of 
Req as [Arf6]→∞. 
 
Crystallization and Structure Determination 
Ternary complexes were formed by incubating 6×His Grp1247-399, 6×His 
Arf6NΔ13 Q67L, and IP4 in a 1:1:1.2 molar ratio at a total concentration of 10 mg/ml for 
16-18 hrs at 25°C.  Crystals were grown by vapor diffusion from 50 mM Tris, pH 8.8, 
16-18% PEG 4000, and 0.2 M sodium citrate, transferred to a cryoprotectant solution (50 
mM Tris, pH 8.8, 20% PEG 4000, 10% glycerol, and 0.2 M sodium citrate), and flash 
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frozen in liquid nitrogen.  The crystals are in the space group P432121 with cell 
dimensions of a = b = 56.6 Å, c = 274.4 Å and contain a single complex in the 
asymmetric unit.  Diffraction data were collected at the Brookhaven NSLS X25 beamline 
and processed/scaled using HKL2000 [187].  The structure was solved by molecular 
replacement with Phaser using the Grp1 PH domain (1FGZ) and Arf6-GTPγS (2J5X) 
structures as search models.  A σA-weighted 2wFo-DFc map calculated after interleaved 
atom-updating and refinement with ARP/wWARP [188] and Refmac-5 [189] was used 
for automated model building with Buccaneer [190].  IP4, GTP and solvent molecules 
were added using Coot [191].  The structure was refined by iterative rebuilding with 
Coot, atom updating with ARP/wARP, positional refinement with Refmac5, and 
simulated annealing with Phenix [192].  Structural figures were generated using PyMOL. 
 
Statistical Analysis 
Values and errors represents mean ± standard deviation for 2-4 independent 
measurements.  
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Chapter III: Development of Data Processing and Analysis Techniques for Size 
Exclusion Chromatography Small Angle X-ray Scattering 
 
Abstract 
 Small Angle X-ray Scattering (SAXS) is a widely-used technique for structural 
analysis of macromolecular systems in solution.  Recently, size exclusion 
chromatography in line with SAXS (SEC-SAXS) at third generation beamlines has 
helped bypass some of the traditional difficulties in data collection with challenging 
samples, but data analysis procedures still rely heavily on somewhat subjective trial and 
error methods unsuited for large data sets produced by SEC-SAXS.  Presented here are 
novel methods for data processing and analysis incorporated into a Python-extensible 
graphical software package.  Intensity normalization, buffer correction, Guinier analysis, 
and constant subtraction procedures have been optimized using data for the GTPase Arf6 
and its Guanine Nucleotide Exchange Factor (GEF) Grp1. 
A method of scattering profile reconstruction was developed using singular value 
decomposition of the sample data and linear combination of basis components 
representing the space of sample and buffer scattering to process data as an alternative to 
direct buffer subtraction.  This technique was especially useful when characterizing 
partially overlapping oligomeric species or in cases where suitable buffer regions are not 
available.  Additionally, constant background subtraction from SAXS data was 
systematically explored so as to accurately generate ab initio shape envelopes for known 
samples.  Overall, these studies highlight the strengths of SEC-SAXS as a tool for 
structural analysis, and unify techniques for data processing and analysis between this 
and other data collection methods.  
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Introduction: 
 X-ray crystallography has remained an unparalleled technique in structural 
biology for its ability to visualize proteins at the atomic level.  Indeed, these static 
structures often accurately inform about mechanisms of action at the whole protein, 
domain, and atomic levels.  However, because this technique requires crystallizing the 
molecule in a non-physiological environment or context that often includes high 
concentrations of salts, truncation of native proteins, and/or incorporation of bulky 
external polypeptide tags, it can be an imperfect, incomplete representation of the 
macromolecular structure, and provides limited information on the conformational 
flexibility in the system.  Alternative techniques such as nuclear magnetic resonance 
(NMR) have size limitations that exclude many large, flexible systems which are often 
highly sought after structural targets.  For these reasons, Small Angle X-ray Scattering 
(SAXS) has emerged as a useful tool to obtain native-like structural information, albeit at 
lower resolution, on a wide variety of biological systems [193-196]. 
In a typical SAXS experiment, buffer and protein samples are exposed to 
synchrotron radiation under flow and the measured intensities at various scattering angles 
(θ) are radially averaged to create one dimensional intensity profiles as a function of the 
momentum transfer vector q (defined herein as |q| = 4π sin θ / λ, where 2θ is the 
scattering angle and λ is the wavelength in Å).  Although dominated by solvent, the 
scattering profile of the sample will contain low resolution information about the protein, 
which is an ensemble of randomly distributed orientations in solution.  Extraction of the 
protein contribution to scattering can be obtained through direct subtraction of the buffer 
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trace from the protein trace after normalization by the incident (I0) or transmitted (I1) 
beam intensity, and may be aided by water calibration using Wide Angle X-ray 
Scattering (WAXS) [197-200] or by inter-protein correction [201].  These corrected 
scattering curves can then be used for subsequent analysis. 
Because SAXS measures bulk scattering in solution rather than specific 
diffraction from highly pure and static crystalline samples, sample quality is the primary 
factor affecting the reliability of the results.  Scattering intensity (I) is directly 
proportional to the molecular weight of the sample and is somewhat difficult to parse 
from total scattering signal of other components.  In practice, this manifests as large 
contributions from any contaminants due to aggregation or degradation and high 
sensitivity to buffer matching procedures.  Buffer matching, reduction of concentration-
dependent effects, and using homogeneous, well-folded samples are necessities of any 
experiment determining protein structure by SAXS [193, 196].  Due to diversity in 
specific requirements for biological macromolecules, however, there is little 
standardization in the way SAXS experiments are set up with regards to these three 
criteria, and often limitations of particular systems dictate experimental procedure [198, 
199, 202].  Recently, Size Exclusion Chromatography in line with SAXS (SEC-SAXS), 
has been integrated at several synchrotron beamlines to ensure highly pure, monodisperse 
samples [203-206].  The clear advantages of this method have made this technique ideal 
for studying many challenging macromolecular systems. 
Regardless of the collection strategy, sample quality is often hard to measure, and 
the presence of protein impurities or other problematic artifacts is not always evident in 
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the raw data, requiring detailed analysis of all experiments.  Graphical analysis 
techniques such as Guinier, Kratky, and Porod plots provide a measure of sample quality 
and more quantitative information about overall size and shape [193].  Current analysis 
tools, while functional, are time-consuming and rely on much manual manipulation and 
interpretation of the data, restricting the amount of data processing that can be performed 
during limited synchrotron beam time, and potentially producing ambiguous results.  
SEC-SAXS further complicates this due to the large quantity of data produced, and the 
fact that buffer and protein samples have long time gaps between their exposure.  There is 
a need for flexible, graphically based tools incorporating objective methods for analysis 
of data quality and optimization of buffer subtraction. 
Beyond graphical analysis, low resolution (typically 5-15 Å) ab initio shape 
envelopes can be generated using spherical harmonic approximation of shapes based on 
the overall pairwise distance distribution function P(r) [207-212].  The Svergun group has 
developed a large suite of programs for calculation of P(r) distributions and generation of 
models [213].  DAMMIF and GASBOR use ab initio dummy atom or dummy residue 
models as an over-parameterized approach to fit the data using simulated annealing [214-
216].  These analyses are generalizable to a wide array of molecules, and give useful 
insight to an overall structure for further study, but due to the large number of parameters 
they are potentially ambiguous and require many trials and averaging for confidence in 
the result [217].  Moreover, while many of the tools developed for shape reconstruction 
using SAXS analysis were developed using highly idealized or theoretical systems and 
optimized using experimental data from traditional methods, little work has been done to 
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address how best to use them with more modern SAXS data collection techniques and 
non-ideal data sets, often having high confidence, but more irregular molecular 
architectures. 
This chapter describes widely applicable, novel approaches for SAXS data 
processing and analysis developed using SEC-SAXS.  A software package called Data 
Evaluation and Likelihood Analysis (DELA) has been developed and integrated with 
python-based scripts to intuitively perform automated SAXS analysis such as data 
manipulation and correction as well as visualization and optimization of Guinier, Kratky, 
and Porod plots [218].  Using this as well as other standard programs we have performed 
intricate analysis troubleshooting beam intensity correction, buffer correction, constant 
subtraction, P(r) calculation, and dummy atom shape envelope construction using data 
from samples with known structures from the Arf GTPase Arf6 and its Guanine 
Nucleotide Exchange Factor (GEF) Grp1. 
For beam intensity normalization, a scouting procedure was developed to 
determine the best method based on SEC-SAXS total intensity chromatograms.  Whereas 
most SAXS experiments include normalization by transmitted intensity at the beam stop, 
the best correction occurred from normalizing by the incident and transmitted intensities 
to account for beam intensity fluctuations obscured in the transmitted recording.  Next, a 
novel buffer correction method was developed that uses singular value decomposition 
and linear combination of protein and buffer scattering components. This reconstruction 
performs markedly better compared to simple buffer subtraction, and importantly allows 
the user to determine the homogeneity of samples and efficiently process large SAXS 
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data sets from any type of data collection with ease.  Multiple, low-abundance species 
could also be reliably analyzed in a single experiment.  Finally, we demonstrate an 
optimized strategy for overall constant subtraction and the use of current dummy atom 
modeling programs that retains high q SAXS data and provides reliable shape envelopes 
for known and novel samples. Overall, our analysis strategies advance the capability of 
SAXS to confidently analyze a variety of potentially low-abundance macromolecules 
through real-time purification and vastly redundant data collection supported by 
sophisticated analysis techniques capable of using this wealth of information. 
 
Results 
SEC-SAXS Data Collection, Processing and Analysis  
 SEC-SAXS provides ideal conditions for sample purity and data quality.  In the 
SEC-SAXS setup at the Advanced Photon Source (APS) at Argonne National Labs in 
Argonne, IL, a commercially available Fast Performance Liquid Chromatography 
(FPLC) gel filtration column is set up for flow in line with SAXS optics.  A Superdex 
200 10/30 (24 mL) or Superdex 10/300 mm (3 mL) column were used for these 
experiments.  When run at 0.5 ml/min at room temperature, the 3 mL column offers 
significantly higher throughput (~10 min per sample), with negligible decreases in 
resolving power.  Scattering from buffer and protein eluting from the column was 
sampled with one second exposures every five seconds. After radial averaging, the result 
is a series of 100-200 SAXS curves corresponding to buffer and protein samples (Figure 
III.1). 
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As a consequence of the amount of data produced by SEC-SAXS, data processing 
becomes a bottleneck.  Thorough assessment of data quality requires analyzing overall 
raw data, mean scattering, buffer subtracted data, and Guinier and/or Kratky plots.  Even 
with the high throughput of SEC-SAXS data collection, current analysis tools present 
challenges for checking every sample during allotted beam time.  To expedite this 
process, we developed a Python-extensible, native Mac OSX application called Data 
Evaluation and Likelihood Analysis (DELA), which allows users to quickly and 
objectively process and analyze data from a variety of experimental methods including 
SAXS using Objective-C coded source functionality extended through an embedded 
Python interpreter, with a suite of modules bridging user-modifiable Python scripts with 
the main application.  The application bundle after extension with SAXS-specific scripts 
supports importing/exporting, processing, and analysis of large quantities of raw 
scattering curves of any size (limited only by available computer memory) in an intuitive, 
graphical interface.  Processed data and results can be archived as a document, exported 
for further analysis, and publication quality plots saved in common image formats. 
To aid in development of SEC-SAXS data processing and analysis, we used 
SAXS data for an Arf GTPase Arf6 and one of its Guanine Nucleotide Exchange Factors 
(GEF), Grp1.  The Arf6 construct (residues 14-175) consists of a core G-domain well 
documented in structural studies (PDB ID 2J5X).  A Grp1 construct (residues 63-399, 
Grp163-399) composed of two uniquely shaped domains that adopt a static, elongated 
structure seen in X-ray crystallography (PDB 2R09) as well as a dimeric construct 
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Figure III.1: SEC-SAXS Analysis for Arf6 and Grp1.  Raw Intensity profiles and total 
intensity chromatograms (inset) for Arf6 (A), Grp163-399 24mL (B), Grp163-399 3mL (C), 
and Grp113-399 (D). 
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including a heptad repeat region (residues 13-399) were analyzed.  All constructs have an 
N-terminal His6 tag for these studies. 
Figure III.1 shows the analysis of SEC-SAXS data for the three constructs.  Arf6 
was analyzed using a 24 mL column, Grp113-399 using a 3 mL column, and Grp163-399 
using both columns (Grp163-399 3mL, Grp163-399 24mL).  Scattering intensities were 
integrated for each data set to generate a total intensity chromatogram as a function of the 
data frame during the experiment. One or more regions of the chromatogram representing 
data sets of interest can be selected and the raw data representing them plotted using a 
graphical selection tool and python scripts (Figure III.1).  Due to larger loading 
concentrations on the 24 mL column, a concentration-dependent Grp1 dimer was isolated 
on the 24 mL column, but not the 3 mL column.  In this way, high and low signal 
experiments analyzing monomeric and dimeric species of the same sample could be 
analyzed.  Overall, monomeric protein of each construct was separated from either 
dimers or contaminants accumulating during sample preparation that would not have 
been separated in traditional SAXS experimental procedures. 
 
Normalization using incident/transmitted beam intensities 
The profiles in Figure III.1 are displayed after correction by incident (I0) and/or 
transmitted (I1) beam intensities.  To determine the best normalization procedure, 
profiles of I0, I1, and total sample intensity for each sample were compared, as shown in 
the example with Grp163-399 3mL (Figure III.2A and B).  All three measurements showed 
fluctuations in intensity throughout the experiment.  I1 and the total intensity both 
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Figure III.2: Data Normalization of Grp163-399.  A) Total intensity chromatogram of the 
Grp163-399 sample (top) and zoomed in view of sample, I0, and I1 intensities (bottom).  B) 
Baseline intensities after indicated normalizations, offset for clarity.  C) Final total 
intensity profile after normalization 
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showed an initial downward slope in the total intensity, while I0 lacked this feature but 
had more pronounced variations reflecting periodic beam injection and decay.  
Normalization corrections were scouted by correcting the sample data with I0 or I1 in 
varying weights through a scriptable, iterative process.  Normalization by I0 alone 
reduced the baseline scattering fluctuations, and normalizing by I1 alone reduced the 
baseline slope somewhat. 
Where applicable, normalization procedures were empirically determined to yield 
a normalized total scattering chromatogram with the least contribution from beam 
intensity artifacts.  Typically, this was either a weighted, scaled average of I0 and I1 or a 
normalization by both factors (Figure III.2B).  From a practical standpoint, normalization 
by the product of I0 and I1 was found to yield consistently better results than 
normalization by either I0 or I1 alone.  Importantly, the details of the correction process 
did not change the overall scattering relationships, and samples corrected multiple ways 
had similar results upon further analysis, but rather produced clean total intensity 
chromatograms to analyze.  This normalization process clearly identifies and corrects for 
significant components in both the incident and transmitted beam intensities, which may 
be especially important for low signal-to-noise/background scattering data. 
 
Buffer Subtraction Scouting 
To investigate data quality, initial scouting of buffer regions for subtraction was 
performed, and data analyzed by a Guinier plot.  The Guinier plot (log I(q) vs. q2) 
provides useful structural information at low q angles.  For the q range satisfying the 
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Guinier approximation, this plot has a linear dependence with a slope dependent on the 
overall size and shape of the molecule [193, 219] and proportional to the radius of 
gyration, Rg.  Since the Guinier plot is independent of concentration, it can be used as a 
measure of data quality across concentrations and provides information on sample 
multimerization, aggregation, and what has commonly been termed ‘interparticle 
interference’, thought of as the exclusion of solvent at high protein concentrations 
through interaction or repulsion of protein molecules. 
Bulk increases in concentration-normalized scattering on a Guinier plot are 
indicative of changes in oligomeric state upon concentration.  Alternatively, samples with 
high amounts of aggregation will produce upward trends near I(0), and those with 
interparticle interference will slope downwards in a similar range [193].  Notably, the 
linearity of the Guinier region is sensitive to buffer subtraction artifacts, and even slight 
mismatches (< 1%) will produce positive or negative features that are difficult to 
distinguish from those associated with small amounts of a high molecular weight 
aggregates or so-called interparticle interference in traditional SAXS experiments.  With 
SEC-SAXS, high molecular weight aggregates can be effectively eliminated, while, 
buffer matching and interparticle interference remain important considerations. 
In SAXS experiments outside of SEC, buffer subtraction would include 
independently averaging beam-normalized buffer and protein scattering curves, after 
rejection of outliers, then performing direct subtraction of the averaged buffer protein 
curves, with or without concentration-dependent buffer scaling to account for the fraction 
of the sample solution volume displaced by the protein.  Similarly, an initial buffer 
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subtraction strategy for the Grp163-399 3mL and Arf6 data sets consisted of averaging and 
subtracting three experimental buffer regions from protein samples comprising the peak 
of the monomer elution (Figure III.3A and C).  This is expedited by the ability within 
DELA to directly plot representative scattering curves from total intensity plots and 
perform sample averaging, buffer subtraction, and an automated Guinier analysis. 
Unexpectedly, despite the high quality of the data and low protein concentration, 
direct subtraction of buffer produced a sharp downward curve in the low q region (Figure 
III.3B and D).  Omission of aberrant data points from the fit produced Guinier fits with 
Rg values of 25.8-27.6 Å for Grp163-399 and 16.4-16.6 Å for Arf6, similar to theoretical 
values from the crystal structures produced by CRYSOL (28.0 Å and 16.7 Å, 
respectively). Although some of these artifacts could be partially ameliorated by choosing 
specific regions for analysis as with Arf6 (Figure III.3D), this trial and error method of 
data analysis was less than ideal, as it was arbitrary and did not take full advantage of the 
large redundancy of data in SEC-SAXS.  More generally, it does not account for 
incompatibility of various buffer and protein regions due to either large time lapses or 
slight compositional differences between buffer and protein sample analysis, imperfect 
beam-normalization, and/or other sources of experimental error, all of which can be 
reduced but not completely eliminated, particularly in the case of dilute or weakly 
scattering samples.  These are inherent issues in SEC-SAXS, but also problematic for 
traditional SAXS data collection, where data for protein and buffer samples are collected 
at different times with perhaps less than ideal buffer matching. 
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Figure III.3: Buffer Subtraction Trials for Arf6 and Grp163-399.  Intensity chromatograms 
for Grp163-399 24mL (A) and Arf6 (C) indicating regions of buffer and protein used in 
buffer subtraction.  Buffer subtraction results are shown for each buffer region after 
sample averaging for Grp163-399 24mL and Arf6 in B and D, respectively. 
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Assessment of Homogeneity by Singular Value Decomposition 
 To assess overall information content of samples for buffer correction, Singular 
Value Decomposition (SVD) was calculated on beam-normalized scattering curves as in 
Figure III.2 from part (e.g. peak of interest and buffer regions) or in some cases all of the 
SAXS chromatogram.  SVD has been used in protein folding and SAXS model fitting in 
cases where a measure of the uniqueness of a scattering result is desired [220, 221].  In 
brief, SVD is a matrix algebra method that is particularly useful for determining the 
minimum components required to accurately represent data with a high degree of 
redundancy, such as protein peaks and buffer regions in SEC-SAXS, which differ 
primarily by the concentration-dependent scattering contribution of the protein.  As 
applied to SEC-SAXS, the data are represented as an M • N matrix with M columns, each 
corresponding to a different scattering curve consisting of N intensity values over the 
observed q range, and deconstructed into orthonormal basis vectors (columns of an M • N 
matrix U), singular values (elements of an N • N diagonal matrix S), and orthonormal 
coefficients (columns of a transposed matrix V) that, after weighting by the singular 
values, specify the linear combination of basis components required to exactly 
reconstruct each scattering curve in the original matrix: 𝐴 𝑀 𝑥 𝑁 = 𝑈 𝑀 𝑥 𝑁 ∗ 𝑆 𝑁 𝑥 𝑁 ∗ 𝑉!(𝑁 𝑥 𝑁)
A particularly useful property of singular value decomposition is the rotation of the 
matrices so as to successively maximize the contribution of each basis vector, creating a 
rank ordered series of basis vectors that maximizes the contribution of the first column of 
U (i.e. it is the most representative) as reflected in its corresponding singular value, then 
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maximizes the contribution of the second column to the remainder (also reflected in its 
corresponding singular value), and so on.  Thus, the singular values are indicative of the 
relative contribution or weight of each column of U to the entire set of data in S, with the 
most significant (i.e. highly weighted) U columns having reduced contributions from 
random noise in the data.  The reduction in noise is immediately apparent when 
considering that the first column of U is simply a normalized summation of the individual 
scattering curves. 
The use of SVD for data analysis was tested with the Grp163-399 24mL data set 
(Figure III.4).  Using a selection of regions of highly pure protein and solvent chosen 
from the plot of total scattering intensities, the data could be represented with two 
dominant components, as evidenced by the magnitude of the singular values and by the 
autocorrelation of the columns of U and V.  This analysis was similar when using data 
from the whole protein peak, and inclusion of dimer or contaminant portions of the 
experimental data produced an additional component seen in the autocorrelation plots 
(Figure III.4C).  Using this technique combined with SEC-SAXS, one can objectively 
assess the quality of data in a specific range and across large amounts of data without the 
need to scale for protein concentration or compare multiple rounds of buffer subtraction 
and graphical analysis. 
 
Indirect Buffer Subtraction by Linear Combination of SVD Basis Vectors 
 The preceding analysis suggests that regions of data consisting primarily of buffer 
and a single homogenous protein species can be identified using SVD, even in cases 
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Figure III.4: Singular Value Decomposition (SVD) of Grp163-399.  A) Schematic 
indicating regions from Grp163-399 24mL used in SVD analysis.  B-D) Singular Values 
and Autocorrelations (insets) of Monomer (B), Monomer and Dimer (C), and Selected 
protein and buffer regions (D). 
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where a suitable buffer region is lacking.  The finding that, apart from noise, the 
scattering data from part or all of an eluting peak with or without additional buffer 
regions can be accurately represented by two components implies that the two 
dimensional space occupied by the pure protein and buffer components can be adequately 
represented by the two significant basis vectors of U.  It then follows that the protein 
component should in principle correspond to a linear combination of U0 and U1, with 
weights c0 and c1: 𝐼! 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 ∝ 𝑐0 × 𝑈0+ 𝑐1 × 𝑈1 
If an arbitrary scale is assumed, one of the coefficients (e.g. c1) can be set to one, and the 
problem reduces to finding the best value for the unknown coefficient (c0).  An 
approximate value for c0 can be empirically determined by visual inspection of the 
Guinier region, which is expected to be linear for the optimal coefficients but deviate 
positively or negatively otherwise.  Deviations from linearity are readily detected using 
weighted or unweighted merit statistics such as R2, suggesting an optimization procedure 
that uses linearity of the Guinier region as a metric for determining the best value for c0.  
An example for the Grp163-399 3 mL sample is shown in Figure III.5.  The two 
highest signal components from SVD were combined using iterations of constants within 
a specified range, and the resulting curves subjected to a Guinier analysis using a Python 
script for determination of the optimal value of c0 based on R2 has been integrated into 
DELA.  The best fitting combination can then be combined.  Non-uniform errors were 
estimated by Savitzky-Golay smoothing using a 3rd order polynomial with a window size 
of 11 points [222].  Reconstruction of both Arf6 and monomeric Grp163-399 data through 
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Figure III.5: Linear Combination of SVD Components.  A) Scattering profiles of two 
most abundant components from SVD of the Grp163-399 3mL sample.  B) Linear 
coefficient analysis from components in A and example Guinier plots and fits from 
specific coefficients (inset) as indicated by colored boxes.  C and D) Corrected scattering 
curve and Guinier plot (inset) after optimal linear combination for Grp163-399 3mL (C) 
and Arf6 (D).  Solid line in both depicts scattering calculated from the crystal structures 
of Grp163-399 (PDB ID 2R09) or Arf6 (PDB ID 2JFX) using CRYSOL with buffer 
subtraction. 
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this method, termed SVD-LC, produced a high signal to noise reconstruction of the 
putative protein scattering that was nearly identical to the theoretical scattering for the 
crystal structure of the same construct calculated with CRYSOL (Figure III.5C and D). 
 Indirect buffer subtraction by SVD-LC was also used to analyze the low 
abundance dimer seen in the Grp163-399 24mL experiment.  Gel filtration experiments 
with a Grp163-399 I307E mutant that showed increased dimer formation confirmed that the 
dimer was concentration dependent, seen maximally as about 10% of the overall sample 
in the presence of reducing agent.  An additional oligomeric peak representing less than 
1% of the sample was observed with loading concentrations above 200 µM.  Traditional 
buffer subtraction with these low signal samples produces noisy corrected curves as 
described, but the SVD-LC approach allowed unambiguous reconstruction of the protein 
contribution with a sample concentration estimated as < 1 mg/ml at the peak.  The 
resulting reconstruction closely matched theoretical scattering for the crystallographic 
dimer for this construct (Figure III.6). 
 
Constant Background Subtraction Optimization for Ab Initio Shape Determination 
 As illustrated by the examples described in the previous section, SVD-LC is 
capable of producing high quality reconstructions of the protein scattering that are 
optimized with respect to linearity of the Guinier region.  The quality of the Guinier 
region is important for determination of the overall size and molecular weight of 
macromolecules by SAXS.  However, the linearity of the Guinier region is relatively 
insensitive to the data at high q and thus the optimization based solely on the Guinier 
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Figure III.6: Characterization of the Grp163-399 dimer species by SEC-SAXS.  A) Gel 
Filtration analysis of Grp163-399 I307E, with protein concentrations at loading as 
indicated.  B) Corrected scattering curve of dimer region from SEC-SAXS analysis of 
Grp163-399 24mL.  Solid line is the theoretical scattering calculated from the 
crystallographic dimer of Grp163-399 from CRYSOL with buffer subtraction.  C) Guinier 
plot and fit from data in B. 
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region may incur small residual deviations that become relatively more significant with 
increasing q.  These small systematic errors are analogous to the problem of buffer 
matching for direct subtraction and may share some common underlying causes (e.g. 
imperfect beam-normalization).  As with direct buffer subtraction, small deviations in 
final curves reconstructed by SVD-LC on the order of a percent or less are difficult to 
diagnose and eliminate.  Nevertheless, the effects of such errors can be partially mitigated 
by constant background subtraction, as implemented by default in many programs for ab 
initio or rigid body modeling.  While many programs in the ATSAS package 
automatically determine a constant for subtraction, in some cases, such as ab initio 
modeling by DAMMIN/DAMMIF, automatic determination of a constant for background 
subtraction is not performed if sufficiently high q data are not available.  
To account for this, the scattering intensity decay dependent on the overall 
volume and shape of the molecule were used [223].  Over a portion of the scattering data, 
referred to as the “power law regime”, purely spherical molecules have scattering decay 
proportional to q4 (Porod’s law) [224], with more complex topologies following lower 
power relationships such as q5/3 for random coils.  Unfolded proteins show little to no 
Porod scattering [193, 196].  These relationships underscore the importance of 
accounting for solvent scattering in this region for an assessment of volume and thus 
structure determination.  One approach is to collect wide angle X-ray scattering (WAXS) 
and SAXS data, using the WAXS data as a guide to determine a scale factor to reduce the 
solvent contribution, seen as a ring of intensity at q ~ 2.0 Å-1 [122, 200].  In effect, this is 
equivalent to a constant subtraction scaled to an independent scattering value measured 
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for each sample.  In the absence of WAXS data, the presence of 'contamination' from 
high q solvent intensity can be seen graphically in Kratky plots (q2*I(q) vs. q) and Porod 
plots (q4*I(q) vs. q), which for well folded proteins, produce a peak related to the overall 
volume of the protein, referred to as the Porod Volume defined by 1st and 2nd Porod 
minima [225].  An accurate Porod volume is necessary for accurate calculation of the 
pairwise distribution function and therefore ab initio shape construction.  Initial analyses 
performed on a subset of structures in order to develop algorithms for this calculation 
found data up to q = 8/Rg was adequate to reconstruct the first and second Porod volume 
[217].  However, as many proteins follow lower power scattering decay than the q4 Porod 
scattering relationship, power law regimes may be more or less extended compared with 
simple models, depending on the actual shape of the molecules investigated. 
To explore the effects of constant background subtraction, protein scattering 
curves for Grp163-399 3mL and Grp113-399 were reconstructed with SVD-LC, normalized to 
1.0, and plotted on a Porod plot (Figure III.7).  Although the data displayed peaks 
indicative of well folded protein, samples lacked a clear 2nd Porod Minimum.  Constant 
subtraction was performed iteratively using constants from 0.001-0.008, with 
significantly improved definition of the 2nd Porod minimum at with constants between 
0.004-0.005.  Oversubtraction produced data with negative intensities and severely 
warped Porod peak shapes.  For Grp163-399 3mL, the 2nd Porod minimum was at about 
0.22 Å-1, well within the 8/Rg cutoff of 0.289 Å-1 for this construct (Rg = 27.7, Figure 
III.7A).  In contrast, the dimeric Grp113-399 had an Rg of 50.4 Å, but a 2nd Porod minimum 
at ~ 0.25 Å-1, well outside the 8/Rg cutoff of 0.159 (Figure III.7B).  Overall, these data 
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Figure III.7: Constant Subtraction Scouting by Porod Plot.  Porod plots of Grp163-399 (A) 
and Grp113-399 (B) showing results after subtraction of constants as indicated. 
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underscore the importance of high q data correction, and represent a rational method for 
assessing a minimum data range for shape reconstruction. 
In order to test how constant subtraction affected shape determination, data from 
the above experiments were used as input for the programs GNOM and DAMMIF. 
DAMMIF runs produced a molecular mass determination from the data that was 
correlated to the constant subtracted similar to independent analysis [201].  Constant 
subtraction of 0.000-0.003 produced underestimates of molecular mass, while constants 
above 0.004 produced overestimates (Figure III.8A).  Shape envelopes generated from 
this data also produced noticeable features correlating to constant subtraction (Figure 
III.8B).  With too little of a constant subtracted, envelopes had large globular structures 
with irregular nodes protruding out. This is presumably an attempt to fit the data using an 
artificially small molecular mass.  Corrections between 0.003 and 0.005 resulted in shape 
envelopes that matched the crystal structure well.  Gross oversubtraction produced an 
enlarged shape envelope with diminished features.  These constants and shape 
characteristics were consistent with results from another ab initio modeling program 
GASBOR, which automatically chooses a constant to subtract.  GASBOR modeling with 
automatic subtraction of constants in the range 0.0055-0.0065 resulted in an 
overestimation of the size and washed out features.  Upon deletion of the incorporated 
solvent layer before averaging, however, the expected envelope was obtained.  Together, 
these observations help define the relationship between accurate solvent subtraction and 
shape envelope determination, and offer a qualitative and quantitative measure constant 
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Figure III.8: Effects of Constant Subtraction on ab initio Shape Envelopes.  A) Estimated 
molecular masses calculated from DAMMIF after constant subtraction as indicated.  
Corrected scattering intensities were normalized to 1.0 before analysis.  Errors on select 
bars represent standard deviation from an arbitrary selection of 10 DAMMIF 
reconstructions.  B, left) DAMMIF dummy atom envelopes after constant subtraction and 
envelope calculation from 100 DAMMIF cycles as described in Materials and Methods.  
B, right) Average GASBOR dummy atom envelopes from 10 cycles after averaging with 
or without added solvent molecules. 
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background subtractions of SAXS data in the high q region in the absence of WAXS 
data. 
 
Discussion 
SEC-SAXS offers the unique advantage of theoretically bypassing the most 
problematic aspects of data quality, producing buffer matched, aggregation-free, 
homogeneous samples at relatively low concentrations (1-5 mg/ml or less).  Because of 
the increased sample quality and large amount of data, a detailed optimization of data 
processing and analysis methods could be performed.  We have developed new 
processing and analysis techniques and tools, some of which may be widely applicable 
beyond SEC-SAXS.  The Python-extensible software package DELA can be used to 
graphically and intuitively scout useable protein and solvent regions for standard buffer 
subtraction, and SVD analysis can inform on sample homogeneity over regions of 
interest in the SAXS chromatogram.  Further, test cases for proteins with known 
structures suggest that linear combination of SVD components can be used to reconstruct 
protein scattering curves of sufficient quality for comparison with theoretical scattering 
as well as ab initio and rigid body modeling, provided the Guinier region is well 
determined and the range of data analyzed is homogenous with respect to protein 
composition. 
While SEC-SAXS greatly oversamples the data, it presents challenges regarding 
buffer subtraction in that pure buffer regions are removed from those of the sample and 
may indeed contain different compositions before and after the sample depending on the 
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experiment.  In these cases, oversampling can be exploited using SVD-LC, which allows 
indirect buffer subtraction from peak sample data alone.  Although having slightly lower 
signal than when including buffer samples, SVD-LC analysis from a whole 
chromatography peak produced reasonable quality data, in part due to noise reduction 
inherent in SVD.  This analysis will be very important with low-abundant samples, as it 
allows confident correction at low signals. 
One potential strength of SEC-SAXS over other techniques that has not been fully 
explored is the ability to analyze multiple species in a single experiment.  Many 
applications of SEC-SAXS are focused on obtaining structural information on hard to 
characterize samples due to poor stability or aggregation, which can be effectively 
mitigated by gel filtration.  But even with well-behaving samples, there is a distinct 
advantage of SEC-SAXS as a method for easily and quantitatively studying homomeric 
or heteromeric complexes.  Indeed, in the Grp163-399 24mL data set, SEC-SAXS was able 
to differentiate between dimeric and monomeric forms of the protein in solution.  Upon 
further analysis, it was reasoned that the dimer is a concentration-dependent species 
produced as an artifact of high concentrations (Figure III.6).  It is not entirely clear why 
the I307E mutant shows increased dimer formation, but analysis of the crystallographic 
dimer led to the hypothesis that the acidic residue could increase local contacts between 
the PH domain and the Sec7 domain (Figure III.9). 
When optimizing direct buffer subtraction, it was additionally puzzling that many 
of the same effects seen in traditional SAXS experiments such as ambiguous buffer 
subtraction results and interparticle interference were still seen in Guinier plots of SEC-
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Figure III.9.  The Grp163-399 Crystallographic Dimer.  Dimer after redefinition of the 
asymmetric unit in the Grp163-399 crystal structure (PDB ID 2R09).  Ile 307 and 
surrounding residues are shown in sticks. 
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SAXS data despite the high quality of the data and low concentration of samples unlikely 
to result in interparticle effects.  These effects were also seen by overcorrection for buffer 
components in SVD-LC reconstruction (Figure III.5B), consistent with the hypothesis 
that these effects were manifested in excluded solvent volume at high concentrations that 
could be corrected in these data [201]. A direct buffer subtraction optimization was 
developed that explores a constant which, when applied to the protein scattering curve 
before buffer subtraction, produces the best R2 value in a Guinier fit, similar to the 
optimization of linear combination after SVD.  This accounts for excluded protein 
volume [226].  Thus buffer subtraction can also be efficiently optimized using a linear 
Guinier region when sample concentrations are accurately measured. 
The results of this analysis represent new developments in the area of SEC-SAXS 
analysis that take advantage of the unique characteristics of these data, but that are 
applicable to all types of SAXS data to increase the breadth of macromolecular samples 
that are viable for this technique.  We envision an application for these analysis 
techniques in complex experiments in which an accurate measure of the buffer sample is 
difficult or the components are at a low population and require merging of many low 
intensity scattering profiles. 
 
Materials and Methods: 
Cloning and Protein Purification 
DNA constructs were amplified by polymerase chain reaction (PCR) with Vent 
polymerase (NEB), digested with BamH1 and SalI or XhoI, and ligated into a modified 
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pET15b vector.  Mutations were generated using whole plasmid PCR with QuikSolution 
(Stratagene) and DpnI (NEB) digestion.  After transformation of BL21(DE3) cells 
(Novagen) with plasmids, cells were grown in 2×YT with 100 mg/L ampicillin to an 
OD600 of 0.2 and expression induced with 50 µM IPTG at 18°C for 16 hrs.  After harvest, 
cells were resuspended in buffer (50mM Tris pH 8.5 or 7.5, 150mM NaCl, 2mM MgCl2, 
0.05% 2-mercaptoethanol) and frozen at -80°C.  Cells were thawed and incubated with 
0.1 mM PMSF, 0.2 mg/ml lysozyme, and 0.01 mg/ml protease free DNAse I 
(Worthington).  After sonication, lysates were supplemented with 0.5% Triton X-100 and 
centrifuged at 30,000 × g for 1 hr.  Proteins were purified on batch Ni-NTA beads 
followed by ion exchange on HiTrap Q or SP and gel filtration on Superdex-75 or 200 
(GE Healthcare). 
 
Gel Filtration Analysis of Grp163-399 Dimers 
 Gel filtration was performed on a Superdex 200 10/300 (24 mL) column in a 
buffer consisting of 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM MgCl2, and 0.1% 2-
mercaptoethanol.  Samples were incubated at room temperature for 5 hours and 200 µL 
samples were loaded and eluted at 4° C.  Standards were analyzed by gel filtration using 
the high molecular weight calibration kit (GE Healthcare). 
 
SEC-SAXS 
 SEC-SAXS was performed at Bio-CAT, Sector 18-ID at the Advanced Photon 
Source (APS) in Argonne National Labs, Argonne, IL.  100 – 500 µl (10-20 mg/ml) or 
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100 µl (10 mg/ml) samples were loaded, respectively, onto 24 or 3 ml Superdex-200 
columns (GE Healthcare) equilibrated with buffer (20 mM Tris pH 8.0, 150 mM NaCl, 2 
mM MgCl2, 0.1% 2-Mercaptoethanol (β-Me), and 1µM Inositol(1,3,4,5)tetrakisphosphate 
(IP4)).  Grp163-399 and Arf6 samples were incubated with 1.2 molar excess of IP4 for 1-5 
hrs before experimentation.  Columns were connected in line with the sample capillary 
and data collected on a Mar CCD detector at a distance of 255.3 cm with 1 s exposures 
taken at 5 s intervals during elution. Data was monitored by UV chromatogram and 
showed consistent and clear separation of monomeric protein on both columns.  Samples 
were calculated to be between 1-3 mg/ml at the peak of the protein elution profile. 
 
Scattering Curve Calculations 
 Theoretical scattering curves from relevant crystal structures Grp1 (PBD 2R09) 
and Arf6 (PBD 2JFX) were generated using the program CRYSOL [213] with buffer 
subtraction. 
 
Guinier Analysis 
The Guinier plots are shown as log I(q) vs. q2 plots and fits are based on the 
following approximation [227], [219] : 𝐼 𝑞 = 𝐼(0)𝑒[! !!!!! /!] 
Where I(0) is scattering intensity at q = 0, and Rg is the radius of gyration, which gives a 
measure of the overall size and shape of the protein.  Rg is visualized as the slope of the 
linear region on a Guinier plot in a given q range.  The Guinier region to fit was set such 
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that the q*Rg was ≤ 1.3.  Larger sizes, either through increases in molecular weight or 
elongated molecules, have steeper Guinier regions and larger Rg values. 
 
P(r) Distribution Calculation 
 Pairwise Distribution Functions P(r) [228, 229] were calculated by indirect 
Fourier transform methods. . Distributions from the software package PRIMUS [219] 
were generally similar to Maximum Entropy Method (MEM) distributions calculated 
with DELA in test cases and were used as input for dummy atom modeling.  PRIMUS 
integrates standalone programs such as AUTORG, AUTOGNOM, and GNOM to 
automatically calculate Rg based on the R2 of a Guinier plot fit which AUTOGNOM uses 
to calculate a maximum distance (Dmax) applied to the distribution [230].  An additional 
smoothing function and a zero distance constraint at the chosen Dmax are also applied. 
Pilot experiments to test the accuracy of P(r) distributions were performed by 
comparing experimental and theoretical data from the Grp163-399 construct, whose crystal 
structure contains a structured N-term His6 tag identical to the experimental construct.  
AUTOGNOM results produced informative distributions maintaining peaks and 
shoulders, and experimental data as well as theoretical data had near identical P(r) 
distributions.  However, when the data were not forced to zero at the chosen Dmax, extra 
frequencies of distances remained, resulting in a tail extending out to ~100 Å.  This tail 
was absent from theoretical data calculated without the tag, suggesting that at this size 
range, small features are represented in the data and the distance cutoff from 
AUTOGNOM is inadequate to represent them.  We therefore chose an analysis method 
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that systematically increased the Dmax until the distribution naturally came down to zero 
as has been documented for other systems [231]. 
 
Construction of Shape Envelopes Using SAXS 
For DAMMIF modeling, P(r) distributions were used as input for 100 cycles of 
DAMMIF.  Structures were grouped in sets of ten and average envelopes were generated 
using DAMSEL and DAMSUP, DAMAVER, and DAMFILT [213].  The ten filtered sets 
were again averaged and filtered.  Within initial sets of ten, Normal Spatial Discrepancy 
(NSD) values ranged between 0.5 and 0.6 ± 0.01-0.07 and for averaged sets of ten NSD 
was 0.452 ± 0.005. 
 For GASBOR modeling, 10 cycles of GASBOR were performed with 344 
dummy residues corresponding to residues 63-399 of Grp1 with an N-terminal His6 tag, 
and 4-residues to approximate scattering from bound IP4.  For comparison with 
DAMMIF models, water molecules in the resulting structures were either maintained or 
removed before averaging with the DAMAVER suite as described above.  Superposition 
of shape envelopes with representative crystal structures or similar envelopes was 
performed using SUPCOMB [232]. 
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CHAPTER IV: LARGE SCALE REORGANIZATION AND DYNAMICS IN 
RELIEF OF CYTOHESIN AUTOINHIBITION 
 
Abstract 
 In Cytohesin Guanine Nucleotide Exchange Factors (GEFs), autoinhibition of the 
catalytic Sec7 domain can be relieved through binding of Arf6-GTP to an allosteric site 
that includes the PH domain as well as proximal autoinhibitory elements consisting of the 
Sec7-PH domain linker and C-terminal helix.  The previously determined crystal 
structure of Arf6-GTP in complex with a C-terminal Cytohesin-3 (Grp1) fragment 
lacking the Sec7 domain suggests that relief of autoinhibition is driven by competitive 
interactions involving large-scale conformational rearrangements that reposition the 
autoinhibitory elements into grooves at the Arf6-GTP/PH domain interface, thereby 
promoting accessibility of substrate to the catalytic site. 
Although a Sec7-PH domain linker contributes to the autoinhibited and active 
conformations, it is unclear whether it adopts a stable or flexible structure upon Arf6 
binding.  In this chapter, small angle X-ray scattering (SAXS) is used to analyze the 
domain organization and flexibility of autoinhibited and active Cytohesins in solution.  
Autoinhibited Grp1 produced scattering data and ab initio shapes similar to the 
theoretical scattering for the crystal structure, and truncation of the autoinhibitory C-
terminal helix produced subtle changes in the overall architecture.  Active Grp1-Arf6 
tandem constructs showed small bulk shape changes compared to autoinhibited forms.  
However, the shape envelopes were incompatible with the arrangement of domains in the 
autoinhibited Grp1 structure.  Comparison of the active tandem data with theoretical 
models through Monte Carlo and rigid body modeling showed a requirement for alternate 
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conformations or flexibility in the Sec7-PH domain linker irrespective of the mobility of 
the Sec7 domain.  These findings suggest movement of the Sec7 domain upon Arf6 
binding into a potentially membrane proximal location primed for Arf-GDP binding. 
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Introduction 
Autoregulation of Guanine Nucleotide Exchange Factors (GEFs) is a common 
theme in GTPase biology, and can be coordinated with membrane association of both 
GEF and substrate molecules for tight spatiotemporal control of cell signals [26, 87, 133, 
138, 141, 142, 145].  GEFs are typically recruited to membranes through protein-lipid 
and protein-protein interactions [10, 78, 107, 152, 154], while GTPases often associate 
with membranes through insertion of lipid-modified elements.  Catalytic output may be 
regulated by post-translational modification or binding events at or with membranes, in 
some cases leading to integration of membrane targeting and exchange activity [233, 
234]. 
Arf GTPases are essential for cellular trafficking, migration, division, insulin 
sensitivity, and cancer [39, 235].  In the GDP bound state, the molecule is transiently 
associated with membranes through a myristoylated (myr) N-terminal amphipathic helix 
and is incompetent to bind classical effectors.  Concerted association of the helix with 
membranes along with nucleotide exchange by Sec7 domain GEFs causes structural 
changes that allow stable membrane association of the N-terminus and effector binding to 
epitopes involving the canonical switch regions [59-61, 236, 237]. 
Cytohesin GEFs perform GDP to GTP exchange on Arf GTPases and include 
Cytohesin (Cyth1), ARNO (Cyth2), and Grp1 (Cyth3).  They contain an N-terminal 
heptad repeat (HR) region, a catalytic Sec7 domain, and a Pleckstrin Homology (PH) 
domain.  The Sec7 domain is physically autoinhibited by a Sec7-PH linker and a C-
terminal helix including a polybasic region (pbr) that competes for Arf-GDP binding to 
121
the Sec7 domain.  Autoinhibition is relieved through phosphorylation of the C-terminal 
helix by protein kinase C (PKC) or binding of both phosphatidyl inositol (PtdIns) (3,4,5) 
tris-phosphate (PIP3) to the PH domain as well as Arf6-GTP to the PH domain and 
flanking autoinhibitory elements [31, 133, 150].  Arf6-GTP binds the PH domain 
including the linker and C-terminal helix, sequestering the autoinhibitory elements into 
nascent grooves formed at the Arf6-GTP/PH domain interface and creating a large 
allosteric shift compared to the autoinhibited configuration.  Arf6-GTP binding is primed 
(i.e. the affinity is enhanced by roughly an order of magnitude) by binding of the PH 
domain to PIP3 or its head group inositol(1,3,4,5)tetrakisphosphate (IP4).  Relief of 
autoinhibition is also aided by membrane association of substrate and activating 
GTPases, further integrating the autoregulatory mechanism with membrane recruitment. 
[31, 151, 234] 
  Despite detailed insights into relief of autoinhibition by Arf6-GTP from 
structural and biochemical analysis, there is no structural information about the Sec7 
domain in the Arf6-stimulated state, as the crystalized complex only includes the 
allosteric site [234].  The extent of mobility in the Sec7 domain upon binding to Arf6 is 
unknown. It is further unclear whether the conformation of the linker in the structure of 
the Arf6-GTP complex with the allosteric site is representative of the complex with the 
full length protein in solution, or an infrequently populated location stabilized by existing 
crystal contacts between molecules. 
To understand the potentially complex Sec7 rearrangements upon Arf6 binding, 
Size Exclusion Chromatography in line with Small Angle X-ray Scattering (SEC-SAXS) 
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was performed with Cytohesin constructs in autoinhibited and active forms as well as 
Grp1-Arf6 fusion constructs.  These showed a large scale rearrangement of Cytohesins 
upon activation compatible with relief of autoinhibition, but incompatible with structural 
observations of a fully ordered Sec7-PH domain linker.  Monte Carlo ensemble modeling 
coupled with rigid body modeling indicate a requirement for greater flexibility in the N-
terminal region of the linker than observed in the crystal structure of the Arf6-GTP 
complex.  While this flexibility allowed multiple orientations of the Sec7 domain, the 
data require a location of the Sec7 domain greatly extended from the autoinhibited 
conformation.  Together, these data suggest a mechanism for relief of autoinhibition in 
which Arf6 promotes a mobile, but more membrane proximal position of the Sec7 
domain. 
  
Results 
SEC-SAXS of Autoinhibited and Active Grp1 Constructs 
 To investigate structural changes of Cytohesins upon relief of autoinhibition, 
SEC-SAXS combined with Singular Value Decomposition (SVD) and Linear 
Combination (LC) as described in Chapter III was performed on Grp1 constructs 
including the Sec7 domain, PH domain, and CtH but lacking the heptad repeat region.  
Proteins were concentrated and incubated at 10 mg/mL with excess of IP4 and loaded 
onto a SEC column in line with SAXS in the presence of IP4.  Reduced data was 
normalized by the incident/transmitted beam intensities and the protein scattering 
reconstructed by linear combination of the two most significant components from SVD, 
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followed by standard Guinier and pairwise distribution function (PDDF, P(r)) analysis 
(Chapter III, and [218, 219]).  P(r) distributions were calculated with GNOM and ab 
initio shape envelopes with DAMMIF and GASBOR [213, 217, 238].  Data were 
collected on known autoinhibited (Grp163-399) and fully active constructs (Grp163-390) 
[133]. 
As shown in Figure IV.1A for Grp163-399, total intensity chromatograms showed a 
predominately homogeneous protein peak that was reasonably well separated from minor 
contaminants.  The reconstructed protein scattering for Grp163-399 was almost identical to 
the theoretical scattering calculated with CRYSOL (Figure IV.1B).  Small deviations in 
the high q region likely reflect expected mobility of the histidine tag in solution compared 
with the ordered conformation trapped by intermolecular contacts in the crystal structure.  
The P(r) distribution for the Grp163-390 construct, with catalytic activity close to that of 
the isolated Sec7 domain [133], overlapped well with the autoinhibited data except for 
the appearance of a clear shoulder at about 50 Å (Figure IV.Ic).  As expected, the Grp163-
399 shape envelope closely resembled the crystal structure of this construct.  
Unexpectedly, the Grp163-390 shape envelope rather than showing limited or variable 
dummy atom density in modeling replicates indicative of greater flexibility, showed a 
consistent shape (NSDavg = .601 ± 0.016) that was elongated compared with the envelope 
for Grp163-399 (Figure IV.1D).  Thus, the scattering data in solution are consistent with the 
overall structure seen in the crystallographic studies of the autoinhibited state, and show 
an unambiguous shape envelope in the absence of the C-terminal helix, suggesting that 
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Figure IV.1: SEC-SAXS analysis of Grp163-399 and Grp163-390.  A) Total Intensity 
Chromatogram of Grp163-399.  B) Corrected scattering curves (circles) and theoretical 
scattering curves produced from CRYSOL (line).  Inset is Guinier plot of the corrected 
data with fit.  C) P(r) distributions of Grp163-399 and Grp163-390 constructs as indicated.  D) 
ab initio shape envelops for Grp163-399 and Grp163-390 constructs. 
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the Sec7 domain may undergo a rearrangement to sample a less restrictive though 
perhaps still limited conformational space. 
  
Relief of Autoinhibition in Grp1-Arf6 Tandems 
 Assessing structural changes in a Grp1-Arf6 complex in solution experiments is 
complicated by the high KD (18 µM) [234] and simultaneous requirement for PIP3 or IP4 
[31, 133, 151, 234].  These properties would lead to heterogeneous populations of bound 
and unbound states within the practical concentration range of SEC-SAXS, confounding 
analysis.  To circumvent this problem, we designed a suite of Grp1-Arf6 tandem 
constructs for biochemical and SAXS analysis based on the crystal structure of the Grp1 
PH domain with N-terminally truncated Arf6 [234].  Modeling in PyMOL and COOT 
indicated that a direct tandem construct could potentially allow relief of autoinhibition in 
cis due to the fortuitous 19 Å distance between the peripheral Grp1 C-terminus and the 
truncated Arf6 N-terminus in the crystal structure that could accommodate the Arf6 
amphipathic helix without obvious steric conflicts.  The presence or absence of a 6 Gly-
Ser (6GS) linker between the Grp1 and Arf6 modules was also generated to provide a 
more flexible linkage and to assess uniqueness of overall kinetic and structural 
observations.  These constructs were optionally supplemented with C-terminal histidine 
or SUMO tags to enhance the confidence of domain assignments, and generated with or 
without the Grp1 K340A mutation known to abolish Arf6-GTP dependent relief of 
autoinhibition and membrane recruitment [31, 217].  All constructs included an N-
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terminal His6 tag and, for Arf6, the Q67L mutation that strongly impairs the already low 
intrinsic rate of GTP hydrolysis (Figure IV.2A) [239]. 
 To investigate autoinhibition in the context of tandem constructs, in vitro GEF 
assays for each construct were performed measuring mant-GDP exchange on N-
terminally truncated Arf1-GDP (NΔ17Arf1) (Figure IV.2B).  Assays using Grp163-399 in 
the presence of 80 µM N-terminally truncated Arf6 and IP4 showed an 11-fold increase in 
catalytic efficiency (kcat/KM) over Grp163-399 alone.  Assays with direct Grp1-Arf6 tandem 
constructs loaded with non-hydrolyzable GppNHp in the presence of IP4 showed 4- to 5-
fold increased activity, which was increased to 13- to 20-fold by addition of the 6 Gly-Ser 
(6GS) linker or C-terminal His6 or SUMO tags.  Removal of IP4 from the system reduced 
stimulation in all cases, and the K340A substitution nearly abolished the effect.  
Despite differences in stimulation among the suite of constructs, these assays 
indicate that in all cases the biochemical and structural requirements for relief of 
autoinhibition are met when Grp1 and Arf6 are expressed as a single polypeptide.  
Decreased kinetic activity in tandems lacking the 6GS linker may be a result of 
competition for substrate binding to the Sec7 domain by Arf6 binding or incomplete 
relief of autoinhibition.  Regardless, results from the Grp1-6GS-Arf6 tandems show 
kinetic properties consistent with fully autoinhibited and active states. 
 
Investigation of Grp1-Arf6 tandems by SEC-SAXS 
To explore potential mechanisms for differences in tandem constructs, and assess 
the overall domain architecture of the Arf6 stimulated state of Grp1, SEC-SAXS 
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Figure IV.2: Domain Structure and Kinetic Analysis of Grp1-Arf6 Tandem Constructs.  
A) Cartoon of domain structure of constructs used for kinetic and SEC-SAXS analysis.  
Variable regions are in parentheses.  Star represents the K340A mutation.  B) Catalytic 
efficiency (kcat/KM) of Grp1-Arf6 tandem constructs for NΔ17Arf1-GDPmant exchange.  
Gray and black bars represent assays measuring kinetics with 125 nM Grp1 in the 
presence or absence of 80 µM NΔ13Arf6(Q67L) and 1 µM IP4.  All other assays 
represent assays using titrations of tandem constructs in the presence of absence of 10 
µM IP4. 
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experiments were performed in the presence of Ins(1,3,4,5)P4 on Grp1-Arf6 tandems with 
or without the 6GS linker, K340A substitution, or C-terminal tags.  These constructs also 
incorporate the E161A catalytically dead mutation in the Grp1 Sec7 domain to decrease 
intramolecular interaction of Arf6-GTP with the substrate site [89].  As shown in Figure 
IV.3 and Table IV.1, the Grp1-6GS-Arf6 tandem, which showed robust relief of 
autoinhibition in GEF assays produced high quality scattering data with an Rg of 32.5 Å 
and Dmax of 136 Å.  Similar high quality data was obtained for all other constructs. 
The K340A variants had consistent increases in Rg and Dmax values over wild type 
and clear shoulders in P(r) distributions (Figure IV.3B). These differences between WT 
and K340A constructs were small (< 2 Å difference in Rg) in comparison to the overall 
size of the construct but consistent between Grp1-Arf6 and/or Grp1-6GS-Arf6 constructs.  
C-terminally His6 tagged constructs showed almost no changes in Rg values and P(r) 
distributions between K340A and WT tandems, likely due to increased overall flexibility.  
When comparing active constructs, addition of C-terminal His6 or SUMO tags and/or 
deletion of the Gly Ser linker produced slight deviations in Rg and Dmax values as well as 
broader P(r) distributions correlating with molecular mass differences between constructs 
(Figure IV.3C and D, and Table IV.1).  Overall, however, these differences were small, 
and the overall P(r) distributions similar, consistent with a common overall domain 
organization and no major changes in shape or oligomeric state.  Taken together, this data 
suggest slight changes in overall shape between autoinhibited and active constructs, and 
provide multiple data sets representing active structures for further analysis. 
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Figure IV.3: SEC-SAXS Analysis of Select Grp1-Arf6 Tandem Constructs.  A) 
Corrected data and Guinier plot of the Grp1-6GS-Arf6 construct.  B) P(r) distributions of 
wild type (WT) and mutant (K340A) Grp1-Arf6 tandems constructs C) Guinier plots of 
Grp1-Arf6 tandems including 6 Gly Ser and linkers and C-terminal SUMO tag for 
comparison.  D) P(r) distributions of constructs in C. 
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Rg Dmax 
 
Guinier GNOM (s.d.) 
Grp163-399 27.7 28.3 (.103) 110 
Grp163-390 27.6 28.8 (.175) 104 
Grp163-390 (Dimer) 40.9 42.0 (.443) 140 
His6-Grp1-Arf6 30.9 31.6 (.082) 108 
His6-Grp1K340A-Arf6 32.5 33.4 (.351) 134 
His6-Grp1-Arf6-His6 32.1 32.4 (.112) 125 
His6-Grp1K340A-Arf6-His6 32.5 33.3 (.103) 132 
His6-Grp1-Arf6-SUMO 35.9 37.2 (.318) 130 
His6-Grp1K340A-Arf6-SUMO 37.0 38.3 (.213) 165 
His6-Grp1-6GlySer-Arf6 32.5 33.4 (.162) 136 
His6-Grp1K340A-6GlySer-Arf6 33.8 35.1 (.233) 151 
His6-Grp1-6GlySer-Arf6-His6 33.5 35.0 (.183) 140 
His6-Grp1K340A-6GlySer-Arf6-His6 34.0 36.2 (.326) 182 
His6-Grp1-Arf6-6GlySer-SUMO 37.8 38.5 (.166) 151 
His6-Grp1K340A-Arf6-6GlySer-SUMO 40.0 41.6 (.372) 187 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table IV.1. Radius of Gyration and Dmax values from SEC-SAXS analysis. 
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Domain Architecture of Arf6-Stimulated Grp1 Tandems 
 In order to visualize the domain architecture for active Grp1-Arf6 tandems, 
dummy atom/residue modeling was used to create low resolution shape envelopes for the 
active Grp1-6GS-Arf6 constructs.  Fusion constructs with or without C-terminal His6 tags 
produced similar envelopes with a consistent size and shape (NSD between 0.453 and 
0.535, Figure IV.4A and Table IV.1) in accordance with their similar P(r) distributions.  
A clear shape for the Grp1 PH domain-Arf6 complex and an additional extended lobe of 
dummy atom density was seen in all constructs, with only slight variability between 
constructs with or without C-terminal tags.  The larger size and elongated shape of the 
Sec7 domain helped assign the domain into this portion of the shape envelope, although 
the orientation of the Sec7 domain could not be unambiguously deduced (Figure IV.4A).  
Determining the location of Arf6 in Grp1-Arf6 tandems was less straightforward than the 
Sec7 domain, owing to the similar sizes and shapes of the Grp1 PH domain and the Arf6 
molecule at low resolution of the SAXS data.  To resolve this, ab initio models for C-
terminally SUMO tagged tandems were compared with constructs lacking the tag.  The 
location of the extra dummy atom density for the SUMO domain was used to assign the 
PH and Arf6 portions of the envelope (Figure IV.4B). 
The major domains without linking regions can be approximately positioned into 
the overall dummy atom envelope for further comparison (Figure IV.4C).  Despite some 
ambiguity in the orientation of the domains and the low resolution of this shape 
information, these data suggest a stable average arrangement of the Grp1-Arf6 tandem 
architecture.  Notably, the shape envelope from Grp163-390 construct showed clear overlap 
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Figure IV.4: Domain Assignment of Grp1-Arf6 Tandem Shape Envelopes.  A and B) 
Filtered DAMMIF shape envelopes for Grp1-6GS-Arf6 (orange), Grp1-6GS-Arf6-His6 
(cyan), and Grp1-6GS-Arf6-SUMO (Blue).  (A and B) Superpositions were performed 
with the program SUMCOMB.  C) Manual domain assignment of Sec7 domain (from 
PDB 2R09) and PH-Arf6 complex (PDB 4KAX).  D) Comparison of Grp163-390 and 
Grp1-6GS-Arf6 shapes showing overlap of the theoretical Sec7 and PH domains. 
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with the Sec7-PH domain portion of the Grp1-6GS-Arf6 envelope, consistent with 
similar active state organization between the Sec7 and PH domains. (Figure IV.4D). 
 
Defining Structural Rearrangement in Grp1-Arf6 Tandem Constructs 
 The Grp1 Sec7-PH domain linker contributes to autoinhibition by interaction with 
the Arf1-GDP binding site [133].  Similarly, the Grp1-PH/Arf6 interface engages the 
linker in a nascent groove at the interface [234].  Superposition of the PH domain in the 
autoinhibited and Arf6-bound structures led to a hypothetical model for active Cytohesins 
whereby sequestration of the linker repositioned the Sec7 domain (Figure IV.5A, top).  
Alternatively, a hypothetical model assuming no rearrangement of the Sec7–PH linker 
upon Arf6 binding would result in a very different, but still compact architecture, as 
evidenced by the superposition of these models at the PH domain-Arf6 modules (Figure 
IV.5A, bottom).  
 To visually test these models with the ab initio shape envelopes from tandem 
constructs, the Grp1-6GS-Arf6 shape envelope was compared with these hypothetical 
structural models by docking the models into positions using the domain assignments in 
Figure IV.4.  Not surprisingly, when the active Grp1-PH/Arf6 structure is docked into the 
active tandem shape envelope, the Sec7 domain density is oriented 90° in the opposite 
direction away from the hypothetical position (Figure IV.5B, top).  Similarly, the Arf6 
density is shifted approximately 90° from the location predicted when the autoinhibited 
Grp1 structure is anchored into the shape envelope at the Sec7 and PH domains (Figure 
IV.5B, bottom).  As opposed to the compact structures theorized in from crystal 
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Figure IV.5: Structural Rearrangement in Active Grp1-Arf6 Tandem Constructs.  A) 
Schematic representing theoretical autoinhibited (pink mesh) and active (blue mesh) 
conformations of the Grp1-Arf6 tandems.  B) Comparison of Grp1-6GS-Arf6 shape 
envelope with conformations in A with (top) hypothetical active and (bottom) 
autoinhibited orientations of the Sec7-PH-Arf6 tandem. 
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structures, the observed architecture is elongated and planar.  This comparison illustrates 
that at least part of the linker region most likely adopts an orientation different from that 
in the crystal structure of the Arf6-GTP complex.  Because shape envelopes represent a 
low-resolution average of all conformations present in the sample, this could be 
explained by either flexibility in the linker region or large degrees of freedom in the Sec7 
domain not represented in the final model.  Manual modeling of the Sec7 domain and 
Grp1 PH-Arf6 structures into the envelope produced arbitrary or otherwise unsatisfactory 
results. 
 
Flexibility of the Sec7-PH Domain Linker 
 The above observations led to a consideration of alternate conformations of the 
15-residue Sec7-PH domain linker, which spans between two proline residues at position 
251 and 265.  In the autoinhibited state, residues 257-262 tightly bury into the Arf-GDP 
SWI binding surface [133].  Similarly, Leu 258 and Phe 262 bury into the interfacial 
groove within the Grp1 PH-Arf6 complex.  However, this complex lacks clear density for 
residues 251 to 254 and, while the C-terminal helix contains mostly interactions with 
Arf6 in the Grp1-PH/Arf6 complex, residues 255 to 259 of the linker mediate interactions 
with the PH domain as well as Arf6 and contribute to crystal contacts.  Consistent with 
these observations, truncations of linker residues up to residue 260 maintain full binding 
to Arf6-GTP [217]. 
In order to investigate the potential requirement for flexibility in the Sec7-PH 
domain linker, scattering data from Grp1-6GS-Arf6 constructs with single N-terminal 
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(Grp1-6GS-Arf6) or dual N/C-terminal His6 tags (Grp1-6GS-Arf6-His6) was analyzed 
directly through an approach using the Ensemble Optimization Method (EOM) [217, 240, 
241].  In this process, 10,000 random structures were generated from a starting model 
with the Sec7 domain (residues 63-251) and the Grp1 PH–Arf6 complex treated as rigid 
bodies followed by a genetic algorithm to choose a best-fitting ensemble of structures.  
The beginning model for EOM was generated from arbitrary positions of the Sec7 
domain and PH domain-Arf6 complex only slightly deviated from Figure IV.4C so as to 
maintain connectivity of the polypeptide chain and approximate the shape seen in ab 
initio envelopes.  The C-terminal limit of the Sec7 domain was defined by a common 
structural feature in which a hydrophobic side chain caps the helical bundle at the C-
terminus [26, 87, 89, 133], and the PH domain-Arf6 structure excluding the Sec7-PH 
domain linker was used as a model for these domains, using dummy residues to represent 
the N—terminal helix of Arf6 and the 6GS linker. 
To assess flexibility requirements in the linker, the PH domain structure bound to 
Arf6 was used and the linker portion modeled as flexible dummy residues from residue 
251 to residue 255 (the entire crystalized linker intact), 260 (retains minimal allosteric 
binding site for Arf6), or 265 (entire linker replaced with dummy residues).  The 255 
truncation mimics the compact active structure hypothesized in Figure IV.5A and the 265 
truncation confers maximal flexibility.  In all cases, dummy residues were used to 
represent the absent His6 tags, the Sec7-PH domain linker as specified above, and the 
6GS linker between Grp1 and Arf6.  As the N-terminal portion of Arf6 is a predicted 
helix and the Sec7-PH domain linker is ordered in the Arf6-bound structure [234], this 
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model potentially overestimates the flexibility, but importantly allows for an unbiased 
sampling of flexibility requirements for the Sec7-PH domain linker. 
EOM ensemble Rg distributions can be compared with the pool distribution to 
give a measure of experimental versus theoretical flexibility.  For both Grp1-6GS-Arf6 
and Grp1-6GS-Arf6-His6, the ensemble produced from the 255 truncation model failed to 
fit the data (χ > 5.0 and 4.4, respectively), producing a distribution shifted far away from 
the pool that could not represent the experimental Rg values of 32.5 Å and 33.5 Å, 
respectively (Figure IV.6A).  The ensemble distributions for the 260 truncation linker 
length fit the data (chi = 1.8 and 1.9) and were sharper and shifted to the right compared 
to the pool distribution, suggesting more elongated, overall structures than represented by 
random mobility of the domains (Figure IV.6B).  Slightly better fits were obtained when 
the entire linker was mobile in the 265 truncation (chi = 1.35, and 1.43, respectively 
Figure IV.6C).  Fits were generally better for the singly His6 tagged construct in all cases, 
both in chi values and by visual analysis of the residuals (Figure IV.6D and E), but 
overall, the two constructs performed equally well in this analysis, offering an 
independent observation of structural relationships. 
 
Refinement of Representative Structures Using Rigid Body Modeling 
To further assess the conformational space potentially represented by the data, 
representative structures from EOM ensembles were used as starting models for rigid 
body modeling in CORAL [242], which uses simulated annealing to refine individual 
starting structures to the data.  As shown in the example in Figure IV.7A, starting 
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Figure IV.6: Ensemble Optimization Method Analysis of Grp1-Arf6 Tandems with 
Flexible Linkers.  Radius of gyration (Rg) distributions from pool (black) and best-fitting 
ensemble of structures from Ensemble Optimization Method (EOM) fit to the His6-Grp1-
6GS-Arf6 (green. left) and His6-Grp1-6GS-His6 (blue, right) data. Starting models in 
which Grp1 residues 252-254 (A), 252-260 (B), or 252:265 (C) were kept as flexible 
dummy residues.  D) EOM ensemble scattering intensities (lines) fit to the data (circles) 
with residuals for the Grp1-6GS-Arf6 data set and models as indicated.  E) As with D, 
but fitting to the Grp1-6GS-Arf6-His6 data set. 
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Figure IV.7: Rigid Body Modeling of Ensemble Optimization Method Structures for 
Grp1-Arf6 Tandems.  A) Example refinement of representative Sec7 domain structure 
from Ensemble Optimization Method (red) using the Grp1-6GS-Arf6 tandem using Rigid 
Body Modeling in CORAL (blue).  B) Fits of structures in A to the data.  The fit for the 
EOM Structure was calculated in CRYSOL after constant subtraction.  C) Fits from 
CORAL refinement of EOM structures with the 260 truncation of the Grp1 PH domain 
described in Figure IV.6.  Representative models are for Grp1-6GS-Arf6 (blue) and 
Grp1-6GS-Arf6-His6 (cyan), with others color in gray.  D) Fits from CORAL refinement 
as in C, but using truncation of the Grp1 PH domain at residue 265. 
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structures that did not initially fit the data could be refined to a structure with deviations 
from the model equal to EOM results.  Using such a wide variety of starting structures 
allows a relative measure of the uniqueness of any one result for a particular data set.  
Rigid Body Modeling was performed using the representative EOM structures from 
models truncating the PH domain at residue 260 or 265.  Similar to the EOM modeling, 
the Grp1 PH domain-Arf6 complex was fixed during simulation.  With the 260 
truncation, refinement of EOM structures from both Grp1-6GS-Arf6 and Grp1-6GS-
Arf6-His6 data sets produced reasonable fits (chi = 1.8-2.0 from four structures, Figure 
7b).  Similar to relationships in EOM, starting models truncating the linker at residue 265 
produced slightly better fits, with chi values of 1.8-1.9 and 1.4-1.6 for the Grp1-6GS-
Arf6 and Grp1-6GS-Arf6-His6 data, respectively (Figure IV.7C and D).  These data 
confirm that some flexibility of the Sec7-PH domain linker is necessary to account for the 
Grp1-Arf6 tandem SAXS data, and provide reasonable starting models for further 
consideration. 
To define possible models for the orientation of the Sec7 domain in these 
molecules, the refined structures from the EOM-CORAL analysis were compared.  
Representative examples of the structures are shown in Figure IV.8.  When fitting the 260 
truncation model to data from Grp1-6GS-Arf6 constructs with or without the His6 tag, a 
variety of Sec7 positions were allowed that oriented the N-terminus toward the PH-
domain/Arf6 complex (Figure IV.8A).  However, the structures from refinement of the 
265 truncation models produced structures with a much greater degree of freedom for the 
Sec7 domain resulting in variable N-terminal orientations (Figure IV.8B).  As an 
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Figure IV.8: Orientations of the Grp1 Sec7 Domain after Rigid Body Refinement with 
Flexible Sec7-PH Domain Linker.  A) Representative structures from EOM and CORAL 
refinement using either the Grp1-6GS-Arf6 or Grp1-6GS-Arf6-His6 data with truncation 
of the Grp1 PH domain at residue 260.  B) Representative structures as in A with 
truncation of the Grp1 PH domain at residue 265. C) Comparison of measured and 
calculated Rg values from EOM or EOM with CORAL refinement colored as indicated.  
For refined structures, Rg values were calculated using CRYSOL with constant 
subtraction.  Error bars represent standard deviations of results in cases with more than 
one refined structure. 
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confirmation of this requirement, Rg values for refined structures in the 260 or 265 
truncation models were in good agreement with the experimental values, but deviated 
from the average EOM pool Rg from the 255 truncation, which has a fixed linker position 
and randomized Sec7 position (Figure IV.8C.)  Together, these observations underscore 
the necessity for flexibility and/or alternate conformations of the Sec7-PH domain linker 
from fully ordered conformation seen in the Arf6-bound crystal structure in addition to a 
likely dynamic Sec7 domain orientation to account for observed SAXS data. 
 
Discussion 
 
 Autoregulation in GEFs presents a challenge for structural studies in that active 
forms often include flexible conformations that either preclude or are not adequately 
represented by crystallographic studies.  For this reason, earlier studies of the active 
states of Cytohesins focused on biochemical determinants for relief of autoinhibition and 
structural studies in the absence of the catalytic domain.  The work presented here 
represents the first structural description of active Cytohesins.  SEC-SAXS analysis of 
Cytohesins stimulated through either truncation of the polybasic region or binding of 
Arf6-GTP showed subtle changes in overall structure compared to autoinhibited forms.  
Ab initio shape envelopes of these constructs showed an elongated architecture that 
appeared to be incompatible with a fully ordered Sec7-PH as observed in the crystal 
structure of the Arf6-GTP complex with a Grp1 construct lacking the Sec7 domain.  
EOM and rigid body analyses confirmed that dynamic flexibility, or at a minimum 
alternate conformations, for the N-terminal portion of the linker are necessary to account 
for the data.  Although individual structures obtained from CORAL were able to fit the 
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data nearly as well as the optimized ensembles from EOM, the lack of interdomain 
contacts involving the Sec7 domain in the individual CORAL refined structures is 
consistent with a more dynamic view of the domain organization and, in particular the 
orientation of the Sec7 domain, such as that provided by the optimized ensembles. 
 Molecular determinants for relief of autoinhibition were maintained in Grp1-Arf6 
tandems and overall ab initio shape envelopes were similar in SEC-SAXS experiments 
with or without the 6GS linker or C-terminal tags.  Still, direct tandems showed relatively 
weak relief of autoinhibition that was increased by addition of the 6GS linker or C-
terminal tags.  This may be due to the necessary absence of the Grp1 E161A mutation in 
kinetic assays.  When the catalytic Sec7 domain glutamate is present, the Arf6 in tandem 
may effectively compete for substrate binding.  This would manifest more in constricted 
contexts, and less so when more flexibility is allowed within the Grp1-Arf6 linker or if a 
C-terminal tag hindered such an interaction.  In SAXS experiments, the Grp1 E161A 
mutation blocks this interaction and favors Arf6 binding with the PH domain predicting a  
more consistent structure between the different active constructs. 
 Despite the resolution limits of SAXS, EOM and rigid body modeling helped to 
clarify a requirement for flexibility in the linker region of active Cytohesins.  Given the 
well defined structures of the Sec7, PH, and Arf6 modules, flexibility would reasonably 
come from the autoinhibitory elements.  In the Arf6-bound state, flexibility is unlikely in 
C-terminal portion of the Sec7-PH linker or the C-terminal helix due to extensive 
contacts of Phe 262 in the linker and multiple contacts involving the polybasic region in 
the Arf6 binding interface.  Although N-terminal portions of the Sec7-PH linker are 
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located at the interface, the ordered conformation in the crystal structure appears to be 
stabilized via intermolecular contacts and there is evidently more flexibility in solution 
and/or in the context of constructs that contain the Sec7 domain.  Consistent with these 
conclusions, defects in Arf6 binding were seen upon truncation of the linker at residue 
263 but not 260 [234].  EOM served as a good test of these properties, since it uses a 
Monte Carlo approach and does not include assumptions about the position of the Sec7 
domain.  If the SAXS data only required mobility of the Sec7 domain, an active model 
simply using the known crystal structures would have fit the data.  Instead, EOM and 
rigid body modeling results indicated that replacing the ordered Sec7 linker in the active 
model with flexible dummy residues up to residue 260 provides sufficient flexibility to fit 
the data, while the inclusion of the fully ordered linker disallowed elongated structures 
suggested by ab initio SAXS envelopes. 
Because of resolution limits of SAXS and uncertainty about flexibility of the 
Sec7-PH domain linker, the exact orientation of the Sec7 domain is unclear and likely 
dynamic.  As shown by EOM and rigid body modeling, models that include flexibility 
starting at residue 260 tend to be more elongated than the pool distribution, suggesting a 
more limited range of motion for the Sec7 domain.  However, models with an entirely 
flexible Sec7-PH linker show a wide range of Sec7 domain orientations and positions.  
Despite this ambiguity, the Sec7 domain is shifted greatly from the autoinhibited state 
and in putative locations diverted from that hypothesized from a rigid linker region.  This 
can be incorporated into a model for relief of autoinhibition integrating the current data, 
which can be constructed by simple superposition of well-fitting rigid body models with 
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Figure IV.9: Model for Relief of Autoinhibition With Sec7 Domain Reorientation.  
Model was constructed using EOM-CORAL analysis of the Grp1-6GS-Arf6 data using 
265 truncation (left) or 260 truncation (right) of the Grp1 PH domain.  The model was 
superposed with the Grp1 PH-Arf6 crystal structure (PDB ID 4KAX).  The Arf1-
GDP/ARNO structure was superimposed at the Sec7 domain and Arf6-GDP aligned with 
Arf1-GDP for the location of the substrate Arf.  The myristoyl and diacyl glycerol 
moieties on Arf6-GTP are modeled in configurations compatible with membrane 
insertion.  The POPC bilayer membrane was derived from the coordinates of a molecular 
dynamics simulation [186]. 
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Grp1 PH domain-Arf6 crystal structure and docking on a simulated membrane 
environment via the 1-phosphate of Grp1 similar to previous studies [234] (Figure IV.9).  
Strict orientation of the Sec7 domain N-terminus away from the Grp1 PH domain could 
orient the Arf-GDP binding site away from the membrane environment too far for 
membrane associated nucleotide exchange [60, 61, 77].  A more dynamic Sec7 domain 
and/or flexible linker may allow sampling of alternate Sec7 domain orientations suited 
for catalysis of membrane bound Arf-GDP.  Finally, flexibility in the N-terminal portion 
of the linker in solution does not exclude the possibility that membrane association would 
further influence the orientation of the Sec7 domain. 
It remains to be seen what role rearrangement of the Sec7 domain and or substrate 
binding plays in the overall mechanism integrating membrane targeting with 
autoregulation.  Arf-GDP binding may help stabilize a membrane-proximal 
conformation, providing a concerted mechanism to create stable microenvironments of 
specialized GEF activity, as has been seen for BRAG2 [87].  In addition, Arf6-bound 
conformations of the Sec7 domain may itself contribute to membrane association through 
direct membrane insertion or dimerization of the heptad repeat regions.  Further 
biochemical and structural studies with dimeric and substrate-bound Cytohesins could 
help to define the sequential or concerted mechanisms for relief of autoinhibition and 
membrane recruitment by GTP-bound Arfs and Arls. 
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Materials and Methods 
 Cloning and Protein Purification 
 DNA constructs were amplified using PCR with Vent polymerase (NEB), 
digested with BamH1, and SalI/XhoI and ligated into a modified pET15b vector.  
Mutants were generated using the whole plasmid PCR with QuikSolution (Stratagene) 
and DpnI (NEB) digestion.  After transformation of BL21(DE3) cells (Novagen) with 
plasmids, cells were grown in 2×YT with 100 mg/L ampicillin to an OD600 of 1.0-1.2 and 
expression induced with 1mM IPTG at 37°C for 3 hrs.  After harvest, cells were 
resuspended in buffer (50 mM Tris pH 8.5 or 8.8, 150 mM NaCl, 2 mM MgCl2, 0.05% 2-
mercaptoethanol) and frozen at -80°C.  Cells were thawed and incubated with 0.1 mM 
PMSF, 0.2 mg/ml lysozyme, and 0.01 mg/ml protease free DNAse I (Worthington).  
After sonication, lysates were supplemented with 0.5% Triton X-100 and centrifuged at 
30,000 × g for 1 hr.  Proteins were purified on batch Ni-NTA beads followed by ion 
exchange on HiTrap Q or SP and gel filtration on Superdex-75 or 200 (GE Healthcare). 
 
Nucleotide Loading 
Tandem Grp1-Arf6 samples were incubated overnight at 4°C in 20 mM Tris, pH 
8.0, 150 mM NaCl, 5 mM EDTA, and 1 mM DTT with a 10 fold molar excess of 
GppNHp.  MgCl2 was added to a final concentration of 10 mM and excess nucleotide 
removed by gel filtration on Superdex-75 (GE Healthcare) or using a D-Salt column 
(Pierce ThermoFisher). 
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GEF Assays 
 The fluorescence decrease upon mantGDP dissociation from Arf1NΔ17 was 
monitored in 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM MgCl2 and 250 µM or 1 mM 
GppNHp.  Grp1 or Grp1-Arf6 tandem constructs with or without active Arf GTPases 
and/or head groups were formatted into 96 well half area microplates (Corning) and 
incubated for 16-24 hrs at 25°C.  Reactions were initiated by addition of 1 µM 
Arf1NΔ17-mantGDP and monitored using a Safire microplate spectrophotometer (Tecan) 
with excitation and emission wavelengths of 360 nm and 440 nm, respectively.  Observed 
rates constants (kobs) were obtained by fitting with It = (I0 - I∞) exp(-kobs t) + I∞, where It, 
I0, and I∞ are the emission intensities at times t, t = 0, and as t→∞.  Catalytic efficiencies 
(kcat/KM) were obtained from the slope of a linear least squares fit with kobs = 
(kcat/KM)[GEF] + kintr, where kintr is the intrinsic dissociation rate constant. 
 
SEC-SAXS 
 SEC-SAXS was performed at Bio-CAT, Sector 18-ID at Advanced Photon 
Source (APS) in Argonne National Labs, Argonne, IL.  100 – 500 µl (10-20 mg/ml) or 
100µl (10 mg/ml) samples were loaded onto 24 or 3 ml Superdex-200 columns, 
respectively (GE Healthcare) equilibrated with buffer (20 mM Tris pH 8.0, 150 mM 
NaCl, 2 mM MgCl2, 0.1% 2-Mercaptoethanol, and 1µM 
inositol(1,3,4,5)tetrakisphosphate (IP4)).  Columns were connected in line with the flow 
cell for SAXS data collection and 1 s exposures were taken at 5 s intervals during elution.  
All samples containing Grp1 either alone or in tandem were incubated with 1.2 molar 
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excess of IP4 for 1-5 hours prior to injection.  The UV absorbance at 280nm was 
monitored during chromatography and showed consistent and clear separation of 
monomeric protein on both columns. 
 
Data Processing 
 A detailed description of data processing including method development is given 
in Chapter III.  Briefly, data images were radially averaged over the q range .00825-.413 
or .00621-.333 Å-1.  Total scattering plots were generated by summing the intensities over 
the entire q range of each data set and plotting against the frame number.  Reduced data 
from contiguous or non-contiguous regions representing buffer alone or a combination of 
protein and buffer were analyzed by singular value decomposition and the protein 
scattering reconstructed by linear combination of the two most signification basis 
components with coefficients optimized by linearity of the Guinier region.  Non-uniform 
errors were estimated by Savitzky-Golay smoothing using a 3rd order polynomial with a 
window size of 11 points [222].  A constant was subtracted from the data to obtain a 
Porod Volume with theoretical molecular weight within 10% of the corresponding 
solvent-free protein.  Kratky, Porod, and Guinier plots and fits were calculated within the 
in-house Mac OSX application DELA.  In test cases using autoinhibited Grp1 as well as 
isolated PH and Arf6 constructs, corrected data produced scattering, Guinier Rg, Porod 
Volume, molecular weight, and Dmax values nearly identical to theoretical values 
calculated from the crystal structure using CRYSOL. 
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Dummy Atom Modeling 
 Programs in the ATSAS packages were used for data modeling [213].  CRYSOL 
with constant subtraction was used to calculate theoretical scattering curves from crystal 
structures.  PRIMUS [219] and maximum entropy method fitting in DELA were used for 
P(r) distribution calculation.  Distributions were calculated using all of the data points, 
and Dmax values were adjusted in Primus until distance frequencies naturally descended to 
0.  GNOM output files containing the P(r) distributions were used as input for DAMMIF 
and GASBOR [215, 216].  One hundred cycles of DAMMIF were performed.  Averaging 
through the DAMAVER suite was performed in groups of ten, and these envelopes 
averaged and filtered.  Average NSD values reported are the final values between the 
groups of ten.  Within each group of ten structures, values ranged from 0.4 - 0.6 for 
autoinhibited Grp1 constructs, and 1.0-1.5 for Grp1-Arf6 tandems. 
 
Ensemble Optimization Method and Rigid Body Modeling 
 The EOM suite integration of the programs RANCH and GAJOE were used to 
generate 10,000 structures based on crystallographic subunits and refine a best-fit 
ensemble.  Representative individual structures had a large range of chi-values and were 
refined to SAXS data for the both full length and relevant truncated constructs using the 
program CORAL [242].  For both EOM and CORAL, the Grp1 PH domain and the Arf6 
module were fixed, with residues representing the linker regions between subunits and 
N/C-terminal histidine tags.  Final solutions in which the Grp1-Arf6 interaction was not 
maintained were rejected. 
153
CHAPTER V: DISCUSSION AND FUTURE DIRECTIONS 
 
A Unified Mechanism for Relief of Autoinhibition 
The work presented in this thesis clearly defines the molecular mechanisms of 
autoinhibition relief in Cytohesin GEFs by Arf GTPases.  Importantly, this mechanism is 
compatible with autoinhibition relief through phosphorylation of Cytohesins by Protein 
Kinase C (PKC) [133, 148] and helps explain Grp1 mutants outside the Sec7 or 
phosphoinositide binding pocket of the PH domain that ablate Arf6-dependent cell 
spreading [243].  Arf-GTP binding may be a more stable form of Grp1 stimulation than 
phosphorylation by sequestering the polybasic region and orienting it for membrane 
insertion, whereas phosphorylation simply disfavors the autoinhibited state. 
Additionally, the requirement of phosphoinositide binding for efficient Arf-GTP 
recognition and participation of the unique hairpin insertion known to insert into 
membranes point to environmental regulation of activity and evolution of cytohesins for 
nucleotide exchange at membrane environments.  As 2G Cytohesin splice variants show 
30-fold selectivity for PIP3 over 3G isoforms, the temporal or tissue-specific expression 
levels of each isoform may play a role in regulating activity.  Similarly, ARNO and 
CYTH1 are predominantly expressed in the 3G forms, but undergo PKC 
phosphorylation, raising the possibility that phosphorylation is a compensatory or 
specialized mechanism for stimulation in these isoforms.  As a whole, current evidence 
has defined general mechanisms for cytohesin activity related to common Sec7 domain 
function and membrane recruitment via PH domain binding to phosphoinositides, with 
specific regulation related to PIP3 and or Arf-GTP levels, PKC expression, and splice 
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variation.  A current focus of ongoing research in GTPase biology will be to analyze 
mechanisms of cytohesin autoinhibition relief in the context of the known dimeric 
species, as well as analyze stimulation by other GTPases.  These insights could lead to 
more informed studies in the development of small molecule cell biological tools or 
therapeutics [128, 135, 244, 245], or used to study other autoregulated GEFs. 
 
Exploring Autoinhibition Relief with Cytohesin Dimers 
 The heptad repeat (HR) region in Cytohesins interacts with scaffolding proteins 
such as CASP and GRASP as well as the associated protein Grsp1 [130-132].  In addition 
to heterodimers with these proteins, the Cytohesin family members ARNO and Grp1 
participate in HR-HR homodimers at physiologically relevant concentrations.  Moreover, 
recent evidence of a HR-PH domain autoinhibited dimer in ARNO centering around an 
Akt phosphorylation site at Thr 276 also implicates a physiologically relevant homodimer 
[134]. 
The role of these dimers in autoregulatory mechanisms is not completely known.  
Autoinhibition and recruitment to membrane environments is unaffected by homo or 
heterodimerization in vitro [130, 133], but it is unknown whether there is an effect of 
dimers in vivo or in the context of Arf6-binding.  Although the crystallographic dimer 
would preclude relief of autoinhibition by Arf6 and is not thought to occur at 
physiological concentrations, both former HR-HR and HR-PH dimers could be 
compatible with Arf6 binding.  The HR-PH domain dimer recently isolated in cells is 
thought to have an added inhibitory role on catalytic activity [134]. 
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The structural organization of these species is unknown, Heterodimers with the 
coiled-coil domain of Grsp1 are believed to be antiparallel [130], but homodimers are 
structurally uncharacterized.  The experiments described in this work led to the 
hypothesis that coiled-coil homodimers could have stable structural organization of the 
Sec7 domain, going from a membrane distal to a membrane proximal location upon 
stimulation.  To structurally characterize HR-dependent Cytohesin dimers, initial SEC-
SAXS was performed on dimeric forms of Grp1 and Arno in autoinhibited (Grp113-399, 
Arno2-400) and active (Grp113-390) forms [133].  All constructs produced a single SEC UV 
absorbance and scattering peaks that could be analyzed by SVD-LC correction followed 
by Guinier and P(r) analysis (Figure V.1 and V.2).  Data were compared to monomer and 
dimer data from experiments with autoinhibited Grp163-399 (Figure III.9).  As might be 
expected by molecular weight rankings, Grp113-399 and Arno2-400 had similar Rg values 
(53.8 and 52.6 Å) higher than Grp113-390 (48.6 Å) and the Grp163-399 (40.0 Å) high 
concentration dimer.  Grp113-399 and Grp113-390 produced broad P(r) distributions pointing 
to a consistently elongated structure without large deviation despite the large increases in 
activity in this construct [133]. (Figure V.2C).  Shape envelopes calculated for Grp113-399 
and Arno2-400 confirmed the appearance of elongated, planar average structures with at 
least partial symmetry. 
Overall, these data show that dimeric Cytohesins form elongated architectures, 
perhaps with flexibility or unique folds within the dimer interface.  These species are 
incompatible with more compact structures seen in crystallographic studies (Figure III.9), 
and point to either a parallel or anti-parallel coiled coil.  More studies are needed to 
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Figure V.1: SAXS Total Intensity Chromatograms for Dimeric Grp1 Constructs.  Total 
Intensity Chromatograms for Grp113-399 (A), Grp113-390 (B), Grp163-399 (C), and ARNO2-
400 (D) 
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Figure V.2: Analysis of Grp1 Dimers by SEC-SAXS.  A) UV Chromatograms from SEC-
SAXS on constructs as indicated.  B) Guinier analysis.  C) P(r) Distributions of Grp113-399 
and Arno2-400. D) DAMMIF shape envelopes of Grp113-399 and Arno2-400. 
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assess flexibility in these molecules and to assign the coiled coil architecture.  Modeling 
analysis with hypothetical parallel or antiparallel coiled-coil models in an autoinhibited 
or active Grp1 molecule may help decipher this overall architecture.  EOM analysis and 
biochemical analysis offers an interesting way to propose and test the feasibility of these 
models.  Alternatively, crystallographic studies of the full length or HR regions of 
cytohesins may also aid in this project.  
While homo- and heterodimers maintain monomeric levels of phosphoinositide 
binding and catalytic activity a potential role of these dimers in autoinhibition relief has 
yet to be probed.  It is unknown whether Arf6 can relieve autoinhibition of these species, 
although given integration of relief of autoinhibition with membrane recruitment, the 
ability of Arf6 to recruit ARNO to the PM suggests that it does indeed function similarly 
in these cases.  As the predicted coiled coil extends completely to the Sec7 domain, 
dimerization may stabilize the Sec7 domain after Arf6 binding (Figure V.3).  Under full 
membrane association conditions, relief of autoinhibition by Arf6 would provide a 
rotation of the PH domain and stabilization of the Sec7 domain, rather than a large 
fluctuation of the Sec7 domain. 
 
Mechanisms of Membrane Recruitment for Cytohesin Recruitment by Arf6 
Arf6 can recruit Cytohesins to the plasma membrane upon PIP3 upregulation by 
binding to the allosteric site [31, 75].  Although molecular determinants in membrane 
recruitment of Arfs and Cytohesins alone has been extensively studied [60, 61, 111, 124, 
234, 246], additional factors in stabilization of the physiological complex of Cytohesins 
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Figure V.3: Model for Autoinhibition Relief in Dimeric Cytohesins.  A) Probability of 
coiled coil formation in Cytohesins using the prediction program COILS with a window 
size of 28.  B) Model depicting stabilization of membrane proximal nucleotide exchange 
by Arf stimulated Cytohesins by substrate binding or HR region dimerization.  Model 
was similar to Figure IV.9, but with manual manipulation of Sec7 domain.  Arf6-GDP 
(PDB 1E0S) was docked into the Sec7 binding site via superposition with the structure of 
the ARNO Sec7 in complex with Arf1-GDP (PDB ID 1R8S) and the C-terminus oriented 
for membrane insertion in PyMol. 
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with active and substrate Arf at membranes have not been investigated.  SAXS 
experiments presented in Chapter IV suggest that allosteric site binding also promotes a 
membrane proximal position of the Sec7 domain upon Arf6 binding.  It remains to be 
seen what role rearrangement of the Sec7 domain and/or substrate binding plays in the 
overall mechanism integrating membrane targeting with autoregulation.  Arf-GDP 
binding may help stabilize a membrane-proximal conformation, providing a concerted 
mechanism to create stable microenvironments of specialized GEF activity.  Stabilization 
of Arf-GDP association through association of the Sec7-PH domain linker has been 
shown in the GEF BRAG2 [87].  In addition, Arf6-bound conformations of the Sec7 
domain may itself contribute to membrane association through direct membrane 
insertion, such as a lysine patch at α1 and α2. 
Mutational analyses of dimeric and monomeric Grp1 using liposome partitioning 
assays in the presence of myristoylated Arf6-GTP may provide insight into determinants 
in the Sec7 domain involved in membrane recruitment.  Additionally, biochemical and 
SAXS experiments using Grp1-Arf6 tandems carrying the Grp1 E161K substitution and 
in the presence of Arf-GDP may help determine the stabilization of the Sec7 domain by 
substrate binding cooperatively or independently of the membrane environment.  These 
and other biochemical and structural studies with dimeric and substrate-bound cytohesins 
will define the sequential and concerted mechanisms of relief of autoinhibition and 
membrane recruitment by GTP-bound Arfs and Arls. 
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Relief of Autoinhibition by Arl4 
 The Grp1-Arf6 crystal structure showed a large binding epitope on Arf6 that is 
conserved amongst broader Arf/Arl family members.  Indeed, Arf1-GTP has been shown 
to relieve autoinhibition in the context of full length, myristoylated Arfs and liposome 
systems, albeit at reduced levels [151, 234].  Despite this, stimulation in the absence of 
membranes was severely reduced with class I and class II Arfs, and could not be rescued 
even with complete substitution of the Arf1 switch region with that of Arf6.  This 
selectivity was 8-10 fold in experiments using soluble Arf effectors, but was almost 1000 
fold for membrane associating Arf1 and Arf6 (Chapter II).  One explanation for this 
selectivity is a simple electrostatic barrier to binding.  Arf6 has a pI of 8.9, whereas other 
Arfs are significantly more acidic.  Indeed, neutralization of electropositive charges in 
Grp1 by phosphoinositide binding may facilitate binding to only basic Arf molecules.  By 
extension, this binding modality may represent a common mechanism of autoinhibition 
relief by Arfs. 
 One Arf protein hypothesized to act similarly to Arf6 is Arl4d, which has also 
been shown to bind to the Cytohesin PH domain and recruit ARNO to the PM in a PIP3 
dependent manner [32, 75].  Recruitment stimulated Arf6-GDP activation at the PM, but 
this effect has not been separated from recruitment to the excluded volume of membrane 
environments.  Arl4d is 40% identical to Arf6, considerably less than other class I and II 
Arfs, but has very high pI of 10.0, in part due to the presence of a C-terminal polybasic 
region important for recruitment.  Arl4 may also have more robust membrane insertion 
due to a four-residue insertion in the ISW region compared to other Arfs [24].  This 
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would promote association of the N-terminus by disfavoring a buried conformation of the 
amphipathic helix.  Crystal structures have shown similar overall GTP-bound structures 
in Arfs and Arls [71, 247, 248], and the Grp1 PH-Arf6 crystal structure is compatible 
with recruitment of Cytohesins to the PM via a C-terminal extension, which is also 
oriented toward a membrane binding surface of the complex. 
Because of the highly basic nature of this protein and poor expression of soluble 
material, initial experiments have proven difficult; however, we have shown relief of 
autoinhibition in solution experiments using full length Arl4d and soluble substrate 
reporter with liposome environments containing PIP3 (Figure V.4).  More experiments 
using truncation of the N and/or C-termini as well as Grp1 mutants in the presence or 
absence of membrane components are expected to elucidate whether the mechanism of 
action is similar to Arf6. Additionally, as the requirement for phosphoinositide in this 
interaction is not clear [32, 75], in vitro experiments as designed in Chapter II with 
liposome compositions will help distinguish allosteric binding effects from membrane 
recruitment. 
 
Mechanisms for Autoinhibition Relief in the Pathogenic GEF RalF 
Many pathogenic bacteria secrete a myriad of effector proteins which help it 
avoid host defenses and hijack cellular machinery [7].  As such, understanding these 
pathways may help treat infections and offer important insight into general mechanisms 
for membrane trafficking [7].  One particular example of this is the Arf GEF RalF from 
Legionella pneumophila and Rickettsia rickettsii.  Arf-GDP binding to a Sec7 domain is 
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Figure V.4: Stimulation of Grp1 Activity by Arl4d-GppNHp.  A) Schematic of kinetic 
experiments measuring mant-GDP dissociation from NΔ17Arf1 with Grp1 in the 
presence of PIP3 containing liposomes and Arl4d-GppNHp.  B) Representative 
dissociation of mant-GDP from 1 µM NΔ17Arf1 with 125 nM Grp163-399 in the absence 
or presence of 6.25 µM Arl4d-GppNHp and .5 mM 97% POPC: 3% PIP3 liposomes C) 
Dependence of nucleotide release on concentration of Arl4d. 
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blocked by a C-terminal capping domain that binds phosphoinositides [26].  Membrane 
environments have been shown to dramatically increase nucleotide exchange, but as 
activity assays have all included full length myristoylated substrates, autoinhibition per se 
has never definitively been measured in vitro.  Because the potential phosphoinositide 
binding site based on homology modeling is far away from the substrate binding site, it is 
unclear how or if phosphoinositide binding may relieve autoinhibition.  Additionally, 
while Legionella RalF shows a binding preference for PI4P, it is unknown whether other 
phosphoinositides can contribute to this mechanism, and phosphoinositide binding for 
Rickettsia RalF may be promiscuous among negatively charged lipids.  Key residue 
differences in an ‘aromatic cluster’ have been shown to underlie these differences [249]. 
 In an effort to clarify these relationships, preliminary liposome sedimentation 
profiling was performed with either Rickettsia rickettsii or Legionella pneumophila 
protein incorporating WT amino acid sequences or reciprocal mutations to convert 
aromatic cluster regions (Figure V.5).  Rickettsia normally has lysines at these positions 
(3K), while Legionella has Phe, Gln, and Asn (FQN) at these sites.  Wild type FQN 
Legionella RalF showed slight preference for PI4P, but significant association with other 
phosphoinositides at higher concentrations.  In contrast, the wild type 3K Rickettsia RalF 
partitioned most strongly with PIP2 and PIP3, but also had notable cosedimentation with 
PI4P.  All 3K variants had increased association with phosphoinositide-containing 
liposomes, but importantly did not override the PI4P preference at low concentrations.   
These assays clearly define PI4P preference in Legionella RalF and a lipid charge sensing 
mechanism for Rickettsia RalF in a liposome environment, consistent with previous data 
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Figure V.5: Liposome Partitioning and Catalytic Activity of RalF.  A) Sedimentation 
assays with varying concentrations of liposomes containing 97% POPC and 3% PI4P, 
PIP2, or PIP3 and Legionella or Rickettsia RalF with the indicated aromatic cluster 
residues.  B) Dependence of kinetic rate of mant-GDP release from NΔ17Arf1 on the 
concentration of Rickettsia RalF Sec7 or Sec7-Cap constructs in the absence of presence 
of either .5 mM PIP3-containing liposomes or 10 µM IP4 and 80 µM NΔ17Arf1(Q71L).  
C) Catalytic efficiencies from the experiments in B. 
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using lipid overlay assays [249].  Addtional biochemical and structural assays will further 
define these mechanistic differences at the molecular level. 
 Preliminary assays were also performed to test autoinhibition relief mechanisms 
in RalF.  To separate mechanisms of membrane recruitment from allosteric activation, 
soluble Arf1ΔN17 was used as substrate for Legionella RalF (Figure V.5B and C).  
Experiments using the Sec7 and Capping domain (Sec7-Cap) showed very low activity 
that was almost undetectable at moderate concentrations.  Conversely, deletion of the 
capping domain showed almost 1000 fold increases in activity.  Liposomes containing 
PIP3 at saturating levels based on the sedimentation assays (0.5 mM liposomes with up to 
1 µM protein) did not increase activity, pointing to an external factor required for full 
relief of autoinhibition.  Interesting candidates include Arfs, which are substrates for RalF 
or Rab1, which is a common target of many Legionella effectors.  In support of this, the 
head group for PIP3, IP4 in combination with truncated Arf1Q71L, which can not 
associate with membranes, did have a modest improvement in catalytic efficiency (Figure 
V.5C).  More biochemical studies screening effector GTPases in soluble and membrane-
bound forms and structural studies of the effector with RalF will shed light into the 
molecular mechanisms of autoinhibition relieve in this system. 
Overall, the unique PI4P preference in Legionella RalF and another effector DrrA 
[250] as well as robust autoinhibition greater than that seen in any mammalian GEF 
system highlight mechanisms that work together to efficiently hijack the ER machinery 
rich in PI4P.  Rickettsia RalF, while having similar autoregulatory properties, has evolved 
a charge sensing C-terminal domain for perhaps more general or widespread membrane 
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recruitment and autoregulation.  It will be exciting to learn potential mechanisms of relief 
of RalF autoinhibition, potentially incorporating host GTPases like Arf1 that are 
upregulated at ER-like membranes necessary for the Legionella life cycle. 
 
Overall Implications and Concluding Remarks 
As mentioned, autoregulation of GEFs is a common theme in GTPase biology, 
seen in GEFs for a variety of Ras superfamily GTPases [87, 133, 137, 139, 233].  These 
GEFs are emerging as key players or therapeutic targets for such diseases as colorectal 
cancer, diabetes, or bacterial infection [47, 244, 245, 251, 252].  Modes of autoinhibition 
relief include phosphorylation by serine/threonine or tyrosine kinases, lipid binding, and 
effector binding.  While phosphorylation recognition is very specific, phosphoinositide 
and effector binding may offer a more fine tuned gradient of activity, controlled as much 
by local environment as specificity of a particular interaction.  Additionally the 
integration of membrane recruitment with mechanisms for relief of autoinhibition 
represents a unique form of regulation beyond simple coincidence detection seen in 
cellular trafficking.  A full understanding of the intricate regulation of these proteins will 
lead to more targeted therapies and a better understanding of the complex processes 
involved in cellular transport. 
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Materials and Methods 
 Cloning and Protein Purification 
 DNA constructs were amplified using PCR with Vent polymerase (NEB), 
digested with BamH1, and SalI/XhoI and ligated into a modified pET15b vector. Mutants 
were generated using whole plasmid PCR with QuikSolution (Stratagene) and DpnI 
(NEB) digestion.  After transformation of BL21(DE3) cells (Novagen) with plasmids, 
cells were grown in 2×YT with 100 mg/L ampicillin to an OD600 of 0.2-0.6 or 1.0-1.2 and 
expression induced with 50 µM or 1mM IPTG at 18°C for 16hrs or  37°C for 3 hrs.  After 
harvest, cells were resuspended in buffer (50mM Tris pH 8.5 or 8.8, 150mM NaCl, 2mM 
MgCl2, 0.05% 2-mercaptoethanol) and frozen at -80°C.  Cells were thawed and incubated 
with 0.1 mM PMSF, 0.2 mg/ml lysozyme, and 0.01 mg/ml protease free DNAse I 
(Worthington).  After sonication, lysates were supplemented with 0.5% Triton X-100 and 
centrifuged at 30,000 × g for 1 hr.  Proteins were purified on batch Ni-NTA beads 
followed by ion exchange on HiTrap Q or SP and gel filtration on Superdex-75 or 200 
(GE Healthcare). 
 RalF constructs consisting of C-terminal Capping Domain and in the pMal5c 
vector were a gift from the lab of Dr. Craig Roy.  BL21(DE3) cells were transformed and 
induced as above.  Cells were lysed in buffer (20 mM Hepes pH 7.4, 300 mM NaCl, 1 
mM MgCl2, 0.05% 2-mercaptoethanol) and purified on maltose binding protein, Q or SP, 
and gel filtration on Superdex-200 (GE Healthcare).  Capping domain constructs purified 
as soluble aggregates and full length proteins as monomeric species, as measured by 
analytical gel filtration. 
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 SEC-SAXS 
 SEC-SAXS was performed at Bio-CAT, Sector 18-ID at Advanced Photon 
Source (APS) in Argonne National Labs, Argonne, IL.  100 – 500 ul (10-20 mg/ml) or 
100ul (10 mg/ml) samples were loaded onto 24 or 3 ml Superdex-200 columns size 
exclusion columns, respectively (GE Healthcare).  Columns were connected in line with 
the beam and 1 s exposures were taken at 5 s intervals during elution.  Data was 
monitored by UV chromatogram and showed consistent and clear separation of 
monomeric protein on both columns.  Samples were calculated to be between 1-3 mg/ml 
at the peak of the protein elution profile. 
 
Data Processing 
 A detailed description of data processing including method development will be 
given in Appendix A.  Briefly, data images were radially averaged over the q range 
.00825-.413 or .00621-.333.  Data normalization, and buffer correction by singular value 
decomposition and linear combination, and constant background subtraction were 
performed as described ([218] and Chapter III) 
 
Dummy Atom Modeling 
 Programs in the ATSAS packages were used for data modeling [213].  Crysol was 
used to calculate theoretical scattering curves from crystal structures.  PRIMUS [219] and 
maximum entropy method fitting were used for P(r) distribution calculation, and the 
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GNOM result used as input for DAMMIF and GASBOR [215, 216].  One hundred cycles 
of DAMMIF were performed.  Averaging through the DAMAVER suite was performed 
in groups of ten, and these envelopes averaged and filtered. 
 
Liposome Preparation 
 Liposomes containing 67-70% palmitoyloleolylphosphatidylcholine (Avanti), 
30% palmitoyloleolylphosphatidylserine (Avanti), and 3% PI4P, PIP2, or PIP3 (Cell 
Signals) were prepared as follows.  Lipids dissolved in 2:1 chloroform:methanol were 
mixed and dried under an argon stream.  For GEF assays, lipid mixtures were rehydrated 
in 20 mM Tris HCl, pH 8.0, 150 mM NaCl, and 2 mM MgCl2.  Large Unilamelar 
Vesicles (LUVs) were prepared by extrusion through 0.1 µm filters (Avanti) after 10 
freeze-thaw cycles in liquid nitrogen.   For GEF Assays, the liposomes were resuspended 
in GEF Assay Buffer (see below).   For liposome partitioning, lipid mixtures were 
rehydrated in 20 mM Hepes, pH 7.5, and 170 mM sucroseFollowing 10 freeze-thaw 
cycles and extrusion as above, the liposomes were diluted 4:1 with 20 mM Hepes, pH 
7.5, and 100 mM KCl, pelleted by ultracentrifugation at 100,000×g for 30 minutes, and 
resuspended at a total lipid concentration of 5 mM. 
 
Liposome Partitioning Assays 
 3 µM RalF was incubated with 0, .25, .5, or 1 mM sucrose loaded liposomes in 
100 reactions in buffer (20 mM Hepes, pH 7.5, and 100 mM KCl) and incubated for 30 
minutes.  Reactions were centrifuged at 100,000 x g and supernatants and pellets 
171
analyzed by SDS-PAGE followed by Coomassie Blue staining and densitometry 
quantification in ImageJ. 
 
Nucleotide Loading 
Arl4d was incubated overnight at 4°C in 20 mM Tris, pH 8.0, 150 mM NaCl, 5 
mM EDTA, and 1 mM DTT with a 10 fold molar excess of GppNHp.  MgCl2 was added 
to a final concentration of 10 mM and excess nucleotide removed by gel filtration on 
Superdex-75 (GE Healthcare) or D-Salt column (Pierce ThermoFisher). 
 
GEF Assays 
 The fluorescence decrease upon mantGDP dissociation from Arf1NΔ17 was 
monitored in 20 mM Tris, pH 8.0, 150 mM NaCl, 2 mM MgCl2 and 250 µM or 1 mM 
GppNHp.  Grp1 or Ricketsia RalF with or without active Arf/Arl GTPases and/or head 
groups/liposomes was formatted into 96 well half area microplates (Corning) and 
incubated for 16-24 hrs at 25°C.  Reactions were initiated by addition of 1 µM 
Arf1NΔ17-mantGDP and monitored using a Safire microplate spectrophotometer (Tecan) 
with excitation and emission wavelengths of 360 nm and 440 nm, respectively.  Observed 
rates constants (kobs) were obtained by fitting with It = (I0 - I∞) exp(-kobs t) + I∞, where It, 
I0, and I∞ are the emission intensities at times t, t = 0, and as t→∞.  Catalytic efficiencies 
(kcat/KM) were obtained from the slope of a linear least squares fit with kobs = 
(kcat/KM)[GEF] + kintr, where kintr is the intrinsic dissociation rate constant. 
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